{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "import os\n",
    "import numpy as np\n",
    "import nltk\n",
    "from keras.models import Sequential\n",
    "from keras.layers import Dense\n",
    "from keras.layers import Dropout\n",
    "from keras.layers import LSTM\n",
    "from keras.callbacks import ModelCheckpoint\n",
    "from keras.utils import np_utils\n",
    "from gensim.models.word2vec import Word2Vec"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "raw_text = ''\n",
    "for file in os.listdir(\"./test/\"):\n",
    "    if file.endswith(\".txt\"):\n",
    "        raw_text += open(\"./test/\"+file, errors='ignore').read() + '\\n\\n'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = raw_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "nlp = spacy.load('en_core_web_sm')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "ner = nlp.create_pipe(\"ner\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc = nlp(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "OBJECTIVE: To evaluate the therapeutic effects of entecavir (ETV) and interferon-伪 (IFN-伪) treatments for 48 weeks for chronic hepatitis B (CHB) in patients with different baseline alanine aminotransferase (ALT) levels.METHODS: We retrospectively analyzed the data of 369 CHB patients receiving ETV and IFN-伪 treatments for 48 weeks. We compared the virological response rates, HBsAg clearance, and HBsAg reduction between the patients receiving ETV and IFN-伪 treatments with different baseline ALT levels[鈮 5脳upper limits of normal (ULN) level (subgroup 1), 5-10脳ULN (subgroup 2), and &gt; 10脳 ULN (subgroup 3)].RESULTS: In patients receiving ETV treatment, the virological response rate was 83.3% in subgroup 1, 91.4% in subgroup 2, and 95.5% in subgroup 3, as compared with 19.7%, 40%, and 42.9% in the 3 subgroups with IFN-伪 treatment, respectively, showing significantly differences both among different subgroups with the same treatment and between the same subgroup with different treatments (P &lt; 0.05). HBeAg clearance rates in the 3 subgroups were 8.3%, 16.7% and 35.5% in patients with ETV treatment and were 1.8%, 41.9%, and 38.1% in patients with IFN-伪 treatment, respectively, showing significant differences among the 3 subgroups with the same treatment (P &lt; 0.05); in the same subgroups with different treatments, the rates differed significantly only between subgroups 2 (P &lt; 0.05). In ETV group, the rate of HBsAg reduction to below 200 IU/ml was 2.5% in subgroup 1 and 13.8% in subgroup 2, showing no significant difference between the two subgroups; in IFN-伪 group, the rates were also similar between subgroups 1 and 2 (30.6% vs 33.3%, P &gt; 0.05); but the rates differed significantly between the same subgroups with different treatments (P &lt; 0.05).CONCLUSIONS: In all the subgroups with different baseline ALT levels, ETV treatment for 48 weeks results in significantly higher virological response rates than IFN-伪 treatment in patients with CHB. In patients with a baseline ALT of 5-10 脳ULN, IFN-伪 can result in a higher HBeAg clearance rate than ETV. In patients with comparable baseline ALT level, IFN-伪 more effectively reduces HBsAg level than ETV. The patients with a relatively high baseline ALT level (&gt; 5 脳 ULN) show better responses to both ETV and IFN-伪 treatment than those with ALT level below 5脳ULN. We thus recommend IFN-伪 for patients with a baseline ALT of 5-10脳ULN and ETV for patients with a baseline ALT either below 5 脳 ULN or beyond 10脳ULN.\n",
       "\n",
       "锘縊bjective To explore the clinical and laboratory characteristics and the prognosis of disseminated non-tuberculous mycobacteria(NTM)diseases in human immunodeficiency virus(HIV)negative patients. Methods Cases of disseminated NTM disease were retrospectively collected in Peking Union Medical College Hospital from January 2012 to October 2018.Clinical manifestations, laboratory findings, treatment, and prognosis of these cases were retrieved from the electronic medical record system. Results Among the 23 HIV negative patients with disseminated NTM disease,21 had underlying diseases, with rheumatoid immune disease(n=7)as the most common one. The main clinical manifestation was fever(n=23).Laboratory tests showed anemia [hemoglobin(85.78卤25.47)g/L],hypoalbuminemia [albumin 29(27-32)g/L],elevated erythrocyte sedimentation rate [(85.73卤43.78)mm/h] and hypersensitive C-reactive protein [(112.00卤70.90)mg/L], and reduction of lymphocyte count [0.69(0.29-2.10)脳10 9/L].Lymphocyte subset analysis indicated reduction in CD4 + T cells [213(113-775)/渭l],CD8 + T cells [267(99-457)/渭l],B cells [39(4-165)/渭l],and NK cells [88(32-279)/渭l] and elevation of human leukocyte antigen-D related(HLA-DR),and CD38 expression in CD8 + T cells [HLA-DR +CD8 +/CD8 +,60(40-68)%;CD38 +CD8 +/CD8 +,81(65-90)%].The most common species of NTM was Mycobacterium intracellular(n=6).Lymphocyte,CD8 + T cell, B cell, and NK cell counts were significantly lower in dead patients than surviving patients(P =0.045,P=0.045,P=0.032,and P=0.010,respectively). Conclusions Disseminated NTM disease in HIV negative patients is mainly manifested as fever, anemia, hypoalbuminemia, and elevated inflammatory indicators. It is more likely to occur in immunocompromised patients. Patients with decreased lymphocytes,CD8 + T cells, B cells and NK cells tend to have a poor prognosis.\n",
       "\n",
       "in\n",
       "\t\t\t\tEnglish, Chinese鐩鐨 閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉 鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵╁瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd-pshuttle-cmv-hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋 鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁 閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂┒鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE: This study aims to establish an effective and stable periodontal ligament cell line stably expressing human telomerase reverse transcriptase (hTERT) gene by using the adenovirus method.METHODS: Polymerase chain reaction (PCR) was used to amplify the full length of hTERT gene to construct recombinant adenovirus plasmid pAd-pshuttle-cmv-hTERT. Packaged adenovirus particles were used for infection of human periodontal ligament cells. The expression levels of hTERT and osteogenic genes, such as alkaline phosphatase, Runt-related transcription factor 2, bone sialoprotein, osteocalcin, osteopontin, and collagen 鈪 mRNA, were detected by quantitative real-time PCR (qRT-PCR). The ability of osteogenic differentiation was observed by alizarin red staining, and the cell proliferation was determined by CCK-8.RESULTS: Adenovirus particles containing the hTERT gene were successfully constructed and infected with periodontal ligament cells. The infected cells were similar to normal periodontal ligament cells. The qRT-PCR results showed that hTERT and osteogenesis-associated genes were highly expressed in the periodontal ligament cell lines constructed by adenoviruses. Alizarin red staining showed that the periodontal ligament cell line had strong osteogenic differentiation capability. CCK-8 showed that the periodontal ligament cell line had strong proliferation capability.CONCLUSIONS: The human periodontal ligament cell line with high efficiency and stable expression of hTERT was established by the adenovirus method, thereby providing an ideal cell line for studying the mechanism of periodontal regeneration.\n",
       "\n",
       "in\n",
       "\t\t\t\tEnglish, FrenchCryoglobulin茅mies. La cryoglobulin茅mie est d茅finie par la pr茅sence d鈥檜ne cryoglobuline circulante, immunoglobuline pr茅cipitant au froid. Le typage de cette cryoglobuline est fondamental. En effet, on distingue deux sous-groupes : les cryoglobulines de type I et les cryoglobulines mixtes. La physiopathologie et les traitements sont diff茅rents dans ces deux entit茅s. Les cryoglobulin茅mies de type I sont li茅es 脿 une h茅mopathie lympho茂de B monoclonale sous-jacente, alors que les cryoglobulin茅mies mixtes (types II et III) 茅mergent dans des situations de stimulation antig茅nique assez vari茅es, la plus fr茅quente 茅tant le virus de l鈥檋茅patite C. L鈥檌ntensit茅 des sympt么mes est tr猫s variable, beaucoup de patients sont asymptomatiques. Chez les patients symptomatiques, les organes les plus fr茅quemment touch茅s sont la peau, le syst猫me nerveux p茅riph茅rique et le glom茅rule r茅nal. Quelques rares patients ont des atteintes visc茅rales mettant en jeu le pronostic vital. Le traitement prend toujours en compte l鈥檌ntensit茅 des sympt么mes et la pathologie sous-jacente. Dans les cryoglobulin茅mies de type I, le traitement du clone sous-jacent est primordial. Dans celles de type II, on associe le plus souvent un traitement immunosuppresseur au traitement de la cause, si elle est identifi茅e.Cryoglobulinemia. Cryoglobulinemia is defined by the presence of a circulating cryoglobulin, a cold-precipitating immunoglobulin. The typing of this cryoglobulin is fundamental. Indeed, there are two subgroups: cryoglobulin type I and mixed cryoglobulins. The physiopathology and treatments are different in these two entities. Cryoglobulinemia type 1 is associated with an underlying monoclonal lymphoid B hemopathy, while mixed cryoglobulinemia (types II and III) emerge in quite varied antigenic stimulation situations, the most common being the hepatitis C virus. The intensity of the symptoms is very variable, many patients are asymptomatic. In symptomatic patients, the most frequently affected organs are the skin, the peripheral nervous system and the renal glomerulus. Few patients have visceral involvement that is life-threatening. The treatment always takes into account the intensity of the symptoms and the underlying pathology. In cryoglobulinemia type I, treatment of the underlying clone is essential. In type II, immunosuppressive therapy is most often associated with treatment of the cause, if identified.\n",
       "\n",
       "Objective To measure the effect of duck viperin protein on the proliferation of duck Tembusu virus (DTMUV). Methods We analyzed the duck viperin gene using a bioinformatics. Plasmids pGEX-6P-viperin and pEGFP-N1-viperin were constructed and transformed into Rosseta and transfected into BHK-21 cells, respectively. BHK-21 cells transfected with plasmid pEGFP-N1-viperin and empty vector were infected with DTMUV. The content of DTMUV in cell precipitation and supernatant was analyzed by real-time fluorescent quantitative PCR. Finally, the effect of viperin on DTMUV proliferation and the binding proteins captured by EGFP monoclonal antibody were evaluated using mass spectrometry. Results Significant differences were observed between the expression levels of viperin gene in duck compared to other species. Duck viperin was found to inhibit the budding of DTMUV in BHK-21 cells. Further, we identified six proteins that might be involved in the inhibition of the proliferation and budding of DTMUV, possibly indicative of the viperin anti-Tembusu virus pathway in ducks. Conclusion Expression patterns of duck viperin reveal how the budding of duck Tembusu virus is inhibited.\n",
       "\n",
       "in\n",
       "\t\t\t\tEnglish, Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem cell leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial cells of Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c-kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24 h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48 h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮┖鐧界粍銆佺┖鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺┖鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48 h锛岄噰鐢╓estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit 铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48 h鍚庯紝绌虹櫧缁勩佺┖鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To determine the effect of a recombinant lentivirus containing human stem cell leukemia (SCL) gene on the expression of c-kit protein in damaged interstitial cells of Cajal (ICC) under high glucose condition.鈥 Methods: After isolation of ICC, the cells were cultured for 24 hours until the cells were adherent. After identification by inverted microscope and immunofluorescence, ICC cells were divided into two groups: A control group and a high glucose group. The control group was added with a medium containing 5 mmol/L of glucose. The high glucose group was added with a medium containing 20 mmol/L of glucose. After 48 h of continuous cultivation, the high glucose group was divided into 3 subgroups: A blank group, an empty lentivirus group, and an experimental group. The blank group, the empty lentivirus group, and the experimental group were added a medium containing PBS solution, empty lentivirus, and a recombinant lentivirus containing the SCL gene with a glucose concentration of 5 mmol/L, respectively. The cultures were incubated for 24 and 48 h. The expression of c-kit protein in ICC in each group was detected by Western blot.鈥 Results: After 24 or 48 h, the expression of c-kit protein in ICC was significantly lower in the blank group and the lentivirus group than that in the control group, and the expression of c-kit protein in ICC was significantly higher in the experimental group than that in the blank group and the empty lentivirus group, but it was still lower than that in the control group (all P<0.05).鈥 Conclusion: The recombinant lentivirus of SCL gene can up-regulate the expression of c-kit protein in functionally impaired ICC under high glucose condition.\n",
       "\n",
       "OBJECTIVE: To study the effects of respiratory syncytial virus (RSV) infection on epidermal growth factor receptor (EGFR), tight junction association proteins and mucin in the human airway epithelial cells.METHODS: Human airway epithelial cells NCI-H292 were randomly treated by ultraviolet light-inactivated RSV (control group) or thawed RSV (RSV infection group). After 48 hours of treatment, the protein levels of occludin, E-cadherin, phosphorylated EGFR and EGFR in NCI-H292 cells were measured by Western blot. The distribution and expression levels of occludin and E-cadherin in NCI-H292 cells were examined by immunofluorescence technique. The expression levels of MUC5AC mRNA in NCI-H292 cells were assessed by RT-PCR.RESULTS: The protein levels of occludin and E-cadherin were significantly reduced in the RSV infection group compared with the control group (P<0.05). The protein levels of phosphorylated EGFR and EGFR increased significantly in the RSV infection group compared with the control group (P<0.05). The MUC5AC mRNA levels also increased significantly in the RSV infection group compared with the control group (P<0.05).CONCLUSIONS: RSV may down-regulate the tight junction association proteins and up-regulate the expression of MUC5AC in airway epithelial cells, which contributes to epithelial barrier dysfunction. EGFR phosphorylation may play an important role in regulation of airway barrier.\n",
       "\n",
       "Objective To establish a human B lymphoma cell line which can stably express Epstein-Barr virus latent membrane protein 1 (LMP1). Methods The LMP1 coding gene with EcoRI and BamHI restriction sites was amplified, cloned into pcDNA3.1-EF1a-mcs-3FLAG-CMV-EGFP plasmid, and positive monoclonal competent cells were picked for PCR and sequencing. The recombinant plasmid was transfected into Ramos cells by electroporation, and the cell line stably expressing LMP1 was picked by G418. The expression of LMP1 in Ramos cells was detected by PCR, Western blot analysis and green fluorescent protein Tag. Results PCR and sequencing confirmed that the LMP1 recombinant plasmid was successfully constructed and a stably transfected Ramos cell line was established. Western blot analysis confirmed that LMP1 protein was successfully expressed in this cell line. Conclusion The Ramos cells stably expressing LMP1 have been successfully established.\n",
       "\n",
       "in\n",
       "\t\t\t\tEnglish, HungarianAbsztrakt: A hepatitis C-v铆rus (HCV) megk枚zel铆t艖leg 4 milli贸 煤j fert艖z茅st okoz 茅vente, 茅s 399聽000 beteg hal meg a fert艖z茅s k枚vetkezt茅ben kialakul贸 sz枚v艖dm茅nyek, cirrhosis 茅s hepatocellularis carcinoma (HCC) miatt. Id眉lt HCV-fert艖z茅sben a mikrok枚rnyezeti v谩ltoz谩sok, a fert艖z茅s kiv谩ltotta id眉lt gyullad谩s, az oxidat铆v stressz 茅s az endoplazm谩s reticulum stressz genetikai, epigenetikai v谩ltoz谩sokon kereszt眉l 茅vtizedek alatt vezethetnek primer m谩jr谩k kialakul谩s谩hoz. A HCV direkt hepatocarcinogen tulajdons谩ga ismert. N茅gy HCV-feh茅rje (core, NS3, NS4B, NS5A) transzform谩ci贸s tulajdons谩ga bizony铆tott. A hat茅kony antivir谩lis kezel茅s, a tart贸s v铆rusv谩lasz el茅r茅se a HCV okozta m谩j-, valamint a nem m谩jeredet疟 hal谩loz谩st cs枚kkenti. Az interferonalap煤 antivir谩lis kezel茅s a HCC el艖fordul谩s谩t cs枚kkenti. A direkt hat贸 antivir谩lis szerek (DAA) el艖nye a nagyobb ar谩ny煤 tart贸s v铆rusv谩lasz, a kevesebb mell茅khat谩s, valamint a r枚videbb ter谩pi谩s id艖tartam. Az elm煤lt n茅h谩ny 茅vben k枚zlem茅nyek jelentek meg, amelyek a DAA-kezel茅sek nem v谩rt hat谩sair贸l sz谩moltak be. A szerz艖k ismertetik a DAA-kezel茅sekben a HCC el艖fordul谩s谩t vizsg谩l贸 tanulm谩nyok eredm茅nyeit. A k茅rd茅s pontos eld枚nt茅s茅re tov谩bbi prospekt铆v, multicentrikus vizsg谩latok, hosszabb k枚vet茅si id艖szakok, a kontrollcsoportok pontos kiv谩laszt谩sa sz眉ks茅ges. A v铆rusellenes kezel茅s befejez茅se ut谩n is kiemelked艖 jelent艖s茅g疟 a HCC-surveillance, amelyet a rendszeres (3鈥6鈥12 havonta v茅gzett) hasi UH-vizsg谩lat jelent, m茅g a sikeresen kezelt betegekn茅l is. Orv Hetil. 2019; 160(22): 846鈥853.Hepatitis C virus infection causes approximately 4 million new infections worldwide, and 399聽000 deaths due to its complications, cirrhosis and hepatocellular carcinoma (HCC). Microenvironmental changes, chronic inflammation, oxidative stress, endoplasmic reticulum stress caused by HCV infection, via genetic and epigenetic changes can result in primary liver cancer during decades. The direct oncogenic property of HCV is wellknown. The transforming effect of four HCV proteins (core, NS3, NS4B, NS5A) has been proven. Effective antiviral therapy, sustained viral response decreases the HCV-related general and liver-related mortality. Interferon-based therapy reduces the risk of HCC development. Shorter therapy with direct acting antiviral agents (DAA) has higher efficacy, fewer side-effects. Publications have reported the unexpected effects of DAA. The authors review the articles focusing on the occurrence of HCC in connection with DAA therapies. There is a need for prospective, multicentric studies with longer follow-up to examine the risk of HCC formation. After antiviral therapy, HCC surveillance is of high importance which means abdominal ultrasound every 3-6-12 months in sustained viral response patients as well. Orv Hetil. 2019; 160(22): 846-853.\n",
       "\n",
       "Although the anti-influenza virus drug oseltamivir ameliorates the fever of influenza, adverse events related to its hypothermic effect have been reported. We found that oseltamivir causes dose-dependent hypothermia in normal mice, and have been studying the pharmacological mechanisms responsible for 12 years. Oseltamivir blocks nicotinic cholinergic transmission at sympathetic ganglia and reduces sympathetic modulation of brown adipose tissue (BAT), a heat generator. Oseltamivir was found to target the ion channels of nicotinic acetylcholine receptors, as demonstrated by patch clamp experiments with cells expressing the human 伪3尾4 nicotinic receptor. Metabolized oseltamivir carboxylate, which inhibits the influenza virus neuraminidase, did not elicit hypothermia and ion channel suppression. Body temperature was decreased by intracerebroventricular administration of oseltamivir. Because this hypothermic effect was inhibited by dopamine D2 receptor blockade, it was suggested that oseltamivir centrally stimulates the D2 receptor. In Japan, the package inserts for oseltamivir and amantadine indicate very similar adverse neuropsychiatric reactions for the two drugs (abnormal behavior, consciousness disturbance, convulsion, delirium, delusion, hallucination). A literature search revealed that in some previous studies, oseltamivir and amantadine were shown to block the ion channel systems and activate the dopaminergic nervous system via several mechanisms. Therefore the similarity of the adverse reactions elicited by oseltamivir and amantadine was considered attributable to their similar pharmacological effects.\n"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE O\n",
      ": O\n",
      "To O\n",
      "evaluate O\n",
      "the O\n",
      "therapeutic O\n",
      "effects O\n",
      "of O\n",
      "entecavir O\n",
      "( O\n",
      "ETV O\n",
      ") O\n",
      "and O\n",
      "interferon-伪 O\n",
      "( O\n",
      "IFN-伪 O\n",
      ") O\n",
      "treatments O\n",
      "for O\n",
      "48 O\n",
      "weeks O\n",
      "for O\n",
      "chronic O\n",
      "hepatitis O\n",
      "B O\n",
      "( O\n",
      "CHB O\n",
      ") O\n",
      "in O\n",
      "patients O\n",
      "with O\n",
      "different O\n",
      "baseline O\n",
      "alanine O\n",
      "aminotransferase O\n",
      "( O\n",
      "ALT O\n",
      ") O\n",
      "levels O\n",
      ". O\n",
      "METHODS O\n",
      ": O\n",
      "We O\n",
      "retrospectively O\n",
      "analyzed O\n",
      "the O\n",
      "data O\n",
      "of O\n",
      "369 O\n",
      "CHB O\n",
      "patients O\n",
      "receiving O\n",
      "ETV O\n",
      "and O\n",
      "IFN-伪 O\n",
      "treatments O\n",
      "for O\n",
      "48 O\n",
      "weeks O\n",
      ". O\n",
      "We O\n",
      "compared O\n",
      "the O\n",
      "virological O\n",
      "response O\n",
      "rates O\n",
      ", O\n",
      "HBsAg O\n",
      "clearance O\n",
      ", O\n",
      "and O\n",
      "HBsAg O\n",
      "reduction O\n",
      "between O\n",
      "the O\n",
      "patients O\n",
      "receiving O\n",
      "ETV O\n",
      "and O\n",
      "IFN-伪 O\n",
      "treatments O\n",
      "with O\n",
      "different O\n",
      "baseline O\n",
      "ALT O\n",
      "levels[鈮 O\n",
      "5脳upper O\n",
      "limits O\n",
      "of O\n",
      "normal O\n",
      "( O\n",
      "ULN O\n",
      ") O\n",
      "level O\n",
      "( O\n",
      "subgroup O\n",
      "1 O\n",
      ") O\n",
      ", O\n",
      "5 O\n",
      "- O\n",
      "10脳ULN O\n",
      "( O\n",
      "subgroup O\n",
      "2 O\n",
      ") O\n",
      ", O\n",
      "and O\n",
      "& O\n",
      "gt O\n",
      "; O\n",
      "10脳 O\n",
      "ULN O\n",
      "( O\n",
      "subgroup O\n",
      "3)].RESULTS O\n",
      ": O\n",
      "In O\n",
      "patients O\n",
      "receiving O\n",
      "ETV O\n",
      "treatment O\n",
      ", O\n",
      "the O\n",
      "virological O\n",
      "response O\n",
      "rate O\n",
      "was O\n",
      "83.3 O\n",
      "% O\n",
      "in O\n",
      "subgroup O\n",
      "1 O\n",
      ", O\n",
      "91.4 O\n",
      "% O\n",
      "in O\n",
      "subgroup O\n",
      "2 O\n",
      ", O\n",
      "and O\n",
      "95.5 O\n",
      "% O\n",
      "in O\n",
      "subgroup O\n",
      "3 O\n",
      ", O\n",
      "as O\n",
      "compared O\n",
      "with O\n",
      "19.7 O\n",
      "% O\n",
      ", O\n",
      "40 O\n",
      "% O\n",
      ", O\n",
      "and O\n",
      "42.9 O\n",
      "% O\n",
      "in O\n",
      "the O\n",
      "3 O\n",
      "subgroups O\n",
      "with O\n",
      "IFN-伪 O\n",
      "treatment O\n",
      ", O\n",
      "respectively O\n",
      ", O\n",
      "showing O\n",
      "significantly O\n",
      "differences O\n",
      "both O\n",
      "among O\n",
      "different O\n",
      "subgroups O\n",
      "with O\n",
      "the O\n",
      "same O\n",
      "treatment O\n",
      "and O\n",
      "between O\n",
      "the O\n",
      "same O\n",
      "subgroup O\n",
      "with O\n",
      "different O\n",
      "treatments O\n",
      "( O\n",
      "P O\n",
      "& O\n",
      "lt O\n",
      "; O\n",
      "0.05 O\n",
      ") O\n",
      ". O\n",
      "HBeAg O\n",
      "clearance O\n",
      "rates O\n",
      "in O\n",
      "the O\n",
      "3 O\n",
      "subgroups O\n",
      "were O\n",
      "8.3 O\n",
      "% O\n",
      ", O\n",
      "16.7 O\n",
      "% O\n",
      "and O\n",
      "35.5 O\n",
      "% O\n",
      "in O\n",
      "patients O\n",
      "with O\n",
      "ETV O\n",
      "treatment O\n",
      "and O\n",
      "were O\n",
      "1.8 O\n",
      "% O\n",
      ", O\n",
      "41.9 O\n",
      "% O\n",
      ", O\n",
      "and O\n",
      "38.1 O\n",
      "% O\n",
      "in O\n",
      "patients O\n",
      "with O\n",
      "IFN-伪 O\n",
      "treatment O\n",
      ", O\n",
      "respectively O\n",
      ", O\n",
      "showing O\n",
      "significant O\n",
      "differences O\n",
      "among O\n",
      "the O\n",
      "3 O\n",
      "subgroups O\n",
      "with O\n",
      "the O\n",
      "same O\n",
      "treatment O\n",
      "( O\n",
      "P O\n",
      "& O\n",
      "lt O\n",
      "; O\n",
      "0.05 O\n",
      ") O\n",
      "; O\n",
      "in O\n",
      "the O\n",
      "same O\n",
      "subgroups O\n",
      "with O\n",
      "different O\n",
      "treatments O\n",
      ", O\n",
      "the O\n",
      "rates O\n",
      "differed O\n",
      "significantly O\n",
      "only O\n",
      "between O\n",
      "subgroups O\n",
      "2 O\n",
      "( O\n",
      "P O\n",
      "& O\n",
      "lt O\n",
      "; O\n",
      "0.05 O\n",
      ") O\n",
      ". O\n",
      "In O\n",
      "ETV O\n",
      "group O\n",
      ", O\n",
      "the O\n",
      "rate O\n",
      "of O\n",
      "HBsAg O\n",
      "reduction O\n",
      "to O\n",
      "below O\n",
      "200 O\n",
      "IU O\n",
      "/ O\n",
      "ml O\n",
      "was O\n",
      "2.5 O\n",
      "% O\n",
      "in O\n",
      "subgroup O\n",
      "1 O\n",
      "and O\n",
      "13.8 O\n",
      "% O\n",
      "in O\n",
      "subgroup O\n",
      "2 O\n",
      ", O\n",
      "showing O\n",
      "no O\n",
      "significant O\n",
      "difference O\n",
      "between O\n",
      "the O\n",
      "two O\n",
      "subgroups O\n",
      "; O\n",
      "in O\n",
      "IFN-伪 O\n",
      "group O\n",
      ", O\n",
      "the O\n",
      "rates O\n",
      "were O\n",
      "also O\n",
      "similar O\n",
      "between O\n",
      "subgroups O\n",
      "1 O\n",
      "and O\n",
      "2 O\n",
      "( O\n",
      "30.6 O\n",
      "% O\n",
      "vs O\n",
      "33.3 O\n",
      "% O\n",
      ", O\n",
      "P O\n",
      "& O\n",
      "gt O\n",
      "; O\n",
      "0.05 O\n",
      ") O\n",
      "; O\n",
      "but O\n",
      "the O\n",
      "rates O\n",
      "differed O\n",
      "significantly O\n",
      "between O\n",
      "the O\n",
      "same O\n",
      "subgroups O\n",
      "with O\n",
      "different O\n",
      "treatments O\n",
      "( O\n",
      "P O\n",
      "& O\n",
      "lt O\n",
      "; O\n",
      "0.05).CONCLUSIONS O\n",
      ": O\n",
      "In O\n",
      "all O\n",
      "the O\n",
      "subgroups O\n",
      "with O\n",
      "different O\n",
      "baseline O\n",
      "ALT O\n",
      "levels O\n",
      ", O\n",
      "ETV O\n",
      "treatment O\n",
      "for O\n",
      "48 O\n",
      "weeks O\n",
      "results O\n",
      "in O\n",
      "significantly O\n",
      "higher O\n",
      "virological O\n",
      "response O\n",
      "rates O\n",
      "than O\n",
      "IFN-伪 O\n",
      "treatment O\n",
      "in O\n",
      "patients O\n",
      "with O\n",
      "CHB O\n",
      ". O\n",
      "In O\n",
      "patients O\n",
      "with O\n",
      "a O\n",
      "baseline O\n",
      "ALT O\n",
      "of O\n",
      "5 O\n",
      "- O\n",
      "10 O\n",
      "脳ULN O\n",
      ", O\n",
      "IFN-伪 O\n",
      "can O\n",
      "result O\n",
      "in O\n",
      "a O\n",
      "higher O\n",
      "HBeAg O\n",
      "clearance O\n",
      "rate O\n",
      "than O\n",
      "ETV O\n",
      ". O\n",
      "In O\n",
      "patients O\n",
      "with O\n",
      "comparable O\n",
      "baseline O\n",
      "ALT O\n",
      "level O\n",
      ", O\n",
      "IFN-伪 O\n",
      "more O\n",
      "effectively O\n",
      "reduces O\n",
      "HBsAg O\n",
      "level O\n",
      "than O\n",
      "ETV O\n",
      ". O\n",
      "The O\n",
      "patients O\n",
      "with O\n",
      "a O\n",
      "relatively O\n",
      "high O\n",
      "baseline O\n",
      "ALT O\n",
      "level O\n",
      "( O\n",
      "& O\n",
      "gt O\n",
      "; O\n",
      "5 O\n",
      "脳 O\n",
      "ULN O\n",
      ") O\n",
      "show O\n",
      "better O\n",
      "responses O\n",
      "to O\n",
      "both O\n",
      "ETV O\n",
      "and O\n",
      "IFN-伪 O\n",
      "treatment O\n",
      "than O\n",
      "those O\n",
      "with O\n",
      "ALT O\n",
      "level O\n",
      "below O\n",
      "5脳ULN O\n",
      ". O\n",
      "We O\n",
      "thus O\n",
      "recommend O\n",
      "IFN-伪 O\n",
      "for O\n",
      "patients O\n",
      "with O\n",
      "a O\n",
      "baseline O\n",
      "ALT O\n",
      "of O\n",
      "5 O\n",
      "- O\n",
      "10脳ULN O\n",
      "and O\n",
      "ETV O\n",
      "for O\n",
      "patients O\n",
      "with O\n",
      "a O\n",
      "baseline O\n",
      "ALT O\n",
      "either O\n",
      "below O\n",
      "5 O\n",
      "脳 O\n",
      "ULN O\n",
      "or O\n",
      "beyond O\n",
      "10脳ULN O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "锘縊bjective O\n",
      "To O\n",
      "explore O\n",
      "the O\n",
      "clinical O\n",
      "and O\n",
      "laboratory O\n",
      "characteristics O\n",
      "and O\n",
      "the O\n",
      "prognosis O\n",
      "of O\n",
      "disseminated O\n",
      "non O\n",
      "- O\n",
      "tuberculous O\n",
      "mycobacteria(NTM)diseases O\n",
      "in O\n",
      "human O\n",
      "immunodeficiency O\n",
      "virus(HIV)negative O\n",
      "patients O\n",
      ". O\n",
      "Methods O\n",
      "Cases O\n",
      "of O\n",
      "disseminated O\n",
      "NTM O\n",
      "disease O\n",
      "were O\n",
      "retrospectively O\n",
      "collected O\n",
      "in O\n",
      "Peking O\n",
      "Union O\n",
      "Medical O\n",
      "College O\n",
      "Hospital O\n",
      "from O\n",
      "January O\n",
      "2012 O\n",
      "to O\n",
      "October O\n",
      "2018.Clinical O\n",
      "manifestations O\n",
      ", O\n",
      "laboratory O\n",
      "findings O\n",
      ", O\n",
      "treatment O\n",
      ", O\n",
      "and O\n",
      "prognosis O\n",
      "of O\n",
      "these O\n",
      "cases O\n",
      "were O\n",
      "retrieved O\n",
      "from O\n",
      "the O\n",
      "electronic O\n",
      "medical O\n",
      "record O\n",
      "system O\n",
      ". O\n",
      "Results O\n",
      "Among O\n",
      "the O\n",
      "23 O\n",
      "HIV O\n",
      "negative O\n",
      "patients O\n",
      "with O\n",
      "disseminated O\n",
      "NTM O\n",
      "disease,21 O\n",
      "had O\n",
      "underlying O\n",
      "diseases O\n",
      ", O\n",
      "with O\n",
      "rheumatoid O\n",
      "immune O\n",
      "disease(n=7)as O\n",
      "the O\n",
      "most O\n",
      "common O\n",
      "one O\n",
      ". O\n",
      "The O\n",
      "main O\n",
      "clinical O\n",
      "manifestation O\n",
      "was O\n",
      "fever(n=23).Laboratory O\n",
      "tests O\n",
      "showed O\n",
      "anemia O\n",
      "[ O\n",
      "hemoglobin(85.78卤25.47)g O\n",
      "/ O\n",
      "L],hypoalbuminemia O\n",
      "[ O\n",
      "albumin O\n",
      "29(27 O\n",
      "- O\n",
      "32)g O\n",
      "/ O\n",
      "L],elevated O\n",
      "erythrocyte O\n",
      "sedimentation O\n",
      "rate O\n",
      "[ O\n",
      "( O\n",
      "85.73卤43.78)mm O\n",
      "/ O\n",
      "h O\n",
      "] O\n",
      "and O\n",
      "hypersensitive O\n",
      "C O\n",
      "- O\n",
      "reactive O\n",
      "protein O\n",
      "[ O\n",
      "( O\n",
      "112.00卤70.90)mg O\n",
      "/ O\n",
      "L O\n",
      "] O\n",
      ", O\n",
      "and O\n",
      "reduction O\n",
      "of O\n",
      "lymphocyte O\n",
      "count O\n",
      "[ O\n",
      "0.69(0.29 O\n",
      "- O\n",
      "2.10)脳10 O\n",
      "9/L].Lymphocyte O\n",
      "subset O\n",
      "analysis O\n",
      "indicated O\n",
      "reduction O\n",
      "in O\n",
      "CD4 O\n",
      "+ O\n",
      "T O\n",
      "cells O\n",
      "[ O\n",
      "213(113 O\n",
      "- O\n",
      "775)/渭l],CD8 O\n",
      "+ O\n",
      "T O\n",
      "cells O\n",
      "[ O\n",
      "267(99 O\n",
      "- O\n",
      "457)/渭l],B O\n",
      "cells O\n",
      "[ O\n",
      "39(4 O\n",
      "- O\n",
      "165)/渭l],and O\n",
      "NK O\n",
      "cells O\n",
      "[ O\n",
      "88(32 O\n",
      "- O\n",
      "279)/渭l O\n",
      "] O\n",
      "and O\n",
      "elevation O\n",
      "of O\n",
      "human O\n",
      "leukocyte O\n",
      "antigen O\n",
      "- O\n",
      "D O\n",
      "related(HLA O\n",
      "- O\n",
      "DR),and O\n",
      "CD38 O\n",
      "expression O\n",
      "in O\n",
      "CD8 O\n",
      "+ O\n",
      "T O\n",
      "cells O\n",
      "[ O\n",
      "HLA O\n",
      "- O\n",
      "DR O\n",
      "+ O\n",
      "CD8 O\n",
      "+ O\n",
      "/CD8 O\n",
      "+ O\n",
      ", O\n",
      "60(40 O\n",
      "- O\n",
      "68)%;CD38 O\n",
      "+ O\n",
      "CD8 O\n",
      "+ O\n",
      "/CD8 O\n",
      "+ O\n",
      ", O\n",
      "81(65 O\n",
      "- O\n",
      "90)%].The O\n",
      "most O\n",
      "common O\n",
      "species O\n",
      "of O\n",
      "NTM O\n",
      "was O\n",
      "Mycobacterium O\n",
      "intracellular(n=6).Lymphocyte O\n",
      ", O\n",
      "CD8 O\n",
      "+ O\n",
      "T O\n",
      "cell O\n",
      ", O\n",
      "B O\n",
      "cell O\n",
      ", O\n",
      "and O\n",
      "NK O\n",
      "cell O\n",
      "counts O\n",
      "were O\n",
      "significantly O\n",
      "lower O\n",
      "in O\n",
      "dead O\n",
      "patients O\n",
      "than O\n",
      "surviving O\n",
      "patients(P O\n",
      "= O\n",
      "0.045,P=0.045,P=0.032,and O\n",
      "P=0.010,respectively O\n",
      ") O\n",
      ". O\n",
      "Conclusions O\n",
      "Disseminated O\n",
      "NTM O\n",
      "disease O\n",
      "in O\n",
      "HIV O\n",
      "negative O\n",
      "patients O\n",
      "is O\n",
      "mainly O\n",
      "manifested O\n",
      "as O\n",
      "fever O\n",
      ", O\n",
      "anemia O\n",
      ", O\n",
      "hypoalbuminemia O\n",
      ", O\n",
      "and O\n",
      "elevated O\n",
      "inflammatory O\n",
      "indicators O\n",
      ". O\n",
      "It O\n",
      "is O\n",
      "more O\n",
      "likely O\n",
      "to O\n",
      "occur O\n",
      "in O\n",
      "immunocompromised O\n",
      "patients O\n",
      ". O\n",
      "Patients O\n",
      "with O\n",
      "decreased O\n",
      "lymphocytes O\n",
      ", O\n",
      "CD8 O\n",
      "+ O\n",
      "T O\n",
      "cells O\n",
      ", O\n",
      "B O\n",
      "cells O\n",
      "and O\n",
      "NK O\n",
      "cells O\n",
      "tend O\n",
      "to O\n",
      "have O\n",
      "a O\n",
      "poor O\n",
      "prognosis O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "in O\n",
      "\n",
      "\t\t\t\t O\n",
      "English O\n",
      ", O\n",
      "Chinese鐩鐨 O\n",
      "閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉 O\n",
      "鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵 O\n",
      "╁ O\n",
      "瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd O\n",
      "- O\n",
      "pshuttle O\n",
      "- O\n",
      "cmv O\n",
      "- O\n",
      "hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋 O\n",
      "鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁 O\n",
      "閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂 O\n",
      "┒ O\n",
      "鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE O\n",
      ": O\n",
      "This O\n",
      "study O\n",
      "aims O\n",
      "to O\n",
      "establish O\n",
      "an O\n",
      "effective O\n",
      "and O\n",
      "stable O\n",
      "periodontal O\n",
      "ligament O\n",
      "cell O\n",
      "line O\n",
      "stably O\n",
      "expressing O\n",
      "human O\n",
      "telomerase O\n",
      "reverse O\n",
      "transcriptase O\n",
      "( O\n",
      "hTERT O\n",
      ") O\n",
      "gene O\n",
      "by O\n",
      "using O\n",
      "the O\n",
      "adenovirus O\n",
      "method O\n",
      ". O\n",
      "METHODS O\n",
      ": O\n",
      "Polymerase O\n",
      "chain O\n",
      "reaction O\n",
      "( O\n",
      "PCR O\n",
      ") O\n",
      "was O\n",
      "used O\n",
      "to O\n",
      "amplify O\n",
      "the O\n",
      "full O\n",
      "length O\n",
      "of O\n",
      "hTERT O\n",
      "gene O\n",
      "to O\n",
      "construct O\n",
      "recombinant O\n",
      "adenovirus O\n",
      "plasmid O\n",
      "pAd O\n",
      "- O\n",
      "pshuttle O\n",
      "- O\n",
      "cmv O\n",
      "- O\n",
      "hTERT O\n",
      ". O\n",
      "Packaged O\n",
      "adenovirus O\n",
      "particles O\n",
      "were O\n",
      "used O\n",
      "for O\n",
      "infection O\n",
      "of O\n",
      "human O\n",
      "periodontal O\n",
      "ligament O\n",
      "cells O\n",
      ". O\n",
      "The O\n",
      "expression O\n",
      "levels O\n",
      "of O\n",
      "hTERT O\n",
      "and O\n",
      "osteogenic O\n",
      "genes O\n",
      ", O\n",
      "such O\n",
      "as O\n",
      "alkaline O\n",
      "phosphatase O\n",
      ", O\n",
      "Runt O\n",
      "- O\n",
      "related O\n",
      "transcription O\n",
      "factor O\n",
      "2 O\n",
      ", O\n",
      "bone O\n",
      "sialoprotein O\n",
      ", O\n",
      "osteocalcin O\n",
      ", O\n",
      "osteopontin O\n",
      ", O\n",
      "and O\n",
      "collagen O\n",
      "鈪 O\n",
      "mRNA O\n",
      ", O\n",
      "were O\n",
      "detected O\n",
      "by O\n",
      "quantitative O\n",
      "real O\n",
      "- O\n",
      "time O\n",
      "PCR O\n",
      "( O\n",
      "qRT O\n",
      "- O\n",
      "PCR O\n",
      ") O\n",
      ". O\n",
      "The O\n",
      "ability O\n",
      "of O\n",
      "osteogenic O\n",
      "differentiation O\n",
      "was O\n",
      "observed O\n",
      "by O\n",
      "alizarin O\n",
      "red O\n",
      "staining O\n",
      ", O\n",
      "and O\n",
      "the O\n",
      "cell O\n",
      "proliferation O\n",
      "was O\n",
      "determined O\n",
      "by O\n",
      "CCK-8.RESULTS O\n",
      ": O\n",
      "Adenovirus O\n",
      "particles O\n",
      "containing O\n",
      "the O\n",
      "hTERT O\n",
      "gene O\n",
      "were O\n",
      "successfully O\n",
      "constructed O\n",
      "and O\n",
      "infected O\n",
      "with O\n",
      "periodontal O\n",
      "ligament O\n",
      "cells O\n",
      ". O\n",
      "The O\n",
      "infected O\n",
      "cells O\n",
      "were O\n",
      "similar O\n",
      "to O\n",
      "normal O\n",
      "periodontal O\n",
      "ligament O\n",
      "cells O\n",
      ". O\n",
      "The O\n",
      "qRT O\n",
      "- O\n",
      "PCR O\n",
      "results O\n",
      "showed O\n",
      "that O\n",
      "hTERT O\n",
      "and O\n",
      "osteogenesis O\n",
      "- O\n",
      "associated O\n",
      "genes O\n",
      "were O\n",
      "highly O\n",
      "expressed O\n",
      "in O\n",
      "the O\n",
      "periodontal O\n",
      "ligament O\n",
      "cell O\n",
      "lines O\n",
      "constructed O\n",
      "by O\n",
      "adenoviruses O\n",
      ". O\n",
      "Alizarin O\n",
      "red O\n",
      "staining O\n",
      "showed O\n",
      "that O\n",
      "the O\n",
      "periodontal O\n",
      "ligament O\n",
      "cell O\n",
      "line O\n",
      "had O\n",
      "strong O\n",
      "osteogenic O\n",
      "differentiation O\n",
      "capability O\n",
      ". O\n",
      "CCK-8 O\n",
      "showed O\n",
      "that O\n",
      "the O\n",
      "periodontal O\n",
      "ligament O\n",
      "cell O\n",
      "line O\n",
      "had O\n",
      "strong O\n",
      "proliferation O\n",
      "capability O\n",
      ". O\n",
      "CONCLUSIONS O\n",
      ": O\n",
      "The O\n",
      "human O\n",
      "periodontal O\n",
      "ligament O\n",
      "cell O\n",
      "line O\n",
      "with O\n",
      "high O\n",
      "efficiency O\n",
      "and O\n",
      "stable O\n",
      "expression O\n",
      "of O\n",
      "hTERT O\n",
      "was O\n",
      "established O\n",
      "by O\n",
      "the O\n",
      "adenovirus O\n",
      "method O\n",
      ", O\n",
      "thereby O\n",
      "providing O\n",
      "an O\n",
      "ideal O\n",
      "cell O\n",
      "line O\n",
      "for O\n",
      "studying O\n",
      "the O\n",
      "mechanism O\n",
      "of O\n",
      "periodontal O\n",
      "regeneration O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "in O\n",
      "\n",
      "\t\t\t\t O\n",
      "English O\n",
      ", O\n",
      "FrenchCryoglobulin茅mies O\n",
      ". O\n",
      "La O\n",
      "cryoglobulin茅mie O\n",
      "est O\n",
      "d茅finie O\n",
      "par O\n",
      "la O\n",
      "pr茅sence O\n",
      "d鈥檜ne O\n",
      "cryoglobuline O\n",
      "circulante O\n",
      ", O\n",
      "immunoglobuline O\n",
      "pr茅cipitant O\n",
      "au O\n",
      "froid O\n",
      ". O\n",
      "Le O\n",
      "typage O\n",
      "de O\n",
      "cette O\n",
      "cryoglobuline O\n",
      "est O\n",
      "fondamental O\n",
      ". O\n",
      "En O\n",
      "effet O\n",
      ", O\n",
      "on O\n",
      "distingue O\n",
      "deux O\n",
      "sous O\n",
      "- O\n",
      "groupes O\n",
      ": O\n",
      "les O\n",
      "cryoglobulines O\n",
      "de O\n",
      "type O\n",
      "I O\n",
      "et O\n",
      "les O\n",
      "cryoglobulines O\n",
      "mixtes O\n",
      ". O\n",
      "La O\n",
      "physiopathologie O\n",
      "et O\n",
      "les O\n",
      "traitements O\n",
      "sont O\n",
      "diff茅rents O\n",
      "dans O\n",
      "ces O\n",
      "deux O\n",
      "entit茅s O\n",
      ". O\n",
      "Les O\n",
      "cryoglobulin茅mies O\n",
      "de O\n",
      "type O\n",
      "I O\n",
      "sont O\n",
      "li茅es O\n",
      "脿 O\n",
      "une O\n",
      "h茅mopathie O\n",
      "lympho茂de O\n",
      "B O\n",
      "monoclonale O\n",
      "sous O\n",
      "- O\n",
      "jacente O\n",
      ", O\n",
      "alors O\n",
      "que O\n",
      "les O\n",
      "cryoglobulin茅mies O\n",
      "mixtes O\n",
      "( O\n",
      "types O\n",
      "II O\n",
      "et O\n",
      "III O\n",
      ") O\n",
      "茅mergent O\n",
      "dans O\n",
      "des O\n",
      "situations O\n",
      "de O\n",
      "stimulation O\n",
      "antig茅nique O\n",
      "assez O\n",
      "vari茅es O\n",
      ", O\n",
      "la O\n",
      "plus O\n",
      "fr茅quente O\n",
      "茅tant O\n",
      "le O\n",
      "virus O\n",
      "de O\n",
      "l鈥檋茅patite O\n",
      "C. O\n",
      "L鈥檌ntensit茅 O\n",
      "des O\n",
      "sympt么mes O\n",
      "est O\n",
      "tr猫s O\n",
      "variable O\n",
      ", O\n",
      "beaucoup O\n",
      "de O\n",
      "patients O\n",
      "sont O\n",
      "asymptomatiques O\n",
      ". O\n",
      "Chez O\n",
      "les O\n",
      "patients O\n",
      "symptomatiques O\n",
      ", O\n",
      "les O\n",
      "organes O\n",
      "les O\n",
      "plus O\n",
      "fr茅quemment O\n",
      "touch茅s O\n",
      "sont O\n",
      "la O\n",
      "peau O\n",
      ", O\n",
      "le O\n",
      "syst猫me O\n",
      "nerveux O\n",
      "p茅riph茅rique O\n",
      "et O\n",
      "le O\n",
      "glom茅rule O\n",
      "r茅nal O\n",
      ". O\n",
      "Quelques O\n",
      "rares O\n",
      "patients O\n",
      "ont O\n",
      "des O\n",
      "atteintes O\n",
      "visc茅rales O\n",
      "mettant O\n",
      "en O\n",
      "jeu O\n",
      "le O\n",
      "pronostic O\n",
      "vital O\n",
      ". O\n",
      "Le O\n",
      "traitement O\n",
      "prend O\n",
      "toujours O\n",
      "en O\n",
      "compte O\n",
      "l鈥檌ntensit茅 O\n",
      "des O\n",
      "sympt么mes O\n",
      "et O\n",
      "la O\n",
      "pathologie O\n",
      "sous O\n",
      "- O\n",
      "jacente O\n",
      ". O\n",
      "Dans O\n",
      "les O\n",
      "cryoglobulin茅mies O\n",
      "de O\n",
      "type O\n",
      "I O\n",
      ", O\n",
      "le O\n",
      "traitement O\n",
      "du O\n",
      "clone O\n",
      "sous O\n",
      "- O\n",
      "jacent O\n",
      "est O\n",
      "primordial O\n",
      ". O\n",
      "Dans O\n",
      "celles O\n",
      "de O\n",
      "type O\n",
      "II O\n",
      ", O\n",
      "on O\n",
      "associe O\n",
      "le O\n",
      "plus O\n",
      "souvent O\n",
      "un O\n",
      "traitement O\n",
      "immunosuppresseur O\n",
      "au O\n",
      "traitement O\n",
      "de O\n",
      "la O\n",
      "cause O\n",
      ", O\n",
      "si O\n",
      "elle O\n",
      "est O\n",
      "identifi茅e O\n",
      ". O\n",
      "Cryoglobulinemia O\n",
      ". O\n",
      "Cryoglobulinemia O\n",
      "is O\n",
      "defined O\n",
      "by O\n",
      "the O\n",
      "presence O\n",
      "of O\n",
      "a O\n",
      "circulating O\n",
      "cryoglobulin O\n",
      ", O\n",
      "a O\n",
      "cold O\n",
      "- O\n",
      "precipitating O\n",
      "immunoglobulin O\n",
      ". O\n",
      "The O\n",
      "typing O\n",
      "of O\n",
      "this O\n",
      "cryoglobulin O\n",
      "is O\n",
      "fundamental O\n",
      ". O\n",
      "Indeed O\n",
      ", O\n",
      "there O\n",
      "are O\n",
      "two O\n",
      "subgroups O\n",
      ": O\n",
      "cryoglobulin O\n",
      "type O\n",
      "I O\n",
      "and O\n",
      "mixed O\n",
      "cryoglobulins O\n",
      ". O\n",
      "The O\n",
      "physiopathology O\n",
      "and O\n",
      "treatments O\n",
      "are O\n",
      "different O\n",
      "in O\n",
      "these O\n",
      "two O\n",
      "entities O\n",
      ". O\n",
      "Cryoglobulinemia O\n",
      "type O\n",
      "1 O\n",
      "is O\n",
      "associated O\n",
      "with O\n",
      "an O\n",
      "underlying O\n",
      "monoclonal O\n",
      "lymphoid O\n",
      "B O\n",
      "hemopathy O\n",
      ", O\n",
      "while O\n",
      "mixed O\n",
      "cryoglobulinemia O\n",
      "( O\n",
      "types O\n",
      "II O\n",
      "and O\n",
      "III O\n",
      ") O\n",
      "emerge O\n",
      "in O\n",
      "quite O\n",
      "varied O\n",
      "antigenic O\n",
      "stimulation O\n",
      "situations O\n",
      ", O\n",
      "the O\n",
      "most O\n",
      "common O\n",
      "being O\n",
      "the O\n",
      "hepatitis O\n",
      "C O\n",
      "virus O\n",
      ". O\n",
      "The O\n",
      "intensity O\n",
      "of O\n",
      "the O\n",
      "symptoms O\n",
      "is O\n",
      "very O\n",
      "variable O\n",
      ", O\n",
      "many O\n",
      "patients O\n",
      "are O\n",
      "asymptomatic O\n",
      ". O\n",
      "In O\n",
      "symptomatic O\n",
      "patients O\n",
      ", O\n",
      "the O\n",
      "most O\n",
      "frequently O\n",
      "affected O\n",
      "organs O\n",
      "are O\n",
      "the O\n",
      "skin O\n",
      ", O\n",
      "the O\n",
      "peripheral O\n",
      "nervous O\n",
      "system O\n",
      "and O\n",
      "the O\n",
      "renal O\n",
      "glomerulus O\n",
      ". O\n",
      "Few O\n",
      "patients O\n",
      "have O\n",
      "visceral O\n",
      "involvement O\n",
      "that O\n",
      "is O\n",
      "life O\n",
      "- O\n",
      "threatening O\n",
      ". O\n",
      "The O\n",
      "treatment O\n",
      "always O\n",
      "takes O\n",
      "into O\n",
      "account O\n",
      "the O\n",
      "intensity O\n",
      "of O\n",
      "the O\n",
      "symptoms O\n",
      "and O\n",
      "the O\n",
      "underlying O\n",
      "pathology O\n",
      ". O\n",
      "In O\n",
      "cryoglobulinemia O\n",
      "type O\n",
      "I O\n",
      ", O\n",
      "treatment O\n",
      "of O\n",
      "the O\n",
      "underlying O\n",
      "clone O\n",
      "is O\n",
      "essential O\n",
      ". O\n",
      "In O\n",
      "type O\n",
      "II O\n",
      ", O\n",
      "immunosuppressive O\n",
      "therapy O\n",
      "is O\n",
      "most O\n",
      "often O\n",
      "associated O\n",
      "with O\n",
      "treatment O\n",
      "of O\n",
      "the O\n",
      "cause O\n",
      ", O\n",
      "if O\n",
      "identified O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "Objective O\n",
      "To O\n",
      "measure O\n",
      "the O\n",
      "effect O\n",
      "of O\n",
      "duck O\n",
      "viperin O\n",
      "protein O\n",
      "on O\n",
      "the O\n",
      "proliferation O\n",
      "of O\n",
      "duck O\n",
      "Tembusu O\n",
      "virus O\n",
      "( O\n",
      "DTMUV O\n",
      ") O\n",
      ". O\n",
      "Methods O\n",
      "We O\n",
      "analyzed O\n",
      "the O\n",
      "duck O\n",
      "viperin O\n",
      "gene O\n",
      "using O\n",
      "a O\n",
      "bioinformatics O\n",
      ". O\n",
      "Plasmids O\n",
      "pGEX-6P O\n",
      "- O\n",
      "viperin O\n",
      "and O\n",
      "pEGFP O\n",
      "- O\n",
      "N1-viperin O\n",
      "were O\n",
      "constructed O\n",
      "and O\n",
      "transformed O\n",
      "into O\n",
      "Rosseta O\n",
      "and O\n",
      "transfected O\n",
      "into O\n",
      "BHK-21 O\n",
      "cells O\n",
      ", O\n",
      "respectively O\n",
      ". O\n",
      "BHK-21 O\n",
      "cells O\n",
      "transfected O\n",
      "with O\n",
      "plasmid O\n",
      "pEGFP O\n",
      "- O\n",
      "N1-viperin O\n",
      "and O\n",
      "empty O\n",
      "vector O\n",
      "were O\n",
      "infected O\n",
      "with O\n",
      "DTMUV O\n",
      ". O\n",
      "The O\n",
      "content O\n",
      "of O\n",
      "DTMUV O\n",
      "in O\n",
      "cell O\n",
      "precipitation O\n",
      "and O\n",
      "supernatant O\n",
      "was O\n",
      "analyzed O\n",
      "by O\n",
      "real O\n",
      "- O\n",
      "time O\n",
      "fluorescent O\n",
      "quantitative O\n",
      "PCR O\n",
      ". O\n",
      "Finally O\n",
      ", O\n",
      "the O\n",
      "effect O\n",
      "of O\n",
      "viperin O\n",
      "on O\n",
      "DTMUV O\n",
      "proliferation O\n",
      "and O\n",
      "the O\n",
      "binding O\n",
      "proteins O\n",
      "captured O\n",
      "by O\n",
      "EGFP O\n",
      "monoclonal O\n",
      "antibody O\n",
      "were O\n",
      "evaluated O\n",
      "using O\n",
      "mass O\n",
      "spectrometry O\n",
      ". O\n",
      "Results O\n",
      "Significant O\n",
      "differences O\n",
      "were O\n",
      "observed O\n",
      "between O\n",
      "the O\n",
      "expression O\n",
      "levels O\n",
      "of O\n",
      "viperin O\n",
      "gene O\n",
      "in O\n",
      "duck O\n",
      "compared O\n",
      "to O\n",
      "other O\n",
      "species O\n",
      ". O\n",
      "Duck O\n",
      "viperin O\n",
      "was O\n",
      "found O\n",
      "to O\n",
      "inhibit O\n",
      "the O\n",
      "budding O\n",
      "of O\n",
      "DTMUV O\n",
      "in O\n",
      "BHK-21 O\n",
      "cells O\n",
      ". O\n",
      "Further O\n",
      ", O\n",
      "we O\n",
      "identified O\n",
      "six O\n",
      "proteins O\n",
      "that O\n",
      "might O\n",
      "be O\n",
      "involved O\n",
      "in O\n",
      "the O\n",
      "inhibition O\n",
      "of O\n",
      "the O\n",
      "proliferation O\n",
      "and O\n",
      "budding O\n",
      "of O\n",
      "DTMUV O\n",
      ", O\n",
      "possibly O\n",
      "indicative O\n",
      "of O\n",
      "the O\n",
      "viperin O\n",
      "anti O\n",
      "- O\n",
      "Tembusu O\n",
      "virus O\n",
      "pathway O\n",
      "in O\n",
      "ducks O\n",
      ". O\n",
      "Conclusion O\n",
      "Expression O\n",
      "patterns O\n",
      "of O\n",
      "duck O\n",
      "viperin O\n",
      "reveal O\n",
      "how O\n",
      "the O\n",
      "budding O\n",
      "of O\n",
      "duck O\n",
      "Tembusu O\n",
      "virus O\n",
      "is O\n",
      "inhibited O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "in O\n",
      "\n",
      "\t\t\t\t O\n",
      "English O\n",
      ", O\n",
      "Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem O\n",
      "cell O\n",
      "leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial O\n",
      "cells O\n",
      "of O\n",
      "Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c O\n",
      "- O\n",
      "kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24 O\n",
      "h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5 O\n",
      "mmol O\n",
      "/ O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20 O\n",
      "mmol O\n",
      "/ O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48 O\n",
      "h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮 O\n",
      "┖ O\n",
      "鐧界粍銆佺 O\n",
      "┖ O\n",
      "鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺 O\n",
      "┖ O\n",
      "鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5 O\n",
      "mmol O\n",
      "/ O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48 O\n",
      "h锛岄噰鐢 O\n",
      "╓ O\n",
      "estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit O\n",
      "铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48 O\n",
      "h鍚庯紝绌虹櫧缁勩佺 O\n",
      "┖ O\n",
      "鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To O\n",
      "determine O\n",
      "the O\n",
      "effect O\n",
      "of O\n",
      "a O\n",
      "recombinant O\n",
      "lentivirus O\n",
      "containing O\n",
      "human O\n",
      "stem O\n",
      "cell O\n",
      "leukemia O\n",
      "( O\n",
      "SCL O\n",
      ") O\n",
      "gene O\n",
      "on O\n",
      "the O\n",
      "expression O\n",
      "of O\n",
      "c O\n",
      "- O\n",
      "kit O\n",
      "protein O\n",
      "in O\n",
      "damaged O\n",
      "interstitial O\n",
      "cells O\n",
      "of O\n",
      "Cajal O\n",
      "( O\n",
      "ICC O\n",
      ") O\n",
      "under O\n",
      "high O\n",
      "glucose O\n",
      "condition.鈥 O\n",
      "Methods O\n",
      ": O\n",
      "After O\n",
      "isolation O\n",
      "of O\n",
      "ICC O\n",
      ", O\n",
      "the O\n",
      "cells O\n",
      "were O\n",
      "cultured O\n",
      "for O\n",
      "24 O\n",
      "hours O\n",
      "until O\n",
      "the O\n",
      "cells O\n",
      "were O\n",
      "adherent O\n",
      ". O\n",
      "After O\n",
      "identification O\n",
      "by O\n",
      "inverted O\n",
      "microscope O\n",
      "and O\n",
      "immunofluorescence O\n",
      ", O\n",
      "ICC O\n",
      "cells O\n",
      "were O\n",
      "divided O\n",
      "into O\n",
      "two O\n",
      "groups O\n",
      ": O\n",
      "A O\n",
      "control O\n",
      "group O\n",
      "and O\n",
      "a O\n",
      "high O\n",
      "glucose O\n",
      "group O\n",
      ". O\n",
      "The O\n",
      "control O\n",
      "group O\n",
      "was O\n",
      "added O\n",
      "with O\n",
      "a O\n",
      "medium O\n",
      "containing O\n",
      "5 O\n",
      "mmol O\n",
      "/ O\n",
      "L O\n",
      "of O\n",
      "glucose O\n",
      ". O\n",
      "The O\n",
      "high O\n",
      "glucose O\n",
      "group O\n",
      "was O\n",
      "added O\n",
      "with O\n",
      "a O\n",
      "medium O\n",
      "containing O\n",
      "20 O\n",
      "mmol O\n",
      "/ O\n",
      "L O\n",
      "of O\n",
      "glucose O\n",
      ". O\n",
      "After O\n",
      "48 O\n",
      "h O\n",
      "of O\n",
      "continuous O\n",
      "cultivation O\n",
      ", O\n",
      "the O\n",
      "high O\n",
      "glucose O\n",
      "group O\n",
      "was O\n",
      "divided O\n",
      "into O\n",
      "3 O\n",
      "subgroups O\n",
      ": O\n",
      "A O\n",
      "blank O\n",
      "group O\n",
      ", O\n",
      "an O\n",
      "empty O\n",
      "lentivirus O\n",
      "group O\n",
      ", O\n",
      "and O\n",
      "an O\n",
      "experimental O\n",
      "group O\n",
      ". O\n",
      "The O\n",
      "blank O\n",
      "group O\n",
      ", O\n",
      "the O\n",
      "empty O\n",
      "lentivirus O\n",
      "group O\n",
      ", O\n",
      "and O\n",
      "the O\n",
      "experimental O\n",
      "group O\n",
      "were O\n",
      "added O\n",
      "a O\n",
      "medium O\n",
      "containing O\n",
      "PBS O\n",
      "solution O\n",
      ", O\n",
      "empty O\n",
      "lentivirus O\n",
      ", O\n",
      "and O\n",
      "a O\n",
      "recombinant O\n",
      "lentivirus O\n",
      "containing O\n",
      "the O\n",
      "SCL O\n",
      "gene O\n",
      "with O\n",
      "a O\n",
      "glucose O\n",
      "concentration O\n",
      "of O\n",
      "5 O\n",
      "mmol O\n",
      "/ O\n",
      "L O\n",
      ", O\n",
      "respectively O\n",
      ". O\n",
      "The O\n",
      "cultures O\n",
      "were O\n",
      "incubated O\n",
      "for O\n",
      "24 O\n",
      "and O\n",
      "48 O\n",
      "h. O\n",
      "The O\n",
      "expression O\n",
      "of O\n",
      "c O\n",
      "- O\n",
      "kit O\n",
      "protein O\n",
      "in O\n",
      "ICC O\n",
      "in O\n",
      "each O\n",
      "group O\n",
      "was O\n",
      "detected O\n",
      "by O\n",
      "Western O\n",
      "blot.鈥 O\n",
      "Results O\n",
      ": O\n",
      "After O\n",
      "24 O\n",
      "or O\n",
      "48 O\n",
      "h O\n",
      ", O\n",
      "the O\n",
      "expression O\n",
      "of O\n",
      "c O\n",
      "- O\n",
      "kit O\n",
      "protein O\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "in O\n",
      "ICC O\n",
      "was O\n",
      "significantly O\n",
      "lower O\n",
      "in O\n",
      "the O\n",
      "blank O\n",
      "group O\n",
      "and O\n",
      "the O\n",
      "lentivirus O\n",
      "group O\n",
      "than O\n",
      "that O\n",
      "in O\n",
      "the O\n",
      "control O\n",
      "group O\n",
      ", O\n",
      "and O\n",
      "the O\n",
      "expression O\n",
      "of O\n",
      "c O\n",
      "- O\n",
      "kit O\n",
      "protein O\n",
      "in O\n",
      "ICC O\n",
      "was O\n",
      "significantly O\n",
      "higher O\n",
      "in O\n",
      "the O\n",
      "experimental O\n",
      "group O\n",
      "than O\n",
      "that O\n",
      "in O\n",
      "the O\n",
      "blank O\n",
      "group O\n",
      "and O\n",
      "the O\n",
      "empty O\n",
      "lentivirus O\n",
      "group O\n",
      ", O\n",
      "but O\n",
      "it O\n",
      "was O\n",
      "still O\n",
      "lower O\n",
      "than O\n",
      "that O\n",
      "in O\n",
      "the O\n",
      "control O\n",
      "group O\n",
      "( O\n",
      "all O\n",
      "P<0.05).鈥 O\n",
      "Conclusion O\n",
      ": O\n",
      "The O\n",
      "recombinant O\n",
      "lentivirus O\n",
      "of O\n",
      "SCL O\n",
      "gene O\n",
      "can O\n",
      "up O\n",
      "- O\n",
      "regulate O\n",
      "the O\n",
      "expression O\n",
      "of O\n",
      "c O\n",
      "- O\n",
      "kit O\n",
      "protein O\n",
      "in O\n",
      "functionally O\n",
      "impaired O\n",
      "ICC O\n",
      "under O\n",
      "high O\n",
      "glucose O\n",
      "condition O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "OBJECTIVE O\n",
      ": O\n",
      "To O\n",
      "study O\n",
      "the O\n",
      "effects O\n",
      "of O\n",
      "respiratory O\n",
      "syncytial O\n",
      "virus O\n",
      "( O\n",
      "RSV O\n",
      ") O\n",
      "infection O\n",
      "on O\n",
      "epidermal O\n",
      "growth O\n",
      "factor O\n",
      "receptor O\n",
      "( O\n",
      "EGFR O\n",
      ") O\n",
      ", O\n",
      "tight O\n",
      "junction O\n",
      "association O\n",
      "proteins O\n",
      "and O\n",
      "mucin O\n",
      "in O\n",
      "the O\n",
      "human O\n",
      "airway O\n",
      "epithelial O\n",
      "cells O\n",
      ". O\n",
      "METHODS O\n",
      ": O\n",
      "Human O\n",
      "airway O\n",
      "epithelial O\n",
      "cells O\n",
      "NCI O\n",
      "- O\n",
      "H292 O\n",
      "were O\n",
      "randomly O\n",
      "treated O\n",
      "by O\n",
      "ultraviolet O\n",
      "light O\n",
      "- O\n",
      "inactivated O\n",
      "RSV O\n",
      "( O\n",
      "control O\n",
      "group O\n",
      ") O\n",
      "or O\n",
      "thawed O\n",
      "RSV O\n",
      "( O\n",
      "RSV O\n",
      "infection O\n",
      "group O\n",
      ") O\n",
      ". O\n",
      "After O\n",
      "48 O\n",
      "hours O\n",
      "of O\n",
      "treatment O\n",
      ", O\n",
      "the O\n",
      "protein O\n",
      "levels O\n",
      "of O\n",
      "occludin O\n",
      ", O\n",
      "E O\n",
      "- O\n",
      "cadherin O\n",
      ", O\n",
      "phosphorylated O\n",
      "EGFR O\n",
      "and O\n",
      "EGFR O\n",
      "in O\n",
      "NCI O\n",
      "- O\n",
      "H292 O\n",
      "cells O\n",
      "were O\n",
      "measured O\n",
      "by O\n",
      "Western O\n",
      "blot O\n",
      ". O\n",
      "The O\n",
      "distribution O\n",
      "and O\n",
      "expression O\n",
      "levels O\n",
      "of O\n",
      "occludin O\n",
      "and O\n",
      "E O\n",
      "- O\n",
      "cadherin O\n",
      "in O\n",
      "NCI O\n",
      "- O\n",
      "H292 O\n",
      "cells O\n",
      "were O\n",
      "examined O\n",
      "by O\n",
      "immunofluorescence O\n",
      "technique O\n",
      ". O\n",
      "The O\n",
      "expression O\n",
      "levels O\n",
      "of O\n",
      "MUC5AC O\n",
      "mRNA O\n",
      "in O\n",
      "NCI O\n",
      "- O\n",
      "H292 O\n",
      "cells O\n",
      "were O\n",
      "assessed O\n",
      "by O\n",
      "RT O\n",
      "- O\n",
      "PCR.RESULTS O\n",
      ": O\n",
      "The O\n",
      "protein O\n",
      "levels O\n",
      "of O\n",
      "occludin O\n",
      "and O\n",
      "E O\n",
      "- O\n",
      "cadherin O\n",
      "were O\n",
      "significantly O\n",
      "reduced O\n",
      "in O\n",
      "the O\n",
      "RSV O\n",
      "infection O\n",
      "group O\n",
      "compared O\n",
      "with O\n",
      "the O\n",
      "control O\n",
      "group O\n",
      "( O\n",
      "P<0.05 O\n",
      ") O\n",
      ". O\n",
      "The O\n",
      "protein O\n",
      "levels O\n",
      "of O\n",
      "phosphorylated O\n",
      "EGFR O\n",
      "and O\n",
      "EGFR O\n",
      "increased O\n",
      "significantly O\n",
      "in O\n",
      "the O\n",
      "RSV O\n",
      "infection O\n",
      "group O\n",
      "compared O\n",
      "with O\n",
      "the O\n",
      "control O\n",
      "group O\n",
      "( O\n",
      "P<0.05 O\n",
      ") O\n",
      ". O\n",
      "The O\n",
      "MUC5AC O\n",
      "mRNA O\n",
      "levels O\n",
      "also O\n",
      "increased O\n",
      "significantly O\n",
      "in O\n",
      "the O\n",
      "RSV O\n",
      "infection O\n",
      "group O\n",
      "compared O\n",
      "with O\n",
      "the O\n",
      "control O\n",
      "group O\n",
      "( O\n",
      "P<0.05).CONCLUSIONS O\n",
      ": O\n",
      "RSV O\n",
      "may O\n",
      "down O\n",
      "- O\n",
      "regulate O\n",
      "the O\n",
      "tight O\n",
      "junction O\n",
      "association O\n",
      "proteins O\n",
      "and O\n",
      "up O\n",
      "- O\n",
      "regulate O\n",
      "the O\n",
      "expression O\n",
      "of O\n",
      "MUC5AC O\n",
      "in O\n",
      "airway O\n",
      "epithelial O\n",
      "cells O\n",
      ", O\n",
      "which O\n",
      "contributes O\n",
      "to O\n",
      "epithelial O\n",
      "barrier O\n",
      "dysfunction O\n",
      ". O\n",
      "EGFR O\n",
      "phosphorylation O\n",
      "may O\n",
      "play O\n",
      "an O\n",
      "important O\n",
      "role O\n",
      "in O\n",
      "regulation O\n",
      "of O\n",
      "airway O\n",
      "barrier O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "Objective O\n",
      "To O\n",
      "establish O\n",
      "a O\n",
      "human O\n",
      "B O\n",
      "lymphoma O\n",
      "cell O\n",
      "line O\n",
      "which O\n",
      "can O\n",
      "stably O\n",
      "express O\n",
      "Epstein O\n",
      "- O\n",
      "Barr O\n",
      "virus O\n",
      "latent O\n",
      "membrane O\n",
      "protein O\n",
      "1 O\n",
      "( O\n",
      "LMP1 O\n",
      ") O\n",
      ". O\n",
      "Methods O\n",
      "The O\n",
      "LMP1 O\n",
      "coding O\n",
      "gene O\n",
      "with O\n",
      "EcoRI O\n",
      "and O\n",
      "BamHI O\n",
      "restriction O\n",
      "sites O\n",
      "was O\n",
      "amplified O\n",
      ", O\n",
      "cloned O\n",
      "into O\n",
      "pcDNA3.1-EF1a O\n",
      "- O\n",
      "mcs-3FLAG O\n",
      "- O\n",
      "CMV O\n",
      "- O\n",
      "EGFP O\n",
      "plasmid O\n",
      ", O\n",
      "and O\n",
      "positive O\n",
      "monoclonal O\n",
      "competent O\n",
      "cells O\n",
      "were O\n",
      "picked O\n",
      "for O\n",
      "PCR O\n",
      "and O\n",
      "sequencing O\n",
      ". O\n",
      "The O\n",
      "recombinant O\n",
      "plasmid O\n",
      "was O\n",
      "transfected O\n",
      "into O\n",
      "Ramos O\n",
      "cells O\n",
      "by O\n",
      "electroporation O\n",
      ", O\n",
      "and O\n",
      "the O\n",
      "cell O\n",
      "line O\n",
      "stably O\n",
      "expressing O\n",
      "LMP1 O\n",
      "was O\n",
      "picked O\n",
      "by O\n",
      "G418 O\n",
      ". O\n",
      "The O\n",
      "expression O\n",
      "of O\n",
      "LMP1 O\n",
      "in O\n",
      "Ramos O\n",
      "cells O\n",
      "was O\n",
      "detected O\n",
      "by O\n",
      "PCR O\n",
      ", O\n",
      "Western O\n",
      "blot O\n",
      "analysis O\n",
      "and O\n",
      "green O\n",
      "fluorescent O\n",
      "protein O\n",
      "Tag O\n",
      ". O\n",
      "Results O\n",
      "PCR O\n",
      "and O\n",
      "sequencing O\n",
      "confirmed O\n",
      "that O\n",
      "the O\n",
      "LMP1 O\n",
      "recombinant O\n",
      "plasmid O\n",
      "was O\n",
      "successfully O\n",
      "constructed O\n",
      "and O\n",
      "a O\n",
      "stably O\n",
      "transfected O\n",
      "Ramos O\n",
      "cell O\n",
      "line O\n",
      "was O\n",
      "established O\n",
      ". O\n",
      "Western O\n",
      "blot O\n",
      "analysis O\n",
      "confirmed O\n",
      "that O\n",
      "LMP1 O\n",
      "protein O\n",
      "was O\n",
      "successfully O\n",
      "expressed O\n",
      "in O\n",
      "this O\n",
      "cell O\n",
      "line O\n",
      ". O\n",
      "Conclusion O\n",
      "The O\n",
      "Ramos O\n",
      "cells O\n",
      "stably O\n",
      "expressing O\n",
      "LMP1 O\n",
      "have O\n",
      "been O\n",
      "successfully O\n",
      "established O\n",
      ". O\n",
      "\n",
      "\n",
      " O\n",
      "in O\n",
      "\n",
      "\t\t\t\t O\n",
      "English O\n",
      ", O\n",
      "HungarianAbsztrakt O\n",
      ": O\n",
      "A O\n",
      "hepatitis O\n",
      "C O\n",
      "- O\n",
      "v铆rus O\n",
      "( O\n",
      "HCV O\n",
      ") O\n",
      "megk枚zel铆t艖leg O\n",
      "4 O\n",
      "milli贸 O\n",
      "煤j O\n",
      "fert艖z茅st O\n",
      "okoz O\n",
      "茅vente O\n",
      ", O\n",
      "茅s O\n",
      "399聽000 O\n",
      "beteg O\n",
      "hal O\n",
      "meg O\n",
      "a O\n",
      "fert艖z茅s O\n",
      "k枚vetkezt茅ben O\n",
      "kialakul贸 O\n",
      "sz枚v艖dm茅nyek O\n",
      ", O\n",
      "cirrhosis O\n",
      "茅s O\n",
      "hepatocellularis O\n",
      "carcinoma O\n",
      "( O\n",
      "HCC O\n",
      ") O\n",
      "miatt O\n",
      ". O\n",
      "Id眉lt O\n",
      "HCV O\n",
      "- O\n",
      "fert艖z茅sben O\n",
      "a O\n",
      "mikrok枚rnyezeti O\n",
      "v谩ltoz谩sok O\n",
      ", O\n",
      "a O\n",
      "fert艖z茅s O\n",
      "kiv谩ltotta O\n",
      "id眉lt O\n",
      "gyullad谩s O\n",
      ", O\n",
      "az O\n",
      "oxidat铆v O\n",
      "stressz O\n",
      "茅s O\n",
      "az O\n",
      "endoplazm谩s O\n",
      "reticulum O\n",
      "stressz O\n",
      "genetikai O\n",
      ", O\n",
      "epigenetikai O\n",
      "v谩ltoz谩sokon O\n",
      "kereszt眉l O\n",
      "茅vtizedek O\n",
      "alatt O\n",
      "vezethetnek O\n",
      "primer O\n",
      "m谩jr谩k O\n",
      "kialakul谩s谩hoz O\n",
      ". O\n",
      "A O\n",
      "HCV O\n",
      "direkt O\n",
      "hepatocarcinogen O\n",
      "tulajdons谩ga O\n",
      "ismert O\n",
      ". O\n",
      "N茅gy O\n",
      "HCV O\n",
      "- O\n",
      "feh茅rje O\n",
      "( O\n",
      "core O\n",
      ", O\n",
      "NS3 O\n",
      ", O\n",
      "NS4B O\n",
      ", O\n",
      "NS5A O\n",
      ") O\n",
      "transzform谩ci贸s O\n",
      "tulajdons谩ga O\n",
      "bizony铆tott O\n",
      ". O\n",
      "A O\n",
      "hat茅kony O\n",
      "antivir谩lis O\n",
      "kezel茅s O\n",
      ", O\n",
      "a O\n",
      "tart贸s O\n",
      "v铆rusv谩lasz O\n",
      "el茅r茅se O\n",
      "a O\n",
      "HCV O\n",
      "okozta O\n",
      "m谩j- O\n",
      ", O\n",
      "valamint O\n",
      "a O\n",
      "nem O\n",
      "m谩jeredet疟 O\n",
      "hal谩loz谩st O\n",
      "cs枚kkenti O\n",
      ". O\n",
      "Az O\n",
      "interferonalap煤 O\n",
      "antivir谩lis O\n",
      "kezel茅s O\n",
      "a O\n",
      "HCC O\n",
      "el艖fordul谩s谩t O\n",
      "cs枚kkenti O\n",
      ". O\n",
      "A O\n",
      "direkt O\n",
      "hat贸 O\n",
      "antivir谩lis O\n",
      "szerek O\n",
      "( O\n",
      "DAA O\n",
      ") O\n",
      "el艖nye O\n",
      "a O\n",
      "nagyobb O\n",
      "ar谩ny煤 O\n",
      "tart贸s O\n",
      "v铆rusv谩lasz O\n",
      ", O\n",
      "a O\n",
      "kevesebb O\n",
      "mell茅khat谩s O\n",
      ", O\n",
      "valamint O\n",
      "a O\n",
      "r枚videbb O\n",
      "ter谩pi谩s O\n",
      "id艖tartam O\n",
      ". O\n",
      "Az O\n",
      "elm煤lt O\n",
      "n茅h谩ny O\n",
      "茅vben O\n",
      "k枚zlem茅nyek O\n",
      "jelentek O\n",
      "meg O\n",
      ", O\n",
      "amelyek O\n",
      "a O\n",
      "DAA O\n",
      "- O\n",
      "kezel茅sek O\n",
      "nem O\n",
      "v谩rt O\n",
      "hat谩sair贸l O\n",
      "sz谩moltak O\n",
      "be O\n",
      ". O\n",
      "A O\n",
      "szerz艖k O\n",
      "ismertetik O\n",
      "a O\n",
      "DAA O\n",
      "- O\n",
      "kezel茅sekben O\n",
      "a O\n",
      "HCC O\n",
      "el艖fordul谩s谩t O\n",
      "vizsg谩l贸 O\n",
      "tanulm谩nyok O\n",
      "eredm茅nyeit O\n",
      ". O\n",
      "A O\n",
      "k茅rd茅s O\n",
      "pontos O\n",
      "eld枚nt茅s茅re O\n",
      "tov谩bbi O\n",
      "prospekt铆v O\n",
      ", O\n",
      "multicentrikus O\n",
      "vizsg谩latok O\n",
      ", O\n",
      "hosszabb O\n",
      "k枚vet茅si O\n",
      "id艖szakok O\n",
      ", O\n",
      "a O\n",
      "kontrollcsoportok O\n",
      "pontos O\n",
      "kiv谩laszt谩sa O\n",
      "sz眉ks茅ges O\n",
      ". O\n",
      "A O\n",
      "v铆rusellenes O\n",
      "kezel茅s O\n",
      "befejez茅se O\n",
      "ut谩n O\n",
      "is O\n",
      "kiemelked艖 O\n",
      "jelent艖s茅g疟 O\n",
      "a O\n",
      "HCC O\n",
      "- O\n",
      "surveillance O\n",
      ", O\n",
      "amelyet O\n",
      "a O\n",
      "rendszeres O\n",
      "( O\n",
      "3鈥6鈥12 O\n",
      "havonta O\n",
      "v茅gzett O\n",
      ") O\n",
      "hasi O\n",
      "UH O\n",
      "- O\n",
      "vizsg谩lat O\n",
      "jelent O\n",
      ", O\n",
      "m茅g O\n",
      "a O\n",
      "sikeresen O\n",
      "kezelt O\n",
      "betegekn茅l O\n",
      "is O\n",
      ". O\n",
      "Orv O\n",
      "Hetil O\n",
      ". O\n",
      "2019 O\n",
      "; O\n",
      "160(22 O\n",
      ") O\n",
      ": O\n",
      "846鈥853.Hepatitis O\n",
      "C O\n",
      "virus O\n",
      "infection O\n",
      "causes O\n",
      "approximately O\n",
      "4 O\n",
      "million O\n",
      "new O\n",
      "infections O\n",
      "worldwide O\n",
      ", O\n",
      "and O\n",
      "399聽000 O\n",
      "deaths O\n",
      "due O\n",
      "to O\n",
      "its O\n",
      "complications O\n",
      ", O\n",
      "cirrhosis O\n",
      "and O\n",
      "hepatocellular O\n",
      "carcinoma O\n",
      "( O\n",
      "HCC O\n",
      ") O\n",
      ". O\n",
      "Microenvironmental O\n",
      "changes O\n",
      ", O\n",
      "chronic O\n",
      "inflammation O\n",
      ", O\n",
      "oxidative O\n",
      "stress O\n",
      ", O\n",
      "endoplasmic O\n",
      "reticulum O\n",
      "stress O\n",
      "caused O\n",
      "by O\n",
      "HCV O\n",
      "infection O\n",
      ", O\n",
      "via O\n",
      "genetic O\n",
      "and O\n",
      "epigenetic O\n",
      "changes O\n",
      "can O\n",
      "result O\n",
      "in O\n",
      "primary O\n",
      "liver O\n",
      "cancer O\n",
      "during O\n",
      "decades O\n",
      ". O\n",
      "The O\n",
      "direct O\n",
      "oncogenic O\n",
      "property O\n",
      "of O\n",
      "HCV O\n",
      "is O\n",
      "wellknown O\n",
      ". O\n",
      "The O\n",
      "transforming O\n",
      "effect O\n",
      "of O\n",
      "four O\n",
      "HCV O\n",
      "proteins O\n",
      "( O\n",
      "core O\n",
      ", O\n",
      "NS3 O\n",
      ", O\n",
      "NS4B O\n",
      ", O\n",
      "NS5A O\n",
      ") O\n",
      "has O\n",
      "been O\n",
      "proven O\n",
      ". O\n",
      "Effective O\n",
      "antiviral O\n",
      "therapy O\n",
      ", O\n",
      "sustained O\n",
      "viral O\n",
      "response O\n",
      "decreases O\n",
      "the O\n",
      "HCV O\n",
      "- O\n",
      "related O\n",
      "general O\n",
      "and O\n",
      "liver O\n",
      "- O\n",
      "related O\n",
      "mortality O\n",
      ". O\n",
      "Interferon O\n",
      "- O\n",
      "based O\n",
      "therapy O\n",
      "reduces O\n",
      "the O\n",
      "risk O\n",
      "of O\n",
      "HCC O\n",
      "development O\n",
      ". O\n",
      "Shorter O\n",
      "therapy O\n",
      "with O\n",
      "direct O\n",
      "acting O\n",
      "antiviral O\n",
      "agents O\n",
      "( O\n",
      "DAA O\n",
      ") O\n",
      "has O\n",
      "higher O\n",
      "efficacy O\n",
      ", O\n",
      "fewer O\n",
      "side O\n",
      "- O\n",
      "effects O\n",
      ". O\n",
      "Publications O\n",
      "have O\n",
      "reported O\n",
      "the O\n",
      "unexpected O\n",
      "effects O\n",
      "of O\n",
      "DAA O\n",
      ". O\n",
      "The O\n",
      "authors O\n",
      "review O\n",
      "the O\n",
      "articles O\n",
      "focusing O\n",
      "on O\n",
      "the O\n",
      "occurrence O\n",
      "of O\n",
      "HCC O\n",
      "in O\n",
      "connection O\n"
     ]
    }
   ],
   "source": [
    "for token in doc:\n",
    "    print(token.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE\t0\tOBJECTIVE\tFalse\tFalse\tXXXX\tPROPN\tNNP\n",
      ":\t9\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "To\t11\tto\tFalse\tFalse\tXx\tPART\tTO\n",
      "evaluate\t14\tevaluate\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "the\t23\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "therapeutic\t27\ttherapeutic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "effects\t39\teffect\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t47\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "entecavir\t50\tentecavir\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t60\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ETV\t61\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t64\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "and\t66\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "interferon-伪\t70\tinterferon-伪\tFalse\tFalse\txxxx-x\tPROPN\tNNP\n",
      "(\t83\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "IFN-伪\t84\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      ")\t89\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "treatments\t91\ttreatment\tFalse\tFalse\txxxx\tVERB\tVBZ\n",
      "for\t102\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "48\t106\t48\tFalse\tFalse\tdd\tNUM\tCD\n",
      "weeks\t109\tweek\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "for\t115\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "chronic\t119\tchronic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "hepatitis\t127\thepatitis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "B\t137\tB\tFalse\tFalse\tX\tPROPN\tNNP\n",
      "(\t139\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "CHB\t140\tCHB\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t143\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "in\t145\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "patients\t148\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t157\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t162\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t172\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "alanine\t181\talanine\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "aminotransferase\t189\taminotransferase\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t206\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ALT\t207\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t210\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "levels\t212\tlevel\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t218\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "METHODS\t219\tmethod\tFalse\tFalse\tXXXX\tNOUN\tNNS\n",
      ":\t226\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "We\t228\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "retrospectively\t231\tretrospectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      "analyzed\t247\tanalyze\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "the\t256\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "data\t260\tdatum\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t265\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "369\t268\t369\tFalse\tFalse\tddd\tNUM\tCD\n",
      "CHB\t272\tCHB\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "patients\t276\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t285\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t295\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "and\t299\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "IFN-伪\t303\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatments\t309\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "for\t320\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "48\t324\t48\tFalse\tFalse\tdd\tNUM\tCD\n",
      "weeks\t327\tweek\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t332\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "We\t334\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "compared\t337\tcompare\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "the\t346\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "virological\t350\tvirological\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "response\t362\tresponse\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rates\t371\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t376\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "HBsAg\t378\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "clearance\t384\tclearance\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t393\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t395\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "HBsAg\t399\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "reduction\t405\treduction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "between\t415\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t423\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "patients\t427\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t436\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t446\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "and\t450\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "IFN-伪\t454\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatments\t460\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t471\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t476\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t486\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "ALT\t495\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "levels[鈮\t499\tlevels[鈮\tFalse\tFalse\txxxx[x\tPUNCT\t.\n",
      "5脳upper\t508\t5脳upper\tFalse\tFalse\tdxxxx\tNUM\tCD\n",
      "limits\t516\tlimit\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t523\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "normal\t526\tnormal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "(\t533\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ULN\t534\tULN\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t537\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "level\t539\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t545\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t546\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "1\t555\t1\tFalse\tFalse\td\tNUM\tCD\n",
      ")\t556\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ",\t557\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "5\t559\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "-\t560\t-\tTrue\tFalse\t-\tSYM\tSYM\n",
      "10脳ULN\t561\t10脳uln\tFalse\tFalse\tddxXXX\tNUM\tCD\n",
      "(\t568\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t569\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t578\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ")\t579\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ",\t580\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t582\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "&\t586\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "gt\t587\tgt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t589\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "10脳\t591\t10脳\tFalse\tFalse\tddx\tVERB\tVBZ\n",
      "ULN\t595\tULN\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "(\t599\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t600\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "3)].RESULTS\t609\t3)].RESULTS\tFalse\tFalse\td)].XXXX\tPROPN\tNNP\n",
      ":\t620\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "In\t622\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "patients\t625\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t634\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t644\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "treatment\t648\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t657\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "the\t659\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "virological\t663\tvirological\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "response\t675\tresponse\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rate\t684\trate\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "was\t689\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "83.3\t693\t83.3\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t697\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t699\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t702\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "1\t711\t1\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t712\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "91.4\t714\t91.4\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t718\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t720\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t723\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t732\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t733\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t735\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "95.5\t739\t95.5\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t743\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t745\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t748\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "3\t757\t3\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t758\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "as\t760\tas\tFalse\tFalse\txx\tADP\tIN\n",
      "compared\t763\tcompare\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "with\t772\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "19.7\t777\t19.7\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t781\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t782\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "40\t784\t40\tFalse\tFalse\tdd\tNUM\tCD\n",
      "%\t786\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t787\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t789\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "42.9\t793\t42.9\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t797\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t799\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "the\t802\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "3\t806\t3\tFalse\tFalse\td\tNUM\tCD\n",
      "subgroups\t808\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t818\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "IFN-伪\t823\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatment\t829\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t838\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "respectively\t840\trespectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      ",\t852\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "showing\t854\tshow\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "significantly\t862\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "differences\t876\tdifference\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "both\t888\tboth\tFalse\tFalse\txxxx\tDET\tDT\n",
      "among\t893\tamong\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t899\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroups\t909\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t919\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t924\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t928\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatment\t933\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "and\t943\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "between\t947\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t955\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t959\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroup\t964\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "with\t973\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t978\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatments\t988\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "(\t999\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "P\t1000\tp\tFalse\tFalse\tX\tNOUN\tNN\n",
      "&\t1002\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "lt\t1003\tlt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1005\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05\t1007\t0.05\tFalse\tFalse\td.dd\tNUM\tCD\n",
      ")\t1011\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ".\t1012\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "HBeAg\t1014\tHBeAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "clearance\t1020\tclearance\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rates\t1030\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "in\t1036\tin\tFalse\tFalse\txx\tADP\tIN\n"
     ]
    }
   ],
   "source": [
    "for token in doc[:200]:\n",
    "    print(\"{0}\\t{1}\\t{2}\\t{3}\\t{4}\\t{5}\\t{6}\\t{7}\".format(\n",
    "        token.text,\n",
    "        token.idx,\n",
    "        token.lemma_,\n",
    "        token.is_punct,\n",
    "        token.is_space,\n",
    "        token.shape_,\n",
    "        token.pos_,\n",
    "        token.tag_\n",
    "    ))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ETV ORG\n",
      "48 weeks DATE\n",
      "CHB ORG\n",
      "METHODS PERSON\n",
      "369 CARDINAL\n",
      "CHB ORG\n",
      "ETV ORG\n",
      "IFN-伪 ORG\n",
      "48 weeks DATE\n",
      "HBsAg PERSON\n",
      "ETV ORG\n",
      "IFN-伪 ORG\n",
      "5脳upper CARDINAL\n",
      "ULN ORG\n",
      "1 CARDINAL\n",
      "5 CARDINAL\n",
      "2 CARDINAL\n",
      "10脳 CARDINAL\n",
      "ULN ORG\n",
      "ETV ORG\n",
      "83.3% PERCENT\n",
      "1 CARDINAL\n",
      "91.4% PERCENT\n",
      "2 CARDINAL\n",
      "95.5% PERCENT\n",
      "3 CARDINAL\n",
      "19.7% PERCENT\n",
      "40% PERCENT\n",
      "42.9% PERCENT\n",
      "3 CARDINAL\n",
      "IFN-伪 NORP\n",
      "P &lt ORG\n",
      "0.05 CARDINAL\n",
      "3 CARDINAL\n",
      "8.3% PERCENT\n",
      "16.7% PERCENT\n",
      "35.5% PERCENT\n",
      "ETV ORG\n",
      "1.8% PERCENT\n",
      "41.9% PERCENT\n",
      "38.1% PERCENT\n",
      "IFN-伪 NORP\n",
      "3 CARDINAL\n",
      "P &lt ORG\n",
      "0.05 CARDINAL\n",
      "2 CARDINAL\n",
      "0.05 CARDINAL\n",
      "ETV ORG\n",
      "HBsAg DATE\n",
      "200 CARDINAL\n",
      "2.5% PERCENT\n",
      "1 CARDINAL\n",
      "13.8% PERCENT\n",
      "2 CARDINAL\n",
      "two CARDINAL\n",
      "IFN-伪 ORG\n",
      "1 CARDINAL\n",
      "30.6% PERCENT\n",
      "33.3% PERCENT\n",
      "P &gt ORG\n",
      "0.05 CARDINAL\n",
      "P &lt ORG\n",
      "ETV ORG\n",
      "48 weeks DATE\n",
      "IFN-伪 NORP\n",
      "CHB ORG\n",
      "5 CARDINAL\n",
      "IFN-伪 ORG\n",
      "HBeAg ORG\n",
      "ETV ORG\n",
      "IFN-伪 ORG\n",
      "ETV ORG\n",
      "5 CARDINAL\n",
      "ULN ORG\n",
      "ETV ORG\n",
      "IFN-伪 ORG\n",
      "5脳ULN GPE\n",
      "IFN-伪 NORP\n",
      "5 CARDINAL\n",
      "ETV ORG\n",
      "5 CARDINAL\n",
      "ULN ORG\n",
      "10脳ULN GPE\n",
      "Methods Cases PERSON\n",
      "NTM ORG\n",
      "Peking Union Medical College Hospital ORG\n",
      "January 2012 to October 2018.Clinical DATE\n",
      "23 CARDINAL\n",
      "NTM ORG\n",
      "29(27 CARDINAL\n",
      "112.00卤70.90)mg/L ORG\n",
      "NK ORG\n",
      "88(32 CARDINAL\n",
      "279)/渭l CARDINAL\n",
      "81(65 CARDINAL\n",
      "NTM ORG\n",
      "Mycobacterium ORG\n",
      "NK ORG\n",
      "NTM ORG\n",
      "NK ORG\n",
      "English LANGUAGE\n",
      "鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁 GPE\n",
      "2 CARDINAL\n",
      "Alizarin PERSON\n",
      "English LANGUAGE\n",
      "FrenchCryoglobulin茅mies ORG\n",
      "II et III PERSON\n",
      "C. L鈥檌ntensit茅 PERSON\n",
      "Quelques ORG\n",
      "II PRODUCT\n",
      "Cryoglobulinemia GPE\n",
      "Cryoglobulinemia GPE\n",
      "two CARDINAL\n",
      "two CARDINAL\n",
      "1 CARDINAL\n",
      "II PERSON\n",
      "III PERSON\n",
      "II PERSON\n",
      "Tembusu NORP\n",
      "DTMUV ORG\n",
      "pEGFP GPE\n",
      "Rosseta ORG\n",
      "pEGFP-N1-viperin PRODUCT\n",
      "DTMUV ORG\n",
      "DTMUV ORG\n",
      "PCR ORG\n",
      "DTMUV ORG\n",
      "EGFP ORG\n",
      "DTMUV ORG\n",
      "six CARDINAL\n",
      "DTMUV ORG\n",
      "anti-Tembusu NORP\n",
      "Tembusu GPE\n",
      "SCL ORG\n",
      "Cajal (ICC ORG\n",
      "Methods PERSON\n",
      "24 hours TIME\n",
      "two CARDINAL\n",
      "5 CARDINAL\n",
      "20 CARDINAL\n",
      "48 CARDINAL\n",
      "3 CARDINAL\n",
      "PBS ORG\n",
      "SCL ORG\n",
      "5 CARDINAL\n",
      "24 CARDINAL\n",
      "48 DATE\n",
      "24 CARDINAL\n",
      "48 CARDINAL\n",
      "SCL ORG\n",
      "EGFR ORG\n",
      "NCI ORG\n",
      "48 hours TIME\n",
      "EGFR ORG\n",
      "EGFR ORG\n",
      "NCI ORG\n",
      "NCI ORG\n",
      "NCI ORG\n",
      "RT-PCR.RESULTS ORG\n",
      "EGFR ORG\n",
      "EGFR ORG\n",
      "MUC5AC ORG\n",
      "MUC5AC DATE\n",
      "Objective PERSON\n",
      "Epstein PERSON\n",
      "1 CARDINAL\n",
      "Ramos ORG\n",
      "Ramos GPE\n",
      "PCR ORG\n",
      "Tag PERSON\n",
      "Ramos ORG\n",
      "Conclusion The Ramos PERSON\n",
      "English LANGUAGE\n",
      "HungarianAbsztrakt ORG\n",
      "HCV ORG\n",
      "4 CARDINAL\n",
      "399聽000 CARDINAL\n",
      "HCC ORG\n",
      "Id眉lt HCV-fert艖z茅sben PERSON\n",
      "HCV ORG\n",
      "N茅gy HCV-feh茅rje PERSON\n",
      "HCV ORG\n",
      "HCC ORG\n",
      "HCC ORG\n",
      "HCC ORG\n",
      "UH ORG\n",
      "Orv Hetil PERSON\n",
      "2019 DATE\n",
      "160(22 DATE\n",
      "846鈥853.Hepatitis CARDINAL\n",
      "approximately 4 million CARDINAL\n",
      "399聽000 CARDINAL\n",
      "HCC ORG\n",
      "decades DATE\n",
      "HCV ORG\n",
      "four CARDINAL\n",
      "HCV ORG\n",
      "HCV ORG\n",
      "Interferon ORG\n",
      "HCC ORG\n",
      "HCC ORG\n",
      "HCC ORG\n",
      "HCC ORG\n",
      "3-6-12 months CARDINAL\n",
      "Orv Hetil PERSON\n",
      "2019 DATE\n",
      "160(22 DATE\n",
      "846-853 CARDINAL\n",
      "12 years DATE\n",
      "Oseltamivir PERSON\n",
      "BAT ORG\n",
      "Oseltamivir PERSON\n",
      "Japan GPE\n",
      "two CARDINAL\n"
     ]
    }
   ],
   "source": [
    "for ent in doc.ents:\n",
    "    print(ent.text, ent.label_)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div class=\"entities\" style=\"line-height: 2.5; direction: ltr\">OBJECTIVE: To evaluate the therapeutic effects of entecavir (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") and interferon-伪 (IFN-伪) treatments for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48 weeks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " for chronic hepatitis B (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    CHB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") in patients with different baseline alanine aminotransferase (ALT) levels.\n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    METHODS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ": We retrospectively analyzed the data of \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    369\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    CHB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " patients receiving \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatments for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48 weeks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ". We compared the virological response rates, HBsAg clearance, and \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HBsAg\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " reduction between the patients receiving \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatments with different baseline ALT levels[鈮 \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5脳upper\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " limits of normal (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") level (subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "), \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-10脳ULN (subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "), and &amp;gt; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    10脳\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " (subgroup 3)].RESULTS: In patients receiving \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatment, the virological response rate was \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    83.3%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    91.4%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    95.5%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", as compared with \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    19.7%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    40%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    42.9%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups with \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " treatment, respectively, showing significantly differences both among different subgroups with the same treatment and between the same subgroup with different treatments (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    P &amp;lt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    0.05\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "). HBeAg clearance rates in the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups were \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    8.3%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    16.7%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    35.5%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in patients with \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatment and were \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1.8%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    41.9%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    38.1%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in patients with \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " treatment, respectively, showing significant differences among the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups with the same treatment (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    P &amp;lt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    0.05\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "); in the same subgroups with different treatments, the rates differed significantly only between subgroups \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " (P &amp;lt; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    0.05\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "). In \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " group, the rate of \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HBsAg\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " reduction to below \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    200\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " IU/ml was \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2.5%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    13.8%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " in subgroup \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", showing no significant difference between the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups; in \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " group, the rates were also similar between subgroups \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " and 2 (\n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    30.6%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       " vs \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    33.3%\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERCENT</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    P &amp;gt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    0.05\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "); but the rates differed significantly between the same subgroups with different treatments (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    P &amp;lt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "; 0.05).CONCLUSIONS: In all the subgroups with different baseline ALT levels, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatment for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48 weeks\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " results in significantly higher virological response rates than \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " treatment in patients with \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    CHB\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". In patients with a baseline ALT of \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-10 脳ULN, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " can result in a higher \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HBeAg\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " clearance rate than \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". In patients with comparable baseline ALT level, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " more effectively reduces HBsAg level than \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". The patients with a relatively high baseline ALT level (&amp;gt; \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " 脳 \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") show better responses to both \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " treatment than those with ALT level below \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5脳ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       ". We thus recommend \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    IFN-伪\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " for patients with a baseline ALT of \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-10脳ULN and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ETV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " for patients with a baseline ALT either below \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " 脳 \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " or beyond \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    10脳ULN\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       ".</br></br>锘縊bjective To explore the clinical and laboratory characteristics and the prognosis of disseminated non-tuberculous mycobacteria(NTM)diseases in human immunodeficiency virus(HIV)negative patients. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Methods Cases\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " of disseminated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NTM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " disease were retrospectively collected in \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Peking Union Medical College Hospital\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " from \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    January 2012 to October 2018.Clinical\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " manifestations, laboratory findings, treatment, and prognosis of these cases were retrieved from the electronic medical record system. Results Among the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    23\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " HIV negative patients with disseminated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NTM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " disease,21 had underlying diseases, with rheumatoid immune disease(n=7)as the most common one. The main clinical manifestation was fever(n=23).Laboratory tests showed anemia [hemoglobin(85.78卤25.47)g/L],hypoalbuminemia [albumin \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    29(27\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-32)g/L],elevated erythrocyte sedimentation rate [(85.73卤43.78)mm/h] and hypersensitive C-reactive protein [(\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    112.00卤70.90)mg/L\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "], and reduction of lymphocyte count [0.69(0.29-2.10)脳10 9/L].Lymphocyte subset analysis indicated reduction in CD4 + T cells [213(113-775)/渭l],CD8 + T cells [267(99-457)/渭l],B cells [39(4-165)/渭l],and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cells [\n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    88(32\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-\n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    279)/渭l\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "] and elevation of human leukocyte antigen-D related(HLA-DR),and CD38 expression in CD8 + T cells [HLA-DR +CD8 +/CD8 +,60(40-68)%;CD38 +CD8 +/CD8 +,\n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    81(65\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       "-90)%].The most common species of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NTM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " was \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Mycobacterium\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " intracellular(n=6).Lymphocyte,CD8 + T cell, B cell, and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cell counts were significantly lower in dead patients than surviving patients(P =0.045,P=0.045,P=0.032,and P=0.010,respectively). Conclusions Disseminated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NTM\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " disease in HIV negative patients is mainly manifested as fever, anemia, hypoalbuminemia, and elevated inflammatory indicators. It is more likely to occur in immunocompromised patients. Patients with decreased lymphocytes,CD8 + T cells, B cells and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NK\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cells tend to have a poor prognosis.</br></br>in</br>\t\t\t\t\n",
       "<mark class=\"entity\" style=\"background: #ff8197; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    English\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">LANGUAGE</span>\n",
       "</mark>\n",
       ", Chinese鐩鐨 閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉 鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵╁瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd-pshuttle-cmv-hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋 \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " 閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂┒鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE: This study aims to establish an effective and stable periodontal ligament cell line stably expressing human telomerase reverse transcriptase (hTERT) gene by using the adenovirus method.METHODS: Polymerase chain reaction (PCR) was used to amplify the full length of hTERT gene to construct recombinant adenovirus plasmid pAd-pshuttle-cmv-hTERT. Packaged adenovirus particles were used for infection of human periodontal ligament cells. The expression levels of hTERT and osteogenic genes, such as alkaline phosphatase, Runt-related transcription factor \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ", bone sialoprotein, osteocalcin, osteopontin, and collagen 鈪 mRNA, were detected by quantitative real-time PCR (qRT-PCR). The ability of osteogenic differentiation was observed by alizarin red staining, and the cell proliferation was determined by CCK-8.RESULTS: Adenovirus particles containing the hTERT gene were successfully constructed and infected with periodontal ligament cells. The infected cells were similar to normal periodontal ligament cells. The qRT-PCR results showed that hTERT and osteogenesis-associated genes were highly expressed in the periodontal ligament cell lines constructed by adenoviruses. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Alizarin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " red staining showed that the periodontal ligament cell line had strong osteogenic differentiation capability. CCK-8 showed that the periodontal ligament cell line had strong proliferation capability.CONCLUSIONS: The human periodontal ligament cell line with high efficiency and stable expression of hTERT was established by the adenovirus method, thereby providing an ideal cell line for studying the mechanism of periodontal regeneration.</br></br>in</br>\t\t\t\t\n",
       "<mark class=\"entity\" style=\"background: #ff8197; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    English\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">LANGUAGE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    FrenchCryoglobulin茅mies\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". La cryoglobulin茅mie est d茅finie par la pr茅sence d鈥檜ne cryoglobuline circulante, immunoglobuline pr茅cipitant au froid. Le typage de cette cryoglobuline est fondamental. En effet, on distingue deux sous-groupes : les cryoglobulines de type I et les cryoglobulines mixtes. La physiopathologie et les traitements sont diff茅rents dans ces deux entit茅s. Les cryoglobulin茅mies de type I sont li茅es 脿 une h茅mopathie lympho茂de B monoclonale sous-jacente, alors que les cryoglobulin茅mies mixtes (types \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    II et III\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ") 茅mergent dans des situations de stimulation antig茅nique assez vari茅es, la plus fr茅quente 茅tant le virus de l鈥檋茅patite \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    C. L鈥檌ntensit茅\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " des sympt么mes est tr猫s variable, beaucoup de patients sont asymptomatiques. Chez les patients symptomatiques, les organes les plus fr茅quemment touch茅s sont la peau, le syst猫me nerveux p茅riph茅rique et le glom茅rule r茅nal. \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Quelques\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " rares patients ont des atteintes visc茅rales mettant en jeu le pronostic vital. Le traitement prend toujours en compte l鈥檌ntensit茅 des sympt么mes et la pathologie sous-jacente. Dans les cryoglobulin茅mies de type I, le traitement du clone sous-jacent est primordial. Dans celles de type \n",
       "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
       "</mark>\n",
       ", on associe le plus souvent un traitement immunosuppresseur au traitement de la cause, si elle est identifi茅e.\n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Cryoglobulinemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Cryoglobulinemia\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " is defined by the presence of a circulating cryoglobulin, a cold-precipitating immunoglobulin. The typing of this cryoglobulin is fundamental. Indeed, there are \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups: cryoglobulin type I and mixed cryoglobulins. The physiopathology and treatments are different in these \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " entities. Cryoglobulinemia type \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " is associated with an underlying monoclonal lymphoid B hemopathy, while mixed cryoglobulinemia (types \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    III\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ") emerge in quite varied antigenic stimulation situations, the most common being the hepatitis C virus. The intensity of the symptoms is very variable, many patients are asymptomatic. In symptomatic patients, the most frequently affected organs are the skin, the peripheral nervous system and the renal glomerulus. Few patients have visceral involvement that is life-threatening. The treatment always takes into account the intensity of the symptoms and the underlying pathology. In cryoglobulinemia type I, treatment of the underlying clone is essential. In type \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    II\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ", immunosuppressive therapy is most often associated with treatment of the cause, if identified.</br></br>Objective To measure the effect of duck viperin protein on the proliferation of duck \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Tembusu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " virus (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). Methods We analyzed the duck viperin gene using a bioinformatics. Plasmids pGEX-6P-viperin and \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    pEGFP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       "-N1-viperin were constructed and transformed into \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Rosseta\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and transfected into BHK-21 cells, respectively. BHK-21 cells transfected with plasmid \n",
       "<mark class=\"entity\" style=\"background: #bfeeb7; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    pEGFP-N1-viperin\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PRODUCT</span>\n",
       "</mark>\n",
       " and empty vector were infected with \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". The content of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " in cell precipitation and supernatant was analyzed by real-time fluorescent quantitative \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    PCR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ". Finally, the effect of viperin on \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " proliferation and the binding proteins captured by \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFP\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " monoclonal antibody were evaluated using mass spectrometry. Results Significant differences were observed between the expression levels of viperin gene in duck compared to other species. Duck viperin was found to inhibit the budding of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " in BHK-21 cells. Further, we identified \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    six\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " proteins that might be involved in the inhibition of the proliferation and budding of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    DTMUV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", possibly indicative of the viperin \n",
       "<mark class=\"entity\" style=\"background: #c887fb; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    anti-Tembusu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">NORP</span>\n",
       "</mark>\n",
       " virus pathway in ducks. Conclusion Expression patterns of duck viperin reveal how the budding of duck \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Tembusu\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " virus is inhibited.</br></br>in</br>\t\t\t\tEnglish, Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem cell leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial cells of Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c-kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24 h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48 h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮┖鐧界粍銆佺┖鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺┖鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48 h锛岄噰鐢╓estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit 铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48 h鍚庯紝绌虹櫧缁勩佺┖鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝&lt;0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To determine the effect of a recombinant lentivirus containing human stem cell leukemia (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    SCL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") gene on the expression of c-kit protein in damaged interstitial cells of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Cajal (ICC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") under high glucose condition.鈥 \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Methods\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ": After isolation of ICC, the cells were cultured for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    24 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       " until the cells were adherent. After identification by inverted microscope and immunofluorescence, ICC cells were divided into \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " groups: A control group and a high glucose group. The control group was added with a medium containing \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " mmol/L of glucose. The high glucose group was added with a medium containing \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    20\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " mmol/L of glucose. After \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " h of continuous cultivation, the high glucose group was divided into \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " subgroups: A blank group, an empty lentivirus group, and an experimental group. The blank group, the empty lentivirus group, and the experimental group were added a medium containing \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    PBS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " solution, empty lentivirus, and a recombinant lentivirus containing the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    SCL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " gene with a glucose concentration of \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    5\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " mmol/L, respectively. The cultures were incubated for \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    24\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " h. The expression of c-kit protein in ICC in each group was detected by Western blot.鈥 Results: After \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    24\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " or \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " h, the expression of c-kit protein in ICC was significantly lower in the blank group and the lentivirus group than that in the control group, and the expression of c-kit protein in ICC was significantly higher in the experimental group than that in the blank group and the empty lentivirus group, but it was still lower than that in the control group (all P&lt;0.05).鈥 Conclusion: The recombinant lentivirus of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    SCL\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " gene can up-regulate the expression of c-kit protein in functionally impaired ICC under high glucose condition.</br></br>OBJECTIVE: To study the effects of respiratory syncytial virus (RSV) infection on epidermal growth factor receptor (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "), tight junction association proteins and mucin in the human airway epithelial cells.METHODS: Human airway epithelial cells \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NCI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-H292 were randomly treated by ultraviolet light-inactivated RSV (control group) or thawed RSV (RSV infection group). After \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    48 hours\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">TIME</span>\n",
       "</mark>\n",
       " of treatment, the protein levels of occludin, E-cadherin, phosphorylated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " in \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NCI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-H292 cells were measured by Western blot. The distribution and expression levels of occludin and E-cadherin in \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NCI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-H292 cells were examined by immunofluorescence technique. The expression levels of MUC5AC mRNA in \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    NCI\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-H292 cells were assessed by \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    RT-PCR.RESULTS\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ": The protein levels of occludin and E-cadherin were significantly reduced in the RSV infection group compared with the control group (P&lt;0.05). The protein levels of phosphorylated \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " and \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    EGFR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " increased significantly in the RSV infection group compared with the control group (P&lt;0.05). The \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    MUC5AC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " mRNA levels also increased significantly in the RSV infection group compared with the control group (P&lt;0.05).CONCLUSIONS: RSV may down-regulate the tight junction association proteins and up-regulate the expression of \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    MUC5AC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       " in airway epithelial cells, which contributes to epithelial barrier dysfunction. EGFR phosphorylation may play an important role in regulation of airway barrier.</br></br>\n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Objective\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " To establish a human B lymphoma cell line which can stably express \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Epstein\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       "-Barr virus latent membrane protein \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    1\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " (LMP1). Methods The LMP1 coding gene with EcoRI and BamHI restriction sites was amplified, cloned into pcDNA3.1-EF1a-mcs-3FLAG-CMV-EGFP plasmid, and positive monoclonal competent cells were picked for PCR and sequencing. The recombinant plasmid was transfected into \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Ramos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cells by electroporation, and the cell line stably expressing LMP1 was picked by G418. The expression of LMP1 in \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Ramos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       " cells was detected by \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    PCR\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ", Western blot analysis and green fluorescent protein \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Tag\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". Results PCR and sequencing confirmed that the LMP1 recombinant plasmid was successfully constructed and a stably transfected \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Ramos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " cell line was established. Western blot analysis confirmed that LMP1 protein was successfully expressed in this cell line. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Conclusion The Ramos\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " cells stably expressing LMP1 have been successfully established.</br></br>in</br>\t\t\t\t\n",
       "<mark class=\"entity\" style=\"background: #ff8197; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    English\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">LANGUAGE</span>\n",
       "</mark>\n",
       ", \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HungarianAbsztrakt\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ": A hepatitis C-v铆rus (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") megk枚zel铆t艖leg \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    4\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " milli贸 煤j fert艖z茅st okoz 茅vente, 茅s \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    399聽000\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " beteg hal meg a fert艖z茅s k枚vetkezt茅ben kialakul贸 sz枚v艖dm茅nyek, cirrhosis 茅s hepatocellularis carcinoma (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       ") miatt. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Id眉lt HCV-fert艖z茅sben\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " a mikrok枚rnyezeti v谩ltoz谩sok, a fert艖z茅s kiv谩ltotta id眉lt gyullad谩s, az oxidat铆v stressz 茅s az endoplazm谩s reticulum stressz genetikai, epigenetikai v谩ltoz谩sokon kereszt眉l 茅vtizedek alatt vezethetnek primer m谩jr谩k kialakul谩s谩hoz. A \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " direkt hepatocarcinogen tulajdons谩ga ismert. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    N茅gy HCV-feh茅rje\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " (core, NS3, NS4B, NS5A) transzform谩ci贸s tulajdons谩ga bizony铆tott. A hat茅kony antivir谩lis kezel茅s, a tart贸s v铆rusv谩lasz el茅r茅se a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " okozta m谩j-, valamint a nem m谩jeredet疟 hal谩loz谩st cs枚kkenti. Az interferonalap煤 antivir谩lis kezel茅s a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " el艖fordul谩s谩t cs枚kkenti. A direkt hat贸 antivir谩lis szerek (DAA) el艖nye a nagyobb ar谩ny煤 tart贸s v铆rusv谩lasz, a kevesebb mell茅khat谩s, valamint a r枚videbb ter谩pi谩s id艖tartam. Az elm煤lt n茅h谩ny 茅vben k枚zlem茅nyek jelentek meg, amelyek a DAA-kezel茅sek nem v谩rt hat谩sair贸l sz谩moltak be. A szerz艖k ismertetik a DAA-kezel茅sekben a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " el艖fordul谩s谩t vizsg谩l贸 tanulm谩nyok eredm茅nyeit. A k茅rd茅s pontos eld枚nt茅s茅re tov谩bbi prospekt铆v, multicentrikus vizsg谩latok, hosszabb k枚vet茅si id艖szakok, a kontrollcsoportok pontos kiv谩laszt谩sa sz眉ks茅ges. A v铆rusellenes kezel茅s befejez茅se ut谩n is kiemelked艖 jelent艖s茅g疟 a \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-surveillance, amelyet a rendszeres (3鈥6鈥12 havonta v茅gzett) hasi \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    UH\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-vizsg谩lat jelent, m茅g a sikeresen kezelt betegekn茅l is. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Orv Hetil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2019\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "; \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    160(22\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "): \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    846鈥853.Hepatitis\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " C virus infection causes \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    approximately 4 million\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " new infections worldwide, and \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    399聽000\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " deaths due to its complications, cirrhosis and hepatocellular carcinoma (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "). Microenvironmental changes, chronic inflammation, oxidative stress, endoplasmic reticulum stress caused by HCV infection, via genetic and epigenetic changes can result in primary liver cancer during \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    decades\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ". The direct oncogenic property of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " is wellknown. The transforming effect of \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    four\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " proteins (core, NS3, NS4B, NS5A) has been proven. Effective antiviral therapy, sustained viral response decreases the \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCV\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-related general and liver-related mortality. \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Interferon\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "-based therapy reduces the risk of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " development. Shorter therapy with direct acting antiviral agents (DAA) has higher efficacy, fewer side-effects. Publications have reported the unexpected effects of DAA. The authors review the articles focusing on the occurrence of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " in connection with DAA therapies. There is a need for prospective, multicentric studies with longer follow-up to examine the risk of \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " formation. After antiviral therapy, \n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    HCC\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       " surveillance is of high importance which means abdominal ultrasound every \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    3-6-12 months\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " in sustained viral response patients as well. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Orv Hetil\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    2019\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "; \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    160(22\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       "): \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    846-853\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       ".</br></br>Although the anti-influenza virus drug oseltamivir ameliorates the fever of influenza, adverse events related to its hypothermic effect have been reported. We found that oseltamivir causes dose-dependent hypothermia in normal mice, and have been studying the pharmacological mechanisms responsible for \n",
       "<mark class=\"entity\" style=\"background: #bfe1d9; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    12 years\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">DATE</span>\n",
       "</mark>\n",
       ". \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Oseltamivir\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " blocks nicotinic cholinergic transmission at sympathetic ganglia and reduces sympathetic modulation of brown adipose tissue (\n",
       "<mark class=\"entity\" style=\"background: #7aecec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    BAT\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">ORG</span>\n",
       "</mark>\n",
       "), a heat generator. \n",
       "<mark class=\"entity\" style=\"background: #aa9cfc; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Oseltamivir\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">PERSON</span>\n",
       "</mark>\n",
       " was found to target the ion channels of nicotinic acetylcholine receptors, as demonstrated by patch clamp experiments with cells expressing the human 伪3尾4 nicotinic receptor. Metabolized oseltamivir carboxylate, which inhibits the influenza virus neuraminidase, did not elicit hypothermia and ion channel suppression. Body temperature was decreased by intracerebroventricular administration of oseltamivir. Because this hypothermic effect was inhibited by dopamine D2 receptor blockade, it was suggested that oseltamivir centrally stimulates the D2 receptor. In \n",
       "<mark class=\"entity\" style=\"background: #feca74; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    Japan\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">GPE</span>\n",
       "</mark>\n",
       ", the package inserts for oseltamivir and amantadine indicate very similar adverse neuropsychiatric reactions for the \n",
       "<mark class=\"entity\" style=\"background: #e4e7d2; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em; box-decoration-break: clone; -webkit-box-decoration-break: clone\">\n",
       "    two\n",
       "    <span style=\"font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem\">CARDINAL</span>\n",
       "</mark>\n",
       " drugs (abnormal behavior, consciousness disturbance, convulsion, delirium, delusion, hallucination). A literature search revealed that in some previous studies, oseltamivir and amantadine were shown to block the ion channel systems and activate the dopaminergic nervous system via several mechanisms. Therefore the similarity of the adverse reactions elicited by oseltamivir and amantadine was considered attributable to their similar pharmacological effects.\n",
       "\n",
       "</div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from spacy import displacy\n",
    "displacy.render(doc, style='ent', jupyter=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE: To evaluate the therapeutic effects of entecavir (ETV) and interferon-伪 (IFN-伪) treatments for 48 weeks for chronic hepatitis B (CHB) in patients with different baseline alanine aminotransferase (ALT) levels.\n",
      "METHODS:\n",
      "We retrospectively analyzed the data of 369 CHB patients receiving ETV and IFN-伪 treatments for 48 weeks.\n",
      "We compared the virological response rates, HBsAg clearance, and HBsAg reduction between the patients receiving ETV and IFN-伪 treatments with different baseline ALT levels[鈮\n",
      "5脳upper limits of normal (ULN) level (subgroup 1), 5-10脳ULN (subgroup 2), and &gt; 10脳 ULN (subgroup 3)].RESULTS:\n",
      "In patients receiving ETV treatment, the virological response rate was 83.3% in subgroup 1, 91.4% in subgroup 2, and 95.5% in subgroup 3, as compared with 19.7%, 40%, and 42.9% in the 3 subgroups with IFN-伪 treatment, respectively, showing significantly differences both among different subgroups with the same treatment and between the same subgroup with different treatments (P &lt; 0.05).\n",
      "HBeAg clearance rates in the 3 subgroups were 8.3%, 16.7% and 35.5% in patients with ETV treatment and were 1.8%, 41.9%, and 38.1% in patients with IFN-伪 treatment, respectively, showing significant differences among the 3 subgroups with the same treatment (P &lt; 0.05); in the same subgroups with different treatments, the rates differed significantly only between subgroups 2 (P &lt; 0.05).\n",
      "In ETV group, the rate of HBsAg reduction to below 200 IU/ml was 2.5% in subgroup 1 and 13.8% in subgroup 2, showing no significant difference between the two subgroups; in IFN-伪 group, the rates were also similar between subgroups 1 and 2 (30.6% vs 33.3%, P &gt; 0.05); but the rates differed significantly between the same subgroups with different treatments (P &lt; 0.05).CONCLUSIONS:\n",
      "In all the subgroups with different baseline ALT levels, ETV treatment for 48 weeks results in significantly higher virological response rates than IFN-伪 treatment in patients with CHB.\n",
      "In patients with a baseline ALT of 5-10 脳ULN, IFN-伪 can result in a higher HBeAg clearance rate than ETV.\n",
      "In patients with comparable baseline ALT level, IFN-伪 more effectively reduces HBsAg level than ETV.\n",
      "The patients with a relatively high baseline ALT level (&gt; 5 脳 ULN) show better responses to both ETV and IFN-伪 treatment than those with ALT level below 5脳ULN.\n",
      "We thus recommend IFN-伪 for patients with a baseline ALT of 5-10脳ULN and ETV for patients with a baseline ALT either below 5 脳 ULN or beyond 10脳ULN.\n",
      "\n",
      "\n",
      "锘縊bjective\n",
      "To explore the clinical and laboratory characteristics and the prognosis of disseminated non-tuberculous mycobacteria(NTM)diseases in human immunodeficiency virus(HIV)negative patients.\n",
      "Methods Cases of disseminated NTM disease were retrospectively collected in Peking Union Medical College Hospital from January 2012 to October 2018.Clinical manifestations, laboratory findings, treatment, and prognosis of these cases were retrieved from the electronic medical record system.\n",
      "Results Among the 23 HIV negative patients with disseminated NTM disease,21 had underlying diseases, with rheumatoid immune disease(n=7)as the most common one.\n",
      "The main clinical manifestation was fever(n=23).Laboratory tests showed anemia\n",
      "[hemoglobin(85.78卤25.47)g/L],hypoalbuminemia\n",
      "[albumin 29(27\n",
      "-32)g/\n",
      "L],elevated erythrocyte sedimentation rate [(85.73卤43.78)mm/h] and hypersensitive C-reactive protein [(112.00卤70.90)mg/L], and reduction of lymphocyte count [0.69(0.29-2.10)脳10 9/L].Lymphocyte subset analysis indicated reduction in CD4 + T cells [213(113-775)/渭l],CD8 + T cells [267(99-457)/渭l],B cells [39(4-165)/渭l],and\n",
      "NK cells [88(32-279)/渭l] and elevation of human leukocyte antigen-D related(HLA-DR),and CD38 expression in CD8 + T cells\n",
      "[HLA-DR +CD8\n",
      "+/CD8\n",
      "+,60(40-68)%;CD38 +CD8\n",
      "+/CD8\n",
      "+,81(65-90)%].The most common species of NTM was Mycobacterium intracellular(n=6).Lymphocyte,CD8 + T cell, B cell, and NK cell counts were significantly lower in dead patients than surviving patients(P =\n",
      "0.045,P=0.045,P=0.032,and P=0.010,respectively).\n",
      "Conclusions Disseminated NTM disease in HIV negative patients is mainly manifested as fever, anemia, hypoalbuminemia, and elevated inflammatory indicators.\n",
      "It is more likely to occur in immunocompromised patients.\n",
      "Patients with decreased lymphocytes,CD8 + T cells, B cells and NK cells tend to have a poor prognosis.\n",
      "\n",
      "\n",
      "in\n",
      "\t\t\t\tEnglish, Chinese鐩鐨 閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉\n",
      "鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵\n",
      "╁瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd-pshuttle-cmv-hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋 鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁 閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂┒鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE: This study aims to establish an effective and stable periodontal ligament cell line stably expressing human telomerase reverse transcriptase (hTERT) gene by using the adenovirus method.\n",
      "METHODS:\n",
      "Polymerase chain reaction (PCR) was used to amplify the full length of hTERT gene to construct recombinant adenovirus plasmid pAd-pshuttle-cmv-hTERT.\n",
      "Packaged adenovirus particles were used for infection of human periodontal ligament cells.\n",
      "The expression levels of hTERT and osteogenic genes, such as alkaline phosphatase, Runt-related transcription factor 2, bone sialoprotein, osteocalcin, osteopontin, and collagen 鈪 mRNA, were detected by quantitative real-time PCR (qRT-PCR).\n",
      "The ability of osteogenic differentiation was observed by alizarin red staining, and the cell proliferation was determined by CCK-8.RESULTS: Adenovirus particles containing the hTERT gene were successfully constructed and infected with periodontal ligament cells.\n",
      "The infected cells were similar to normal periodontal ligament cells.\n",
      "The qRT-PCR results showed that hTERT and osteogenesis-associated genes were highly expressed in the periodontal ligament cell lines constructed by adenoviruses.\n",
      "Alizarin red staining showed that the periodontal ligament cell line had strong osteogenic differentiation capability.\n",
      "CCK-8 showed that the periodontal ligament cell line had strong proliferation capability.\n",
      "CONCLUSIONS:\n",
      "The human periodontal ligament cell line with high efficiency and stable expression of hTERT was established by the adenovirus method, thereby providing an ideal cell line for studying the mechanism of periodontal regeneration.\n",
      "\n",
      "\n",
      "in\n",
      "\t\t\t\tEnglish, FrenchCryoglobulin茅mies.\n",
      "La cryoglobulin茅mie est d茅finie par la pr茅sence d鈥檜ne cryoglobuline circulante, immunoglobuline pr茅cipitant au froid.\n",
      "Le typage de cette cryoglobuline est fondamental.\n",
      "En effet, on distingue deux sous-groupes : les cryoglobulines de type I et les cryoglobulines mixtes.\n",
      "La physiopathologie et les traitements sont diff茅rents dans ces deux entit茅s.\n",
      "Les cryoglobulin茅mies de type\n",
      "I sont li茅es 脿 une h茅mopathie lympho茂de B monoclonale sous-jacente\n",
      ", alors que les cryoglobulin茅mies mixtes (types II et III) 茅mergent dans des situations de stimulation antig茅nique assez vari茅es,\n",
      "la plus fr茅quente 茅tant le virus de l鈥檋茅patite C. L鈥檌ntensit茅 des sympt么mes est tr猫s variable, beaucoup de patients sont asymptomatiques.\n",
      "Chez les patients symptomatiques, les organes les plus fr茅quemment touch茅s sont la peau, le syst猫me nerveux p茅riph茅rique et le glom茅rule r茅nal.\n",
      "Quelques rares patients ont\n",
      "des atteintes visc茅rales mettant en\n",
      "jeu le\n",
      "pronostic vital.\n",
      "Le traitement prend toujours en\n",
      "compte l鈥檌ntensit茅 des sympt么mes et\n",
      "la pathologie sous-jacente.\n",
      "Dans les cryoglobulin茅mies de type I, le traitement du clone sous-jacent est primordial.\n",
      "Dans celles de type II, on associe le plus souvent un traitement immunosuppresseur au traitement de la cause, si elle est identifi茅e.\n",
      "Cryoglobulinemia.\n",
      "Cryoglobulinemia is defined by the presence of a circulating cryoglobulin, a cold-precipitating immunoglobulin.\n",
      "The typing of this cryoglobulin is fundamental.\n",
      "Indeed, there are two subgroups: cryoglobulin type I and mixed cryoglobulins.\n",
      "The physiopathology and treatments are different in these two entities.\n",
      "Cryoglobulinemia type 1 is associated with an underlying monoclonal lymphoid B hemopathy, while mixed cryoglobulinemia (types II and III) emerge in quite varied antigenic stimulation situations, the most common being the hepatitis C virus.\n",
      "The intensity of the symptoms is very variable, many patients are asymptomatic.\n",
      "In symptomatic patients, the most frequently affected organs are the skin, the peripheral nervous system and the renal glomerulus.\n",
      "Few patients have visceral involvement that is life-threatening.\n",
      "The treatment always takes into account the intensity of the symptoms and the underlying pathology.\n",
      "In cryoglobulinemia type I, treatment of the underlying clone is essential.\n",
      "In type II, immunosuppressive therapy is most often associated with treatment of the cause, if identified.\n",
      "\n",
      "\n",
      "Objective\n",
      "To measure the effect of duck viperin protein on the proliferation of duck Tembusu virus (DTMUV).\n",
      "Methods\n",
      "We analyzed the duck viperin gene using a bioinformatics.\n",
      "Plasmids pGEX-6P-viperin and pEGFP-N1-viperin were constructed and transformed into Rosseta and transfected into BHK-21 cells, respectively.\n",
      "BHK-21\n",
      "cells transfected with plasmid pEGFP-N1-viperin and empty vector were infected with DTMUV.\n",
      "The content of DTMUV in cell precipitation and supernatant was analyzed by real-time fluorescent quantitative PCR.\n",
      "Finally, the effect of viperin on DTMUV proliferation and the binding proteins captured by EGFP monoclonal antibody were evaluated using mass spectrometry.\n",
      "Results Significant differences were observed between the expression levels of viperin gene in duck compared to other species.\n",
      "Duck viperin was found to inhibit the budding of DTMUV in BHK-21 cells.\n",
      "Further, we identified six proteins that might be involved in the inhibition of the proliferation and budding of DTMUV, possibly indicative of the viperin anti-Tembusu virus pathway in ducks.\n",
      "Conclusion Expression patterns of duck viperin reveal how the budding of duck Tembusu virus is inhibited.\n",
      "\n",
      "\n",
      "in\n",
      "\t\t\t\tEnglish, Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem cell leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial cells of Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c-kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24\n",
      "h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48 h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮┖鐧界粍銆佺┖鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺\n",
      "┖鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48 h锛岄噰鐢\n",
      "╓\n",
      "estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit\n",
      "铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48 h鍚庯紝绌虹櫧缁勩佺┖鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To determine the effect of a recombinant lentivirus containing human stem cell leukemia (SCL) gene on the expression of c-kit protein in damaged interstitial cells of Cajal (ICC) under high glucose condition.鈥\n",
      "Methods:\n",
      "After isolation of ICC, the cells were cultured for 24 hours until the cells were adherent.\n",
      "After identification by inverted microscope and immunofluorescence, ICC cells were divided into two groups: A control group and a high glucose group.\n",
      "The control group was added with a medium containing 5 mmol/L of glucose.\n",
      "The high glucose group was added with a medium containing 20 mmol/L of glucose.\n",
      "After 48 h of continuous cultivation, the high glucose group was divided into 3 subgroups: A blank group, an empty lentivirus group, and an experimental group.\n",
      "The blank group, the empty lentivirus group, and the experimental group were added a medium containing PBS solution, empty lentivirus, and a recombinant lentivirus containing the SCL gene with a glucose concentration of 5 mmol/L, respectively.\n",
      "The cultures were incubated for 24 and 48 h.\n",
      "The expression of c-kit protein in ICC in each group was detected by Western blot.鈥 Results: After 24 or 48 h, the expression of c-kit protein in ICC was significantly lower in the blank group and the lentivirus group than that in the control group, and the expression of c-kit protein in ICC was significantly higher in the experimental group than that in the blank group and the empty lentivirus group, but it was still lower than that in the control group (all P<0.05).鈥 Conclusion: The recombinant lentivirus of SCL gene can up-regulate the expression of c-kit protein in functionally impaired ICC under high glucose condition.\n",
      "\n",
      "\n",
      "OBJECTIVE: To study the effects of respiratory syncytial virus (RSV) infection on epidermal growth factor receptor (EGFR), tight junction association proteins and mucin in the human airway epithelial cells.\n",
      "METHODS:\n",
      "Human airway epithelial cells\n",
      "NCI-H292 were randomly treated by ultraviolet light-inactivated RSV (control group) or thawed RSV (RSV infection group).\n",
      "After 48 hours of treatment, the protein levels of occludin, E-cadherin, phosphorylated EGFR and EGFR in NCI-H292 cells were measured by Western blot.\n",
      "The distribution and expression levels of occludin and E-cadherin in NCI-H292 cells were examined by immunofluorescence technique.\n",
      "The expression levels of MUC5AC mRNA in NCI-H292 cells were assessed by RT-PCR.RESULTS:\n",
      "The protein levels of occludin and E-cadherin were significantly reduced in the RSV infection group compared with the control group (P<0.05).\n",
      "The protein levels of phosphorylated EGFR and EGFR increased significantly in the RSV infection group compared with the control group (P<0.05).\n",
      "The MUC5AC mRNA levels also increased significantly in the RSV infection group compared with the control group (P<0.05).CONCLUSIONS:\n",
      "RSV may down-regulate the tight junction association proteins and up-regulate the expression of MUC5AC in airway epithelial cells, which contributes to epithelial barrier dysfunction.\n",
      "EGFR phosphorylation may play an important role in regulation of airway barrier.\n",
      "\n",
      "\n",
      "Objective\n",
      "To establish a human B lymphoma cell line which can stably express Epstein-Barr virus latent membrane protein 1 (LMP1).\n",
      "Methods The LMP1 coding gene with EcoRI and BamHI restriction sites was amplified, cloned into pcDNA3.1-EF1a-mcs-3FLAG-CMV-EGFP plasmid, and positive monoclonal competent cells were picked for PCR and sequencing.\n",
      "The recombinant plasmid was transfected into Ramos cells by electroporation, and the cell line stably expressing LMP1 was picked by G418.\n",
      "The expression of LMP1 in Ramos cells was detected by PCR, Western blot analysis and green fluorescent protein Tag.\n",
      "Results PCR and sequencing confirmed that the LMP1 recombinant plasmid was successfully constructed and a stably transfected Ramos cell line was established.\n",
      "Western blot analysis confirmed that LMP1 protein was successfully expressed in this cell line.\n",
      "Conclusion The Ramos cells stably expressing LMP1 have been successfully established.\n",
      "\n",
      "\n",
      "in\n",
      "\t\t\t\tEnglish, HungarianAbsztrakt:\n",
      "A hepatitis C-v铆rus (HCV) megk枚zel铆t艖leg 4 milli贸 煤j fert艖z茅st okoz 茅vente,\n",
      "茅s\n",
      "399聽000 beteg hal meg a fert艖z茅s k枚vetkezt茅ben kialakul贸 sz枚v艖dm茅nyek,\n",
      "cirrhosis 茅s hepatocellularis carcinoma\n",
      "(HCC) miatt.\n",
      "Id眉lt HCV-fert艖z茅sben a mikrok枚rnyezeti v谩ltoz谩sok, a fert艖z茅s kiv谩ltotta id眉lt gyullad谩s\n",
      ", az oxidat铆v stressz 茅s az endoplazm谩s reticulum stressz genetikai, epigenetikai v谩ltoz谩sokon kereszt眉l 茅vtizedek alatt vezethetnek primer m谩jr谩k kialakul谩s谩hoz.\n",
      "A HCV direkt hepatocarcinogen tulajdons谩ga ismert.\n",
      "N茅gy HCV-feh茅rje (core, NS3, NS4B, NS5A) transzform谩ci贸s tulajdons谩ga bizony铆tott.\n",
      "A hat茅kony antivir谩lis kezel茅s, a tart贸s v铆rusv谩lasz el茅r茅se a HCV okozta m谩j-\n",
      ", valamint a nem m谩jeredet疟 hal谩loz谩st cs枚kkenti.\n",
      "Az interferonalap煤 antivir谩lis kezel茅s a HCC el艖fordul谩s谩t cs枚kkenti.\n",
      "A direkt hat贸 antivir谩lis szerek (DAA) el艖nye a nagyobb ar谩ny煤 tart贸s v铆rusv谩lasz, a kevesebb mell茅khat谩s, valamint a r枚videbb ter谩pi谩s id艖tartam.\n",
      "Az elm煤lt n茅h谩ny 茅vben k枚zlem茅nyek jelentek meg, amelyek a DAA-kezel茅sek nem v谩rt hat谩sair贸l sz谩moltak be.\n",
      "A szerz艖k ismertetik a DAA-kezel茅sekben a HCC el艖fordul谩s谩t vizsg谩l贸 tanulm谩nyok eredm茅nyeit.\n",
      "A k茅rd茅s pontos eld枚nt茅s茅re\n",
      "tov谩bbi prospekt铆v, multicentrikus vizsg谩latok, hosszabb k枚vet茅si id艖szakok, a kontrollcsoportok pontos kiv谩laszt谩sa sz眉ks茅ges.\n",
      "A v铆rusellenes kezel茅s befejez茅se ut谩n is kiemelked艖 jelent艖s茅g疟 a HCC-surveillance,\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "amelyet a rendszeres (3鈥6鈥12 havonta v茅gzett)\n",
      "hasi UH-vizsg谩lat jelent, m茅g\n",
      "a sikeresen kezelt betegekn茅l is.\n",
      "Orv Hetil.\n",
      "2019\n",
      "; 160(22): 846鈥853.Hepatitis C virus infection causes approximately 4 million new infections worldwide, and 399聽000 deaths due to its complications, cirrhosis and hepatocellular carcinoma (HCC).\n",
      "Microenvironmental changes, chronic inflammation, oxidative stress, endoplasmic reticulum stress caused by HCV infection, via genetic and epigenetic changes can result in primary liver cancer during decades.\n",
      "The direct oncogenic property of HCV is wellknown.\n",
      "The transforming effect of four HCV proteins (core, NS3, NS4B, NS5A) has been proven.\n",
      "Effective antiviral therapy, sustained viral response decreases the HCV-related general and liver-related mortality.\n",
      "Interferon-based therapy reduces the risk of HCC development.\n",
      "Shorter therapy with direct acting antiviral agents (DAA) has higher efficacy, fewer side-effects.\n",
      "Publications have reported the unexpected effects of DAA.\n",
      "The authors review the articles focusing on the occurrence of HCC in connection with DAA therapies.\n",
      "There is a need for prospective, multicentric studies with longer follow-up to examine the risk of HCC formation.\n",
      "After antiviral therapy, HCC surveillance is of high importance which means abdominal ultrasound every 3-6-12 months in sustained viral response patients as well.\n",
      "Orv Hetil.\n",
      "2019\n",
      "; 160(22): 846-853.\n",
      "\n",
      "\n",
      "Although the anti-influenza virus drug oseltamivir ameliorates the fever of influenza, adverse events related to its hypothermic effect have been reported.\n",
      "We found that oseltamivir causes dose-dependent hypothermia in normal mice, and have been studying the pharmacological mechanisms responsible for 12 years.\n",
      "Oseltamivir blocks nicotinic cholinergic transmission at sympathetic ganglia and reduces sympathetic modulation of brown adipose tissue (BAT), a heat generator.\n",
      "Oseltamivir was found to target the ion channels of nicotinic acetylcholine receptors, as demonstrated by patch clamp experiments with cells expressing the human 伪3尾4 nicotinic receptor.\n",
      "Metabolized oseltamivir carboxylate, which inhibits the influenza virus neuraminidase, did not elicit hypothermia and ion channel suppression.\n",
      "Body temperature was decreased by intracerebroventricular administration of oseltamivir.\n",
      "Because this hypothermic effect was inhibited by dopamine D2 receptor blockade, it was suggested that oseltamivir centrally stimulates the D2 receptor.\n",
      "In Japan, the package inserts for oseltamivir and amantadine indicate very similar adverse neuropsychiatric reactions for the two drugs (abnormal behavior, consciousness disturbance, convulsion, delirium, delusion, hallucination).\n",
      "A literature search revealed that in some previous studies, oseltamivir and amantadine were shown to block the ion channel systems and activate the dopaminergic nervous system via several mechanisms.\n",
      "Therefore the similarity of the adverse reactions elicited by oseltamivir and amantadine was considered attributable to their similar pharmacological effects.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for sent in doc.sents:\n",
    "    print(sent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<generator at 0x1a89fa58e88>"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "doc.sents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[OBJECTIVE: To evaluate the therapeutic effects of entecavir (ETV) and interferon-伪 (IFN-伪) treatments for 48 weeks for chronic hepatitis B (CHB) in patients with different baseline alanine aminotransferase (ALT) levels.,\n",
       " METHODS:,\n",
       " We retrospectively analyzed the data of 369 CHB patients receiving ETV and IFN-伪 treatments for 48 weeks.,\n",
       " We compared the virological response rates, HBsAg clearance, and HBsAg reduction between the patients receiving ETV and IFN-伪 treatments with different baseline ALT levels[鈮,\n",
       " 5脳upper limits of normal (ULN) level (subgroup 1), 5-10脳ULN (subgroup 2), and &gt; 10脳 ULN (subgroup 3)].RESULTS:,\n",
       " In patients receiving ETV treatment, the virological response rate was 83.3% in subgroup 1, 91.4% in subgroup 2, and 95.5% in subgroup 3, as compared with 19.7%, 40%, and 42.9% in the 3 subgroups with IFN-伪 treatment, respectively, showing significantly differences both among different subgroups with the same treatment and between the same subgroup with different treatments (P &lt; 0.05).,\n",
       " HBeAg clearance rates in the 3 subgroups were 8.3%, 16.7% and 35.5% in patients with ETV treatment and were 1.8%, 41.9%, and 38.1% in patients with IFN-伪 treatment, respectively, showing significant differences among the 3 subgroups with the same treatment (P &lt; 0.05); in the same subgroups with different treatments, the rates differed significantly only between subgroups 2 (P &lt; 0.05).,\n",
       " In ETV group, the rate of HBsAg reduction to below 200 IU/ml was 2.5% in subgroup 1 and 13.8% in subgroup 2, showing no significant difference between the two subgroups; in IFN-伪 group, the rates were also similar between subgroups 1 and 2 (30.6% vs 33.3%, P &gt; 0.05); but the rates differed significantly between the same subgroups with different treatments (P &lt; 0.05).CONCLUSIONS:,\n",
       " In all the subgroups with different baseline ALT levels, ETV treatment for 48 weeks results in significantly higher virological response rates than IFN-伪 treatment in patients with CHB.,\n",
       " In patients with a baseline ALT of 5-10 脳ULN, IFN-伪 can result in a higher HBeAg clearance rate than ETV.,\n",
       " In patients with comparable baseline ALT level, IFN-伪 more effectively reduces HBsAg level than ETV.,\n",
       " The patients with a relatively high baseline ALT level (&gt; 5 脳 ULN) show better responses to both ETV and IFN-伪 treatment than those with ALT level below 5脳ULN.,\n",
       " We thus recommend IFN-伪 for patients with a baseline ALT of 5-10脳ULN and ETV for patients with a baseline ALT either below 5 脳 ULN or beyond 10脳ULN.\n",
       " ,\n",
       " 锘縊bjective,\n",
       " To explore the clinical and laboratory characteristics and the prognosis of disseminated non-tuberculous mycobacteria(NTM)diseases in human immunodeficiency virus(HIV)negative patients.,\n",
       " Methods Cases of disseminated NTM disease were retrospectively collected in Peking Union Medical College Hospital from January 2012 to October 2018.Clinical manifestations, laboratory findings, treatment, and prognosis of these cases were retrieved from the electronic medical record system.,\n",
       " Results Among the 23 HIV negative patients with disseminated NTM disease,21 had underlying diseases, with rheumatoid immune disease(n=7)as the most common one.,\n",
       " The main clinical manifestation was fever(n=23).Laboratory tests showed anemia,\n",
       " [hemoglobin(85.78卤25.47)g/L],hypoalbuminemia,\n",
       " [albumin 29(27,\n",
       " -32)g/,\n",
       " L],elevated erythrocyte sedimentation rate [(85.73卤43.78)mm/h] and hypersensitive C-reactive protein [(112.00卤70.90)mg/L], and reduction of lymphocyte count [0.69(0.29-2.10)脳10 9/L].Lymphocyte subset analysis indicated reduction in CD4 + T cells [213(113-775)/渭l],CD8 + T cells [267(99-457)/渭l],B cells [39(4-165)/渭l],and,\n",
       " NK cells [88(32-279)/渭l] and elevation of human leukocyte antigen-D related(HLA-DR),and CD38 expression in CD8 + T cells,\n",
       " [HLA-DR +CD8,\n",
       " +/CD8,\n",
       " +,60(40-68)%;CD38 +CD8,\n",
       " +/CD8,\n",
       " +,81(65-90)%].The most common species of NTM was Mycobacterium intracellular(n=6).Lymphocyte,CD8 + T cell, B cell, and NK cell counts were significantly lower in dead patients than surviving patients(P =,\n",
       " 0.045,P=0.045,P=0.032,and P=0.010,respectively).,\n",
       " Conclusions Disseminated NTM disease in HIV negative patients is mainly manifested as fever, anemia, hypoalbuminemia, and elevated inflammatory indicators.,\n",
       " It is more likely to occur in immunocompromised patients.,\n",
       " Patients with decreased lymphocytes,CD8 + T cells, B cells and NK cells tend to have a poor prognosis.\n",
       " ,\n",
       " in\n",
       " \t\t\t\tEnglish, Chinese鐩鐨 閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉,\n",
       " 鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵,\n",
       " ╁瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd-pshuttle-cmv-hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋 鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁 閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂┒鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE: This study aims to establish an effective and stable periodontal ligament cell line stably expressing human telomerase reverse transcriptase (hTERT) gene by using the adenovirus method.,\n",
       " METHODS:,\n",
       " Polymerase chain reaction (PCR) was used to amplify the full length of hTERT gene to construct recombinant adenovirus plasmid pAd-pshuttle-cmv-hTERT.,\n",
       " Packaged adenovirus particles were used for infection of human periodontal ligament cells.,\n",
       " The expression levels of hTERT and osteogenic genes, such as alkaline phosphatase, Runt-related transcription factor 2, bone sialoprotein, osteocalcin, osteopontin, and collagen 鈪 mRNA, were detected by quantitative real-time PCR (qRT-PCR).,\n",
       " The ability of osteogenic differentiation was observed by alizarin red staining, and the cell proliferation was determined by CCK-8.RESULTS: Adenovirus particles containing the hTERT gene were successfully constructed and infected with periodontal ligament cells.,\n",
       " The infected cells were similar to normal periodontal ligament cells.,\n",
       " The qRT-PCR results showed that hTERT and osteogenesis-associated genes were highly expressed in the periodontal ligament cell lines constructed by adenoviruses.,\n",
       " Alizarin red staining showed that the periodontal ligament cell line had strong osteogenic differentiation capability.,\n",
       " CCK-8 showed that the periodontal ligament cell line had strong proliferation capability.,\n",
       " CONCLUSIONS:,\n",
       " The human periodontal ligament cell line with high efficiency and stable expression of hTERT was established by the adenovirus method, thereby providing an ideal cell line for studying the mechanism of periodontal regeneration.\n",
       " ,\n",
       " in\n",
       " \t\t\t\tEnglish, FrenchCryoglobulin茅mies.,\n",
       " La cryoglobulin茅mie est d茅finie par la pr茅sence d鈥檜ne cryoglobuline circulante, immunoglobuline pr茅cipitant au froid.,\n",
       " Le typage de cette cryoglobuline est fondamental.,\n",
       " En effet, on distingue deux sous-groupes : les cryoglobulines de type I et les cryoglobulines mixtes.,\n",
       " La physiopathologie et les traitements sont diff茅rents dans ces deux entit茅s.,\n",
       " Les cryoglobulin茅mies de type,\n",
       " I sont li茅es 脿 une h茅mopathie lympho茂de B monoclonale sous-jacente,\n",
       " , alors que les cryoglobulin茅mies mixtes (types II et III) 茅mergent dans des situations de stimulation antig茅nique assez vari茅es,,\n",
       " la plus fr茅quente 茅tant le virus de l鈥檋茅patite C. L鈥檌ntensit茅 des sympt么mes est tr猫s variable, beaucoup de patients sont asymptomatiques.,\n",
       " Chez les patients symptomatiques, les organes les plus fr茅quemment touch茅s sont la peau, le syst猫me nerveux p茅riph茅rique et le glom茅rule r茅nal.,\n",
       " Quelques rares patients ont,\n",
       " des atteintes visc茅rales mettant en,\n",
       " jeu le,\n",
       " pronostic vital.,\n",
       " Le traitement prend toujours en,\n",
       " compte l鈥檌ntensit茅 des sympt么mes et,\n",
       " la pathologie sous-jacente.,\n",
       " Dans les cryoglobulin茅mies de type I, le traitement du clone sous-jacent est primordial.,\n",
       " Dans celles de type II, on associe le plus souvent un traitement immunosuppresseur au traitement de la cause, si elle est identifi茅e.,\n",
       " Cryoglobulinemia.,\n",
       " Cryoglobulinemia is defined by the presence of a circulating cryoglobulin, a cold-precipitating immunoglobulin.,\n",
       " The typing of this cryoglobulin is fundamental.,\n",
       " Indeed, there are two subgroups: cryoglobulin type I and mixed cryoglobulins.,\n",
       " The physiopathology and treatments are different in these two entities.,\n",
       " Cryoglobulinemia type 1 is associated with an underlying monoclonal lymphoid B hemopathy, while mixed cryoglobulinemia (types II and III) emerge in quite varied antigenic stimulation situations, the most common being the hepatitis C virus.,\n",
       " The intensity of the symptoms is very variable, many patients are asymptomatic.,\n",
       " In symptomatic patients, the most frequently affected organs are the skin, the peripheral nervous system and the renal glomerulus.,\n",
       " Few patients have visceral involvement that is life-threatening.,\n",
       " The treatment always takes into account the intensity of the symptoms and the underlying pathology.,\n",
       " In cryoglobulinemia type I, treatment of the underlying clone is essential.,\n",
       " In type II, immunosuppressive therapy is most often associated with treatment of the cause, if identified.\n",
       " ,\n",
       " Objective,\n",
       " To measure the effect of duck viperin protein on the proliferation of duck Tembusu virus (DTMUV).,\n",
       " Methods,\n",
       " We analyzed the duck viperin gene using a bioinformatics.,\n",
       " Plasmids pGEX-6P-viperin and pEGFP-N1-viperin were constructed and transformed into Rosseta and transfected into BHK-21 cells, respectively.,\n",
       " BHK-21,\n",
       " cells transfected with plasmid pEGFP-N1-viperin and empty vector were infected with DTMUV.,\n",
       " The content of DTMUV in cell precipitation and supernatant was analyzed by real-time fluorescent quantitative PCR.,\n",
       " Finally, the effect of viperin on DTMUV proliferation and the binding proteins captured by EGFP monoclonal antibody were evaluated using mass spectrometry.,\n",
       " Results Significant differences were observed between the expression levels of viperin gene in duck compared to other species.,\n",
       " Duck viperin was found to inhibit the budding of DTMUV in BHK-21 cells.,\n",
       " Further, we identified six proteins that might be involved in the inhibition of the proliferation and budding of DTMUV, possibly indicative of the viperin anti-Tembusu virus pathway in ducks.,\n",
       " Conclusion Expression patterns of duck viperin reveal how the budding of duck Tembusu virus is inhibited.\n",
       " ,\n",
       " in\n",
       " \t\t\t\tEnglish, Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem cell leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial cells of Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c-kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24,\n",
       " h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48 h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮┖鐧界粍銆佺┖鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺,\n",
       " ┖鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5 mmol/L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48 h锛岄噰鐢,\n",
       " ╓,\n",
       " estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit,\n",
       " 铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48 h鍚庯紝绌虹櫧缁勩佺┖鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To determine the effect of a recombinant lentivirus containing human stem cell leukemia (SCL) gene on the expression of c-kit protein in damaged interstitial cells of Cajal (ICC) under high glucose condition.鈥,\n",
       " Methods:,\n",
       " After isolation of ICC, the cells were cultured for 24 hours until the cells were adherent.,\n",
       " After identification by inverted microscope and immunofluorescence, ICC cells were divided into two groups: A control group and a high glucose group.,\n",
       " The control group was added with a medium containing 5 mmol/L of glucose.,\n",
       " The high glucose group was added with a medium containing 20 mmol/L of glucose.,\n",
       " After 48 h of continuous cultivation, the high glucose group was divided into 3 subgroups: A blank group, an empty lentivirus group, and an experimental group.,\n",
       " The blank group, the empty lentivirus group, and the experimental group were added a medium containing PBS solution, empty lentivirus, and a recombinant lentivirus containing the SCL gene with a glucose concentration of 5 mmol/L, respectively.,\n",
       " The cultures were incubated for 24 and 48 h.,\n",
       " The expression of c-kit protein in ICC in each group was detected by Western blot.鈥 Results: After 24 or 48 h, the expression of c-kit protein in ICC was significantly lower in the blank group and the lentivirus group than that in the control group, and the expression of c-kit protein in ICC was significantly higher in the experimental group than that in the blank group and the empty lentivirus group, but it was still lower than that in the control group (all P<0.05).鈥 Conclusion: The recombinant lentivirus of SCL gene can up-regulate the expression of c-kit protein in functionally impaired ICC under high glucose condition.\n",
       " ,\n",
       " OBJECTIVE: To study the effects of respiratory syncytial virus (RSV) infection on epidermal growth factor receptor (EGFR), tight junction association proteins and mucin in the human airway epithelial cells.,\n",
       " METHODS:,\n",
       " Human airway epithelial cells,\n",
       " NCI-H292 were randomly treated by ultraviolet light-inactivated RSV (control group) or thawed RSV (RSV infection group).,\n",
       " After 48 hours of treatment, the protein levels of occludin, E-cadherin, phosphorylated EGFR and EGFR in NCI-H292 cells were measured by Western blot.,\n",
       " The distribution and expression levels of occludin and E-cadherin in NCI-H292 cells were examined by immunofluorescence technique.,\n",
       " The expression levels of MUC5AC mRNA in NCI-H292 cells were assessed by RT-PCR.RESULTS:,\n",
       " The protein levels of occludin and E-cadherin were significantly reduced in the RSV infection group compared with the control group (P<0.05).,\n",
       " The protein levels of phosphorylated EGFR and EGFR increased significantly in the RSV infection group compared with the control group (P<0.05).,\n",
       " The MUC5AC mRNA levels also increased significantly in the RSV infection group compared with the control group (P<0.05).CONCLUSIONS:,\n",
       " RSV may down-regulate the tight junction association proteins and up-regulate the expression of MUC5AC in airway epithelial cells, which contributes to epithelial barrier dysfunction.,\n",
       " EGFR phosphorylation may play an important role in regulation of airway barrier.\n",
       " ,\n",
       " Objective,\n",
       " To establish a human B lymphoma cell line which can stably express Epstein-Barr virus latent membrane protein 1 (LMP1).,\n",
       " Methods The LMP1 coding gene with EcoRI and BamHI restriction sites was amplified, cloned into pcDNA3.1-EF1a-mcs-3FLAG-CMV-EGFP plasmid, and positive monoclonal competent cells were picked for PCR and sequencing.,\n",
       " The recombinant plasmid was transfected into Ramos cells by electroporation, and the cell line stably expressing LMP1 was picked by G418.,\n",
       " The expression of LMP1 in Ramos cells was detected by PCR, Western blot analysis and green fluorescent protein Tag.,\n",
       " Results PCR and sequencing confirmed that the LMP1 recombinant plasmid was successfully constructed and a stably transfected Ramos cell line was established.,\n",
       " Western blot analysis confirmed that LMP1 protein was successfully expressed in this cell line.,\n",
       " Conclusion The Ramos cells stably expressing LMP1 have been successfully established.\n",
       " ,\n",
       " in\n",
       " \t\t\t\tEnglish, HungarianAbsztrakt:,\n",
       " A hepatitis C-v铆rus (HCV) megk枚zel铆t艖leg 4 milli贸 煤j fert艖z茅st okoz 茅vente,,\n",
       " 茅s,\n",
       " 399聽000 beteg hal meg a fert艖z茅s k枚vetkezt茅ben kialakul贸 sz枚v艖dm茅nyek,,\n",
       " cirrhosis 茅s hepatocellularis carcinoma,\n",
       " (HCC) miatt.,\n",
       " Id眉lt HCV-fert艖z茅sben a mikrok枚rnyezeti v谩ltoz谩sok, a fert艖z茅s kiv谩ltotta id眉lt gyullad谩s,\n",
       " , az oxidat铆v stressz 茅s az endoplazm谩s reticulum stressz genetikai, epigenetikai v谩ltoz谩sokon kereszt眉l 茅vtizedek alatt vezethetnek primer m谩jr谩k kialakul谩s谩hoz.,\n",
       " A HCV direkt hepatocarcinogen tulajdons谩ga ismert.,\n",
       " N茅gy HCV-feh茅rje (core, NS3, NS4B, NS5A) transzform谩ci贸s tulajdons谩ga bizony铆tott.,\n",
       " A hat茅kony antivir谩lis kezel茅s, a tart贸s v铆rusv谩lasz el茅r茅se a HCV okozta m谩j-,\n",
       " , valamint a nem m谩jeredet疟 hal谩loz谩st cs枚kkenti.,\n",
       " Az interferonalap煤 antivir谩lis kezel茅s a HCC el艖fordul谩s谩t cs枚kkenti.,\n",
       " A direkt hat贸 antivir谩lis szerek (DAA) el艖nye a nagyobb ar谩ny煤 tart贸s v铆rusv谩lasz, a kevesebb mell茅khat谩s, valamint a r枚videbb ter谩pi谩s id艖tartam.,\n",
       " Az elm煤lt n茅h谩ny 茅vben k枚zlem茅nyek jelentek meg, amelyek a DAA-kezel茅sek nem v谩rt hat谩sair贸l sz谩moltak be.,\n",
       " A szerz艖k ismertetik a DAA-kezel茅sekben a HCC el艖fordul谩s谩t vizsg谩l贸 tanulm谩nyok eredm茅nyeit.,\n",
       " A k茅rd茅s pontos eld枚nt茅s茅re,\n",
       " tov谩bbi prospekt铆v, multicentrikus vizsg谩latok, hosszabb k枚vet茅si id艖szakok, a kontrollcsoportok pontos kiv谩laszt谩sa sz眉ks茅ges.,\n",
       " A v铆rusellenes kezel茅s befejez茅se ut谩n is kiemelked艖 jelent艖s茅g疟 a HCC-surveillance,,\n",
       " amelyet a rendszeres (3鈥6鈥12 havonta v茅gzett),\n",
       " hasi UH-vizsg谩lat jelent, m茅g,\n",
       " a sikeresen kezelt betegekn茅l is.,\n",
       " Orv Hetil.,\n",
       " 2019,\n",
       " ; 160(22): 846鈥853.Hepatitis C virus infection causes approximately 4 million new infections worldwide, and 399聽000 deaths due to its complications, cirrhosis and hepatocellular carcinoma (HCC).,\n",
       " Microenvironmental changes, chronic inflammation, oxidative stress, endoplasmic reticulum stress caused by HCV infection, via genetic and epigenetic changes can result in primary liver cancer during decades.,\n",
       " The direct oncogenic property of HCV is wellknown.,\n",
       " The transforming effect of four HCV proteins (core, NS3, NS4B, NS5A) has been proven.,\n",
       " Effective antiviral therapy, sustained viral response decreases the HCV-related general and liver-related mortality.,\n",
       " Interferon-based therapy reduces the risk of HCC development.,\n",
       " Shorter therapy with direct acting antiviral agents (DAA) has higher efficacy, fewer side-effects.,\n",
       " Publications have reported the unexpected effects of DAA.,\n",
       " The authors review the articles focusing on the occurrence of HCC in connection with DAA therapies.,\n",
       " There is a need for prospective, multicentric studies with longer follow-up to examine the risk of HCC formation.,\n",
       " After antiviral therapy, HCC surveillance is of high importance which means abdominal ultrasound every 3-6-12 months in sustained viral response patients as well.,\n",
       " Orv Hetil.,\n",
       " 2019,\n",
       " ; 160(22): 846-853.\n",
       " ,\n",
       " Although the anti-influenza virus drug oseltamivir ameliorates the fever of influenza, adverse events related to its hypothermic effect have been reported.,\n",
       " We found that oseltamivir causes dose-dependent hypothermia in normal mice, and have been studying the pharmacological mechanisms responsible for 12 years.,\n",
       " Oseltamivir blocks nicotinic cholinergic transmission at sympathetic ganglia and reduces sympathetic modulation of brown adipose tissue (BAT), a heat generator.,\n",
       " Oseltamivir was found to target the ion channels of nicotinic acetylcholine receptors, as demonstrated by patch clamp experiments with cells expressing the human 伪3尾4 nicotinic receptor.,\n",
       " Metabolized oseltamivir carboxylate, which inhibits the influenza virus neuraminidase, did not elicit hypothermia and ion channel suppression.,\n",
       " Body temperature was decreased by intracerebroventricular administration of oseltamivir.,\n",
       " Because this hypothermic effect was inhibited by dopamine D2 receptor blockade, it was suggested that oseltamivir centrally stimulates the D2 receptor.,\n",
       " In Japan, the package inserts for oseltamivir and amantadine indicate very similar adverse neuropsychiatric reactions for the two drugs (abnormal behavior, consciousness disturbance, convulsion, delirium, delusion, hallucination).,\n",
       " A literature search revealed that in some previous studies, oseltamivir and amantadine were shown to block the ion channel systems and activate the dopaminergic nervous system via several mechanisms.,\n",
       " Therefore the similarity of the adverse reactions elicited by oseltamivir and amantadine was considered attributable to their similar pharmacological effects.\n",
       " ]"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(doc.sents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "newdoc = nlp(list(doc.sents)[0].text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE/NNP <--ROOT-- OBJECTIVE/NNP\n",
      ":/: <--punct-- OBJECTIVE/NNP\n",
      "To/TO <--aux-- evaluate/VB\n",
      "evaluate/VB <--acl-- OBJECTIVE/NNP\n",
      "the/DT <--det-- effects/NNS\n",
      "therapeutic/JJ <--amod-- effects/NNS\n",
      "effects/NNS <--dobj-- evaluate/VB\n",
      "of/IN <--prep-- effects/NNS\n",
      "entecavir/NN <--pobj-- of/IN\n",
      "(/-LRB- <--punct-- entecavir/NN\n",
      "ETV/NNP <--appos-- entecavir/NN\n",
      ")/-RRB- <--punct-- entecavir/NN\n",
      "and/CC <--cc-- entecavir/NN\n",
      "interferon-伪/NNP <--nmod-- treatments/VBZ\n",
      "(/-LRB- <--punct-- treatments/VBZ\n",
      "IFN-伪/JJ <--nmod-- treatments/VBZ\n",
      ")/-RRB- <--punct-- treatments/VBZ\n",
      "treatments/VBZ <--conj-- entecavir/NN\n",
      "for/IN <--prep-- treatments/VBZ\n",
      "48/CD <--nummod-- weeks/NNS\n",
      "weeks/NNS <--pobj-- for/IN\n",
      "for/IN <--prep-- weeks/NNS\n",
      "chronic/JJ <--amod-- B/NNP\n",
      "hepatitis/NN <--compound-- B/NNP\n",
      "B/NNP <--pobj-- for/IN\n",
      "(/-LRB- <--punct-- CHB/NNP\n",
      "CHB/NNP <--appos-- B/NNP\n",
      ")/-RRB- <--punct-- B/NNP\n",
      "in/IN <--prep-- treatments/VBZ\n",
      "patients/NNS <--pobj-- in/IN\n",
      "with/IN <--prep-- patients/NNS\n",
      "different/JJ <--amod-- aminotransferase/NN\n",
      "baseline/NN <--compound-- alanine/NN\n",
      "alanine/NN <--compound-- aminotransferase/NN\n",
      "aminotransferase/NN <--pobj-- with/IN\n",
      "(/-LRB- <--punct-- levels/NNS\n",
      "ALT/NNP <--nmod-- levels/NNS\n",
      ")/-RRB- <--punct-- levels/NNS\n",
      "levels/NNS <--appos-- aminotransferase/NN\n",
      "./. <--punct-- OBJECTIVE/NNP\n"
     ]
    }
   ],
   "source": [
    "for token in newdoc:\n",
    "    print(\"{0}/{1} <--{2}-- {3}/{4}\".format(\n",
    "        token.text, token.tag_, token.dep_, token.head.text, token.head.tag_))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" xml:lang=\"en\" id=\"b6d989a1046a44cd997e07597e118946-0\" class=\"displacy\" width=\"2750\" height=\"407.0\" direction=\"ltr\" style=\"max-width: none; height: 407.0px; color: #000000; background: #ffffff; font-family: Arial; direction: ltr\">\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"50\">OBJECTIVE:</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"50\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"140\">To</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"140\">PART</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"230\">evaluate</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"230\">VERB</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"320\">the</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"320\">DET</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"410\">therapeutic</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"410\">ADJ</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"500\">effects</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"500\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"590\">of</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"590\">ADP</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"680\">entecavir (</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"680\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"770\">ETV)</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"770\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"860\">and</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"860\">CCONJ</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"950\">interferon-伪 (</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"950\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1040\">IFN-伪)</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1040\">ADJ</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1130\">treatments</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1130\">VERB</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1220\">for</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1220\">ADP</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1310\">48</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1310\">NUM</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1400\">weeks</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1400\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1490\">for</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1490\">ADP</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1580\">chronic</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1580\">ADJ</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1670\">hepatitis</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1670\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1760\">B (</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1760\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1850\">CHB)</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1850\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"1940\">in</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"1940\">ADP</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2030\">patients</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2030\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2120\">with</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2120\">ADP</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2210\">different</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2210\">ADJ</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2300\">baseline</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2300\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2390\">alanine</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2390\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2480\">aminotransferase (</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2480\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2570\">ALT)</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2570\">PROPN</tspan>\n",
       "</text>\n",
       "\n",
       "<text class=\"displacy-token\" fill=\"currentColor\" text-anchor=\"middle\" y=\"317.0\">\n",
       "    <tspan class=\"displacy-word\" fill=\"currentColor\" x=\"2660\">levels.</tspan>\n",
       "    <tspan class=\"displacy-tag\" dy=\"2em\" fill=\"currentColor\" x=\"2660\">NOUN</tspan>\n",
       "</text>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-0\" stroke-width=\"2px\" d=\"M160,272.0 C160,227.0 205.0,227.0 205.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-0\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">aux</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M160,274.0 L152,262.0 168,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-1\" stroke-width=\"2px\" d=\"M70,272.0 C70,182.0 210.0,182.0 210.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-1\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">acl</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M210.0,274.0 L218.0,262.0 202.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-2\" stroke-width=\"2px\" d=\"M340,272.0 C340,182.0 480.0,182.0 480.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-2\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">det</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M340,274.0 L332,262.0 348,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-3\" stroke-width=\"2px\" d=\"M430,272.0 C430,227.0 475.0,227.0 475.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-3\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">amod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M430,274.0 L422,262.0 438,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-4\" stroke-width=\"2px\" d=\"M250,272.0 C250,137.0 485.0,137.0 485.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-4\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">dobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M485.0,274.0 L493.0,262.0 477.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-5\" stroke-width=\"2px\" d=\"M520,272.0 C520,227.0 565.0,227.0 565.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-5\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">prep</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M565.0,274.0 L573.0,262.0 557.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-6\" stroke-width=\"2px\" d=\"M610,272.0 C610,227.0 655.0,227.0 655.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-6\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">pobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M655.0,274.0 L663.0,262.0 647.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-7\" stroke-width=\"2px\" d=\"M700,272.0 C700,227.0 745.0,227.0 745.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-7\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">appos</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M745.0,274.0 L753.0,262.0 737.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-8\" stroke-width=\"2px\" d=\"M700,272.0 C700,182.0 840.0,182.0 840.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-8\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">cc</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M840.0,274.0 L848.0,262.0 832.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-9\" stroke-width=\"2px\" d=\"M970,272.0 C970,182.0 1110.0,182.0 1110.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-9\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">nmod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M970,274.0 L962,262.0 978,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-10\" stroke-width=\"2px\" d=\"M1060,272.0 C1060,227.0 1105.0,227.0 1105.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-10\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">nmod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1060,274.0 L1052,262.0 1068,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-11\" stroke-width=\"2px\" d=\"M700,272.0 C700,47.0 1125.0,47.0 1125.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-11\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">conj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1125.0,274.0 L1133.0,262.0 1117.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-12\" stroke-width=\"2px\" d=\"M1150,272.0 C1150,227.0 1195.0,227.0 1195.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-12\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">prep</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1195.0,274.0 L1203.0,262.0 1187.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-13\" stroke-width=\"2px\" d=\"M1330,272.0 C1330,227.0 1375.0,227.0 1375.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-13\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">nummod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1330,274.0 L1322,262.0 1338,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-14\" stroke-width=\"2px\" d=\"M1240,272.0 C1240,182.0 1380.0,182.0 1380.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-14\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">pobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1380.0,274.0 L1388.0,262.0 1372.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-15\" stroke-width=\"2px\" d=\"M1420,272.0 C1420,227.0 1465.0,227.0 1465.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-15\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">prep</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1465.0,274.0 L1473.0,262.0 1457.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-16\" stroke-width=\"2px\" d=\"M1600,272.0 C1600,182.0 1740.0,182.0 1740.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-16\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">amod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1600,274.0 L1592,262.0 1608,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-17\" stroke-width=\"2px\" d=\"M1690,272.0 C1690,227.0 1735.0,227.0 1735.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-17\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">compound</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1690,274.0 L1682,262.0 1698,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-18\" stroke-width=\"2px\" d=\"M1510,272.0 C1510,137.0 1745.0,137.0 1745.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-18\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">pobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1745.0,274.0 L1753.0,262.0 1737.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-19\" stroke-width=\"2px\" d=\"M1780,272.0 C1780,227.0 1825.0,227.0 1825.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-19\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">appos</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1825.0,274.0 L1833.0,262.0 1817.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-20\" stroke-width=\"2px\" d=\"M1150,272.0 C1150,2.0 1940.0,2.0 1940.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-20\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">prep</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M1940.0,274.0 L1948.0,262.0 1932.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-21\" stroke-width=\"2px\" d=\"M1960,272.0 C1960,227.0 2005.0,227.0 2005.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-21\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">pobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2005.0,274.0 L2013.0,262.0 1997.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-22\" stroke-width=\"2px\" d=\"M2050,272.0 C2050,227.0 2095.0,227.0 2095.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-22\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">prep</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2095.0,274.0 L2103.0,262.0 2087.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-23\" stroke-width=\"2px\" d=\"M2230,272.0 C2230,137.0 2465.0,137.0 2465.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-23\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">amod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2230,274.0 L2222,262.0 2238,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-24\" stroke-width=\"2px\" d=\"M2320,272.0 C2320,227.0 2365.0,227.0 2365.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-24\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">compound</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2320,274.0 L2312,262.0 2328,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-25\" stroke-width=\"2px\" d=\"M2410,272.0 C2410,227.0 2455.0,227.0 2455.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-25\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">compound</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2410,274.0 L2402,262.0 2418,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-26\" stroke-width=\"2px\" d=\"M2140,272.0 C2140,92.0 2470.0,92.0 2470.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-26\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">pobj</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2470.0,274.0 L2478.0,262.0 2462.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-27\" stroke-width=\"2px\" d=\"M2590,272.0 C2590,227.0 2635.0,227.0 2635.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-27\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">nmod</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2590,274.0 L2582,262.0 2598,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "\n",
       "<g class=\"displacy-arrow\">\n",
       "    <path class=\"displacy-arc\" id=\"arrow-b6d989a1046a44cd997e07597e118946-0-28\" stroke-width=\"2px\" d=\"M2500,272.0 C2500,182.0 2640.0,182.0 2640.0,272.0\" fill=\"none\" stroke=\"currentColor\"/>\n",
       "    <text dy=\"1.25em\" style=\"font-size: 0.8em; letter-spacing: 1px\">\n",
       "        <textPath xlink:href=\"#arrow-b6d989a1046a44cd997e07597e118946-0-28\" class=\"displacy-label\" startOffset=\"50%\" side=\"left\" fill=\"currentColor\" text-anchor=\"middle\">appos</textPath>\n",
       "    </text>\n",
       "    <path class=\"displacy-arrowhead\" d=\"M2640.0,274.0 L2648.0,262.0 2632.0,262.0\" fill=\"currentColor\"/>\n",
       "</g>\n",
       "</svg>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "displacy.render(newdoc, style='dep', jupyter=True, options={'distance': 90})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "ename": "OSError",
     "evalue": "[E053] Could not read meta.json from D:\\en_core_web_lg-2.0.0.tar.gz\\meta.json",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mOSError\u001b[0m                                   Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-42-40824e7ff2b0>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mnlp\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mspacy\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mload\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'D:\\\\en_core_web_lg-2.0.0.tar.gz'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m      2\u001b[0m \u001b[0mprint\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mnlp\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mvocab\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;34m'subgroup'\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mvector\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\AAAAAAFor ZLY\\PYTHON\\ANACONDA\\realANACONDA\\envs\\deeplearning1\\lib\\site-packages\\spacy\\__init__.py\u001b[0m in \u001b[0;36mload\u001b[1;34m(name, **overrides)\u001b[0m\n\u001b[0;32m     25\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[0mdepr_path\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[1;32min\u001b[0m \u001b[1;33m(\u001b[0m\u001b[1;32mTrue\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;32mFalse\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;32mNone\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     26\u001b[0m         \u001b[0mdeprecation_warning\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mWarnings\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mW001\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mformat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mdepr_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 27\u001b[1;33m     \u001b[1;32mreturn\u001b[0m \u001b[0mutil\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mload_model\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0moverrides\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     28\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     29\u001b[0m \u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\AAAAAAFor ZLY\\PYTHON\\ANACONDA\\realANACONDA\\envs\\deeplearning1\\lib\\site-packages\\spacy\\util.py\u001b[0m in \u001b[0;36mload_model\u001b[1;34m(name, **overrides)\u001b[0m\n\u001b[0;32m    134\u001b[0m             \u001b[1;32mreturn\u001b[0m \u001b[0mload_model_from_package\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0moverrides\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    135\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[0mPath\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mexists\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m  \u001b[1;31m# path to model data directory\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 136\u001b[1;33m             \u001b[1;32mreturn\u001b[0m \u001b[0mload_model_from_path\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mPath\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0moverrides\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    137\u001b[0m     \u001b[1;32melif\u001b[0m \u001b[0mhasattr\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m\"exists\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m  \u001b[1;31m# Path or Path-like to model data\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    138\u001b[0m         \u001b[1;32mreturn\u001b[0m \u001b[0mload_model_from_path\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mname\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;33m**\u001b[0m\u001b[0moverrides\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\AAAAAAFor ZLY\\PYTHON\\ANACONDA\\realANACONDA\\envs\\deeplearning1\\lib\\site-packages\\spacy\\util.py\u001b[0m in \u001b[0;36mload_model_from_path\u001b[1;34m(model_path, meta, **overrides)\u001b[0m\n\u001b[0;32m    160\u001b[0m     pipeline from meta.json and then calls from_disk() with path.\"\"\"\n\u001b[0;32m    161\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mmeta\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 162\u001b[1;33m         \u001b[0mmeta\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mget_model_meta\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmodel_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    163\u001b[0m     \u001b[1;31m# Support language factories registered via entry points (e.g. custom\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    164\u001b[0m     \u001b[1;31m# language subclass) while keeping top-level language identifier \"lang\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32mC:\\AAAAAAFor ZLY\\PYTHON\\ANACONDA\\realANACONDA\\envs\\deeplearning1\\lib\\site-packages\\spacy\\util.py\u001b[0m in \u001b[0;36mget_model_meta\u001b[1;34m(path)\u001b[0m\n\u001b[0;32m    208\u001b[0m     \u001b[0mmeta_path\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mmodel_path\u001b[0m \u001b[1;33m/\u001b[0m \u001b[1;34m\"meta.json\"\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    209\u001b[0m     \u001b[1;32mif\u001b[0m \u001b[1;32mnot\u001b[0m \u001b[0mmeta_path\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mis_file\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m--> 210\u001b[1;33m         \u001b[1;32mraise\u001b[0m \u001b[0mIOError\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mErrors\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mE053\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mformat\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mpath\u001b[0m\u001b[1;33m=\u001b[0m\u001b[0mmeta_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m    211\u001b[0m     \u001b[0mmeta\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0msrsly\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mread_json\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mmeta_path\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m    212\u001b[0m     \u001b[1;32mfor\u001b[0m \u001b[0msetting\u001b[0m \u001b[1;32min\u001b[0m \u001b[1;33m[\u001b[0m\u001b[1;34m\"lang\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m\"name\"\u001b[0m\u001b[1;33m,\u001b[0m \u001b[1;34m\"version\"\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mOSError\u001b[0m: [E053] Could not read meta.json from D:\\en_core_web_lg-2.0.0.tar.gz\\meta.json"
     ]
    }
   ],
   "source": [
    "nlp = spacy.load('en_core_web_sm')\n",
    "print(nlp.vocab['subgroup'].vector)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "import plac\n",
    "import random\n",
    "import pathlib\n",
    "import cytoolz\n",
    "import numpy\n",
    "from keras.models import Sequential, model_from_json\n",
    "from keras.layers import LSTM, Dense, Embedding, Bidirectional\n",
    "from keras.layers import TimeDistributed\n",
    "from keras.optimizers import Adam\n",
    "import thinc.extra.datasets\n",
    "from spacy.compat import pickle"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "dog = nlp.vocab[\"dog\"]\n",
    "cat = nlp.vocab[\"cat\"]\n",
    "apple = nlp.vocab[\"apple\"]\n",
    "orange = nlp.vocab[\"orange\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "ename": "ValueError",
     "evalue": "[E010] Word vectors set to length 0. This may be because you don't have a model installed or loaded, or because your model doesn't include word vectors. For more info, see the docs:\nhttps://spacy.io/usage/models",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-22-475ba1f20a1b>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0mdog\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msimilarity\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0mcat\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;32mlexeme.pyx\u001b[0m in \u001b[0;36mspacy.lexeme.Lexeme.similarity\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mlexeme.pyx\u001b[0m in \u001b[0;36mspacy.lexeme.Lexeme.vector_norm.__get__\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;32mlexeme.pyx\u001b[0m in \u001b[0;36mspacy.lexeme.Lexeme.vector.__get__\u001b[1;34m()\u001b[0m\n",
      "\u001b[1;31mValueError\u001b[0m: [E010] Word vectors set to length 0. This may be because you don't have a model installed or loaded, or because your model doesn't include word vectors. For more info, see the docs:\nhttps://spacy.io/usage/models"
     ]
    }
   ],
   "source": [
    "dog.similarity(cat)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "from scipy.spatial.distance import cosine"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE\t0\tOBJECTIVE\tFalse\tFalse\tXXXX\tPROPN\tNNP\n",
      ":\t9\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "To\t11\tto\tFalse\tFalse\tXx\tPART\tTO\n",
      "evaluate\t14\tevaluate\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "the\t23\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "therapeutic\t27\ttherapeutic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "effects\t39\teffect\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t47\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "entecavir\t50\tentecavir\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t60\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ETV\t61\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t64\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "and\t66\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "interferon-伪\t70\tinterferon-伪\tFalse\tFalse\txxxx-x\tPROPN\tNNP\n",
      "(\t83\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "IFN-伪\t84\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      ")\t89\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "treatments\t91\ttreatment\tFalse\tFalse\txxxx\tVERB\tVBZ\n",
      "for\t102\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "48\t106\t48\tFalse\tFalse\tdd\tNUM\tCD\n",
      "weeks\t109\tweek\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "for\t115\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "chronic\t119\tchronic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "hepatitis\t127\thepatitis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "B\t137\tB\tFalse\tFalse\tX\tPROPN\tNNP\n",
      "(\t139\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "CHB\t140\tCHB\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t143\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "in\t145\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "patients\t148\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t157\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t162\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t172\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "alanine\t181\talanine\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "aminotransferase\t189\taminotransferase\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t206\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ALT\t207\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t210\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "levels\t212\tlevel\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t218\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "METHODS\t219\tmethod\tFalse\tFalse\tXXXX\tNOUN\tNNS\n",
      ":\t226\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "We\t228\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "retrospectively\t231\tretrospectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      "analyzed\t247\tanalyze\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "the\t256\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "data\t260\tdatum\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t265\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "369\t268\t369\tFalse\tFalse\tddd\tNUM\tCD\n",
      "CHB\t272\tCHB\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "patients\t276\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t285\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t295\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "and\t299\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "IFN-伪\t303\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatments\t309\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "for\t320\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "48\t324\t48\tFalse\tFalse\tdd\tNUM\tCD\n",
      "weeks\t327\tweek\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t332\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "We\t334\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "compared\t337\tcompare\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "the\t346\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "virological\t350\tvirological\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "response\t362\tresponse\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rates\t371\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t376\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "HBsAg\t378\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "clearance\t384\tclearance\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t393\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t395\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "HBsAg\t399\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "reduction\t405\treduction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "between\t415\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t423\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "patients\t427\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t436\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t446\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "and\t450\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "IFN-伪\t454\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatments\t460\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t471\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t476\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t486\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "ALT\t495\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "levels[鈮\t499\tlevels[鈮\tFalse\tFalse\txxxx[x\tPUNCT\t.\n",
      "5脳upper\t508\t5脳upper\tFalse\tFalse\tdxxxx\tNUM\tCD\n",
      "limits\t516\tlimit\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t523\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "normal\t526\tnormal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "(\t533\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "ULN\t534\tULN\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t537\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "level\t539\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t545\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t546\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "1\t555\t1\tFalse\tFalse\td\tNUM\tCD\n",
      ")\t556\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ",\t557\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "5\t559\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "-\t560\t-\tTrue\tFalse\t-\tSYM\tSYM\n",
      "10脳ULN\t561\t10脳uln\tFalse\tFalse\tddxXXX\tNUM\tCD\n",
      "(\t568\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t569\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t578\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ")\t579\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ",\t580\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t582\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "&\t586\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "gt\t587\tgt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t589\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "10脳\t591\t10脳\tFalse\tFalse\tddx\tVERB\tVBZ\n",
      "ULN\t595\tULN\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "(\t599\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "subgroup\t600\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "3)].RESULTS\t609\t3)].RESULTS\tFalse\tFalse\td)].XXXX\tPROPN\tNNP\n",
      ":\t620\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "In\t622\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "patients\t625\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "receiving\t634\treceive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "ETV\t644\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "treatment\t648\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t657\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "the\t659\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "virological\t663\tvirological\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "response\t675\tresponse\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rate\t684\trate\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "was\t689\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "83.3\t693\t83.3\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t697\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t699\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t702\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "1\t711\t1\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t712\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "91.4\t714\t91.4\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t718\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t720\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t723\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t732\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t733\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t735\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "95.5\t739\t95.5\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t743\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t745\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t748\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "3\t757\t3\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t758\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "as\t760\tas\tFalse\tFalse\txx\tADP\tIN\n",
      "compared\t763\tcompare\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "with\t772\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "19.7\t777\t19.7\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t781\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t782\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "40\t784\t40\tFalse\tFalse\tdd\tNUM\tCD\n",
      "%\t786\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t787\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t789\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "42.9\t793\t42.9\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t797\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t799\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "the\t802\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "3\t806\t3\tFalse\tFalse\td\tNUM\tCD\n",
      "subgroups\t808\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t818\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "IFN-伪\t823\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatment\t829\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t838\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "respectively\t840\trespectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      ",\t852\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "showing\t854\tshow\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "significantly\t862\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "differences\t876\tdifference\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "both\t888\tboth\tFalse\tFalse\txxxx\tDET\tDT\n",
      "among\t893\tamong\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t899\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroups\t909\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t919\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t924\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t928\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatment\t933\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "and\t943\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "between\t947\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t955\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t959\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroup\t964\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "with\t973\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t978\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatments\t988\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "(\t999\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "P\t1000\tp\tFalse\tFalse\tX\tNOUN\tNN\n",
      "&\t1002\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "lt\t1003\tlt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1005\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05\t1007\t0.05\tFalse\tFalse\td.dd\tNUM\tCD\n",
      ")\t1011\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ".\t1012\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "HBeAg\t1014\tHBeAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "clearance\t1020\tclearance\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rates\t1030\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "in\t1036\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "the\t1039\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "3\t1043\t3\tFalse\tFalse\td\tNUM\tCD\n",
      "subgroups\t1045\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t1055\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "8.3\t1060\t8.3\tFalse\tFalse\td.d\tNUM\tCD\n",
      "%\t1063\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t1064\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "16.7\t1066\t16.7\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1070\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "and\t1072\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "35.5\t1076\t35.5\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1080\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t1082\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "patients\t1085\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1094\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "ETV\t1099\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "treatment\t1103\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "and\t1113\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "were\t1117\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "1.8\t1122\t1.8\tFalse\tFalse\td.d\tNUM\tCD\n",
      "%\t1125\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t1126\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "41.9\t1128\t41.9\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1132\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t1133\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t1135\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "38.1\t1139\t38.1\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1143\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t1145\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "patients\t1148\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1157\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "IFN-伪\t1162\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatment\t1168\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t1177\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "respectively\t1179\trespectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      ",\t1191\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "showing\t1193\tshow\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "significant\t1201\tsignificant\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "differences\t1213\tdifference\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "among\t1225\tamong\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t1231\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "3\t1235\t3\tFalse\tFalse\td\tNUM\tCD\n",
      "subgroups\t1237\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1247\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t1252\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t1256\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatment\t1261\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t1271\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "P\t1272\tp\tFalse\tFalse\tX\tNOUN\tNN\n",
      "&\t1274\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "lt\t1275\tlt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1277\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05\t1279\t0.05\tFalse\tFalse\td.dd\tNUM\tCD\n",
      ")\t1283\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ";\t1284\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "in\t1286\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "the\t1289\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t1293\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroups\t1298\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1308\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t1313\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatments\t1323\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t1333\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "the\t1335\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "rates\t1339\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "differed\t1345\tdiffer\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "significantly\t1354\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "only\t1368\tonly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "between\t1373\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "subgroups\t1381\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "2\t1391\t2\tFalse\tFalse\td\tNUM\tCD\n",
      "(\t1393\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "P\t1394\tp\tFalse\tFalse\tX\tNOUN\tNN\n",
      "&\t1396\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "lt\t1397\tlt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1399\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05\t1401\t0.05\tFalse\tFalse\td.dd\tNUM\tCD\n",
      ")\t1405\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ".\t1406\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "In\t1408\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "ETV\t1411\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "group\t1415\tgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t1420\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "the\t1422\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "rate\t1426\trate\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t1431\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "HBsAg\t1434\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "reduction\t1440\treduction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "to\t1450\tto\tFalse\tFalse\txx\tADP\tIN\n",
      "below\t1453\tbelow\tFalse\tFalse\txxxx\tADP\tIN\n",
      "200\t1459\t200\tFalse\tFalse\tddd\tNUM\tCD\n",
      "IU\t1463\tIU\tFalse\tFalse\tXX\tPROPN\tNNP\n",
      "/\t1465\t/\tTrue\tFalse\t/\tSYM\tSYM\n",
      "ml\t1466\tml\tFalse\tFalse\txx\tPROPN\tNNP\n",
      "was\t1469\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "2.5\t1473\t2.5\tFalse\tFalse\td.d\tNUM\tCD\n",
      "%\t1476\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t1478\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t1481\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "1\t1490\t1\tFalse\tFalse\td\tNUM\tCD\n",
      "and\t1492\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "13.8\t1496\t13.8\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1500\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "in\t1502\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "subgroup\t1505\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t1514\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t1515\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "showing\t1517\tshow\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "no\t1525\tno\tFalse\tFalse\txx\tDET\tDT\n",
      "significant\t1528\tsignificant\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "difference\t1540\tdifference\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "between\t1551\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t1559\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "two\t1563\ttwo\tFalse\tFalse\txxx\tNUM\tCD\n",
      "subgroups\t1567\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ";\t1576\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "in\t1578\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "IFN-伪\t1581\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "group\t1587\tgroup\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t1592\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "the\t1594\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "rates\t1598\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t1604\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "also\t1609\talso\tFalse\tFalse\txxxx\tADV\tRB\n",
      "similar\t1614\tsimilar\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "between\t1622\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "subgroups\t1630\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "1\t1640\t1\tFalse\tFalse\td\tNUM\tCD\n",
      "and\t1642\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "2\t1646\t2\tFalse\tFalse\td\tNUM\tCD\n",
      "(\t1648\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "30.6\t1649\t30.6\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1653\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      "vs\t1655\tvs\tFalse\tFalse\txx\tADP\tIN\n",
      "33.3\t1658\t33.3\tFalse\tFalse\tdd.d\tNUM\tCD\n",
      "%\t1662\t%\tTrue\tFalse\t%\tNOUN\tNN\n",
      ",\t1663\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "P\t1665\tP\tFalse\tFalse\tX\tPROPN\tNNP\n",
      "&\t1667\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "gt\t1668\tgt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1670\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05\t1672\t0.05\tFalse\tFalse\td.dd\tNUM\tCD\n",
      ")\t1676\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ";\t1677\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "but\t1679\tbut\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "the\t1683\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "rates\t1687\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "differed\t1693\tdiffer\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "significantly\t1702\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "between\t1716\tbetween\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t1724\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "same\t1728\tsame\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "subgroups\t1733\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1743\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t1748\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "treatments\t1758\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "(\t1769\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "P\t1770\tp\tFalse\tFalse\tX\tNOUN\tNN\n",
      "&\t1772\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "lt\t1773\tlt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t1775\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "0.05).CONCLUSIONS\t1777\t0.05).conclusions\tFalse\tFalse\td.dd).XXXX\tNOUN\tNN\n",
      ":\t1794\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "In\t1796\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "all\t1799\tall\tFalse\tFalse\txxx\tDET\tPDT\n",
      "the\t1803\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "subgroups\t1807\tsubgroup\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1817\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "different\t1822\tdifferent\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t1832\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "ALT\t1841\talt\tFalse\tFalse\tXXX\tNOUN\tNN\n",
      "levels\t1845\tlevel\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t1851\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "ETV\t1853\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "treatment\t1857\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "for\t1867\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "48\t1871\t48\tFalse\tFalse\tdd\tNUM\tCD\n",
      "weeks\t1874\tweek\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "results\t1880\tresult\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "in\t1888\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "significantly\t1891\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "higher\t1905\thigh\tFalse\tFalse\txxxx\tADJ\tJJR\n",
      "virological\t1912\tvirological\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "response\t1924\tresponse\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rates\t1933\trate\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "than\t1939\tthan\tFalse\tFalse\txxxx\tADP\tIN\n",
      "IFN-伪\t1944\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatment\t1950\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "in\t1960\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "patients\t1963\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1972\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "CHB\t1977\tCHB\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ".\t1980\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "In\t1982\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "patients\t1985\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t1994\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "a\t1999\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "baseline\t2001\tbaseline\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ALT\t2010\talt\tFalse\tFalse\tXXX\tNOUN\tNN\n",
      "of\t2014\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "5\t2017\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "-\t2018\t-\tTrue\tFalse\t-\tSYM\tSYM\n",
      "10\t2019\t10\tFalse\tFalse\tdd\tNUM\tCD\n",
      "脳ULN\t2022\t脳ULN\tFalse\tFalse\txXXX\tPROPN\tNNP\n",
      ",\t2026\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "IFN-伪\t2028\tIFN-伪\tFalse\tFalse\tXXX-x\tPROPN\tNNP\n",
      "can\t2034\tcan\tFalse\tFalse\txxx\tVERB\tMD\n",
      "result\t2038\tresult\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "in\t2045\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "a\t2048\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "higher\t2050\thigh\tFalse\tFalse\txxxx\tADJ\tJJR\n",
      "HBeAg\t2057\tHBeAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "clearance\t2063\tclearance\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rate\t2073\trate\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "than\t2078\tthan\tFalse\tFalse\txxxx\tADP\tIN\n",
      "ETV\t2083\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ".\t2086\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "In\t2088\tin\tFalse\tFalse\tXx\tADP\tIN\n",
      "patients\t2091\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t2100\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "comparable\t2105\tcomparable\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t2116\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ALT\t2125\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "level\t2129\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t2134\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "IFN-伪\t2136\tifn-伪\tFalse\tFalse\tXXX-x\tADP\tIN\n",
      "more\t2142\tmore\tFalse\tFalse\txxxx\tADV\tRBR\n",
      "effectively\t2147\teffectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      "reduces\t2159\treduce\tFalse\tFalse\txxxx\tVERB\tVBZ\n",
      "HBsAg\t2167\tHBsAg\tFalse\tFalse\tXXxXx\tPROPN\tNNP\n",
      "level\t2173\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "than\t2179\tthan\tFalse\tFalse\txxxx\tADP\tIN\n",
      "ETV\t2184\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ".\t2187\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t2189\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "patients\t2193\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t2202\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "a\t2207\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "relatively\t2209\trelatively\tFalse\tFalse\txxxx\tADV\tRB\n",
      "high\t2220\thigh\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "baseline\t2225\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "ALT\t2234\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "level\t2238\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t2244\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "&\t2245\t&\tTrue\tFalse\t&\tCCONJ\tCC\n",
      "gt\t2246\tgt\tFalse\tFalse\txx\tNOUN\tNN\n",
      ";\t2248\t;\tTrue\tFalse\t;\tPUNCT\t:\n",
      "5\t2250\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "脳\t2252\t脳\tFalse\tFalse\tx\tNOUN\tNN\n",
      "ULN\t2254\tULN\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t2257\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "show\t2259\tshow\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "better\t2264\twell\tFalse\tFalse\txxxx\tADJ\tJJR\n",
      "responses\t2271\tresponse\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "to\t2281\tto\tFalse\tFalse\txx\tADP\tIN\n",
      "both\t2284\tboth\tFalse\tFalse\txxxx\tCCONJ\tCC\n",
      "ETV\t2289\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "and\t2293\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "IFN-伪\t2297\tifn-伪\tFalse\tFalse\tXXX-x\tADJ\tJJ\n",
      "treatment\t2303\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "than\t2313\tthan\tFalse\tFalse\txxxx\tADP\tIN\n",
      "those\t2318\tthose\tFalse\tFalse\txxxx\tDET\tDT\n",
      "with\t2324\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "ALT\t2329\tALT\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "level\t2333\tlevel\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "below\t2339\tbelow\tFalse\tFalse\txxxx\tADP\tIN\n",
      "5脳ULN\t2345\t5脳uln\tFalse\tFalse\tdxXXX\tNUM\tCD\n",
      ".\t2350\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "We\t2352\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "thus\t2355\tthus\tFalse\tFalse\txxxx\tADV\tRB\n",
      "recommend\t2360\trecommend\tFalse\tFalse\txxxx\tVERB\tVBP\n",
      "IFN-伪\t2370\tifn-伪\tFalse\tFalse\tXXX-x\tADP\tIN\n",
      "for\t2376\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "patients\t2380\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t2389\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "a\t2394\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "baseline\t2396\tbaseline\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ALT\t2405\talt\tFalse\tFalse\tXXX\tNOUN\tNN\n",
      "of\t2409\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "5\t2412\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "-\t2413\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "10脳ULN\t2414\t10脳uln\tFalse\tFalse\tddxXXX\tNUM\tCD\n",
      "and\t2421\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "ETV\t2425\tETV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "for\t2429\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "patients\t2433\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t2442\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "a\t2447\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "baseline\t2449\tbaseline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "ALT\t2458\talt\tFalse\tFalse\tXXX\tNOUN\tNN\n",
      "either\t2462\teither\tFalse\tFalse\txxxx\tCCONJ\tCC\n",
      "below\t2469\tbelow\tFalse\tFalse\txxxx\tADP\tIN\n",
      "5\t2475\t5\tFalse\tFalse\td\tNUM\tCD\n",
      "脳\t2477\t脳\tFalse\tFalse\tx\tNOUN\tNN\n",
      "ULN\t2479\tuln\tFalse\tFalse\tXXX\tADJ\tJJ\n",
      "or\t2483\tor\tFalse\tFalse\txx\tCCONJ\tCC\n",
      "beyond\t2486\tbeyond\tFalse\tFalse\txxxx\tADP\tIN\n",
      "10脳ULN\t2493\t10脳uln\tFalse\tFalse\tddxXXX\tNUM\tCD\n",
      ".\t2499\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "\n",
      "\n",
      "\t2500\t\n",
      "\n",
      "\tFalse\tTrue\t\n",
      "\n",
      "\tSPACE\t_SP\n",
      "锘縊bjective\t2502\t锘縊bjective\tFalse\tFalse\txxxx\tVERB\tVBP\n",
      "To\t2513\tto\tFalse\tFalse\tXx\tPART\tTO\n",
      "explore\t2516\texplore\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "the\t2524\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "clinical\t2528\tclinical\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "and\t2537\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "laboratory\t2541\tlaboratory\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "characteristics\t2552\tcharacteristic\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "and\t2568\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "the\t2572\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "prognosis\t2576\tprognosis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t2586\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "disseminated\t2589\tdisseminate\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "non\t2602\tnon\tFalse\tFalse\txxx\tADJ\tJJ\n",
      "-\t2605\t-\tTrue\tFalse\t-\tADJ\tJJ\n",
      "tuberculous\t2606\ttuberculous\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "mycobacteria(NTM)diseases\t2618\tmycobacteria(ntm)disease\tFalse\tFalse\txxxx(XXX)xxxx\tNOUN\tNNS\n",
      "in\t2644\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "human\t2647\thuman\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "immunodeficiency\t2653\timmunodeficiency\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "virus(HIV)negative\t2670\tvirus(HIV)negative\tFalse\tFalse\txxxx(XXX)xxxx\tPROPN\tNNP\n",
      "patients\t2689\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t2697\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "Methods\t2699\tmethod\tFalse\tFalse\tXxxxx\tNOUN\tNNS\n",
      "Cases\t2707\tcase\tFalse\tFalse\tXxxxx\tNOUN\tNNS\n",
      "of\t2713\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "disseminated\t2716\tdisseminate\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "NTM\t2729\tNTM\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "disease\t2733\tdisease\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "were\t2741\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "retrospectively\t2746\tretrospectively\tFalse\tFalse\txxxx\tADV\tRB\n",
      "collected\t2762\tcollect\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "in\t2772\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "Peking\t2775\tPeking\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "Union\t2782\tUnion\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "Medical\t2788\tMedical\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "College\t2796\tCollege\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "Hospital\t2804\tHospital\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "from\t2813\tfrom\tFalse\tFalse\txxxx\tADP\tIN\n",
      "January\t2818\tJanuary\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "2012\t2826\t2012\tFalse\tFalse\tdddd\tNUM\tCD\n",
      "to\t2831\tto\tFalse\tFalse\txx\tADP\tIN\n",
      "October\t2834\tOctober\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "2018.Clinical\t2842\t2018.clinical\tFalse\tFalse\tdddd.Xxxxx\tNUM\tCD\n",
      "manifestations\t2856\tmanifestation\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t2870\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "laboratory\t2872\tlaboratory\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "findings\t2883\tfinding\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t2891\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "treatment\t2893\ttreatment\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t2902\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t2904\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "prognosis\t2908\tprognosis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t2918\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "these\t2921\tthese\tFalse\tFalse\txxxx\tDET\tDT\n",
      "cases\t2927\tcase\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t2933\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "retrieved\t2938\tretrieve\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "from\t2948\tfrom\tFalse\tFalse\txxxx\tADP\tIN\n",
      "the\t2953\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "electronic\t2957\telectronic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "medical\t2968\tmedical\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "record\t2976\trecord\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "system\t2983\tsystem\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ".\t2989\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "Results\t2991\tresult\tFalse\tFalse\tXxxxx\tNOUN\tNNS\n",
      "Among\t2999\tamong\tFalse\tFalse\tXxxxx\tADP\tIN\n",
      "the\t3005\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "23\t3009\t23\tFalse\tFalse\tdd\tNUM\tCD\n",
      "HIV\t3012\tHIV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "negative\t3016\tnegative\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "patients\t3025\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "with\t3034\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "disseminated\t3039\tdisseminate\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "NTM\t3052\tNTM\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "disease,21\t3056\tdisease,21\tFalse\tFalse\txxxx,dd\tNOUN\tNN\n",
      "had\t3067\thave\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "underlying\t3071\tunderlie\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "diseases\t3082\tdisease\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t3090\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "with\t3092\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "rheumatoid\t3097\trheumatoid\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "immune\t3108\timmune\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "disease(n=7)as\t3115\tdisease(n=7)as\tFalse\tFalse\txxxx(x=d)xx\tPROPN\tNNP\n",
      "the\t3130\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "most\t3134\tmost\tFalse\tFalse\txxxx\tADV\tRBS\n",
      "common\t3139\tcommon\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "one\t3146\tone\tFalse\tFalse\txxx\tNUM\tCD\n",
      ".\t3149\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t3151\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "main\t3155\tmain\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "clinical\t3160\tclinical\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "manifestation\t3169\tmanifestation\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "was\t3183\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "fever(n=23).Laboratory\t3187\tfever(n=23).laboratory\tFalse\tFalse\txxxx(x=dd).Xxxxx\tADJ\tJJ\n",
      "tests\t3210\ttest\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "showed\t3216\tshow\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "anemia\t3223\tanemia\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "[\t3230\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "hemoglobin(85.78卤25.47)g\t3231\themoglobin(85.78卤25.47)g\tFalse\tFalse\txxxx(dd.ddxdd.dd)x\tPROPN\tNNP\n",
      "/\t3255\t/\tTrue\tFalse\t/\tSYM\tSYM\n",
      "L],hypoalbuminemia\t3256\tL],hypoalbuminemia\tFalse\tFalse\tX],xxxx\tNOUN\tNNS\n",
      "[\t3275\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "albumin\t3276\talbumin\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "29(27\t3284\t29(27\tFalse\tFalse\tdd(dd\tNUM\tCD\n",
      "-\t3289\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "32)g\t3290\t32)g\tFalse\tFalse\tdd)x\tPROPN\tNNP\n",
      "/\t3294\t/\tTrue\tFalse\t/\tSYM\tSYM\n",
      "L],elevated\t3295\tl],elevated\tFalse\tFalse\tX],xxxx\tADJ\tJJ\n",
      "erythrocyte\t3307\terythrocyte\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "sedimentation\t3319\tsedimentation\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "rate\t3333\trate\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "[\t3338\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "(\t3339\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "85.73卤43.78)mm\t3340\t85.73卤43.78)mm\tFalse\tFalse\tdd.ddxdd.dd)xx\tNUM\tCD\n",
      "/\t3354\t/\tTrue\tFalse\t/\tSYM\tSYM\n",
      "h\t3355\th\tFalse\tFalse\tx\tNOUN\tNN\n",
      "]\t3356\t]\tTrue\tFalse\t]\tPUNCT\t-RRB-\n",
      "and\t3358\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "hypersensitive\t3362\thypersensitive\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "C\t3377\tc\tFalse\tFalse\tX\tNOUN\tNN\n",
      "-\t3378\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "reactive\t3379\treactive\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "protein\t3388\tprotein\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "[\t3396\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "(\t3397\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "112.00卤70.90)mg\t3398\t112.00卤70.90)mg\tFalse\tFalse\tddd.ddxdd.dd)xx\tNUM\tCD\n",
      "/\t3413\t/\tTrue\tFalse\t/\tSYM\tSYM\n",
      "L\t3414\tl\tFalse\tFalse\tX\tNOUN\tNN\n",
      "]\t3415\t]\tTrue\tFalse\t]\tPUNCT\t-RRB-\n",
      ",\t3416\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t3418\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "reduction\t3422\treduction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t3432\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "lymphocyte\t3435\tlymphocyte\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "count\t3446\tcount\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "[\t3452\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "0.69(0.29\t3453\t0.69(0.29\tFalse\tFalse\td.dd(d.dd\tNUM\tCD\n",
      "-\t3462\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "2.10)脳10\t3463\t2.10)脳10\tFalse\tFalse\td.dd)xdd\tNUM\tCD\n",
      "9/L].Lymphocyte\t3472\t9/l].lymphocyte\tFalse\tFalse\td/X].Xxxxx\tNUM\tCD\n",
      "subset\t3488\tsubset\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "analysis\t3495\tanalysis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "indicated\t3504\tindicate\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "reduction\t3514\treduction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "in\t3524\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "CD4\t3527\tCD4\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t3531\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "T\t3533\tt\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cells\t3535\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "[\t3541\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "213(113\t3542\t213(113\tFalse\tFalse\tddd(ddd\tPROPN\tNNP\n",
      "-\t3549\t-\tTrue\tFalse\t-\tPUNCT\t:\n",
      "775)/渭l],CD8\t3550\t775)/渭l],cd8\tFalse\tFalse\tddd)/xx],XXd\tNOUN\tNN\n",
      "+\t3563\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "T\t3565\tt\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cells\t3567\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "[\t3573\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "267(99\t3574\t267(99\tFalse\tFalse\tddd(dd\tNUM\tCD\n",
      "-\t3580\t-\tTrue\tFalse\t-\tSYM\tSYM\n",
      "457)/渭l],B\t3581\t457)/渭l],b\tFalse\tFalse\tddd)/xx],X\tNUM\tCD\n",
      "cells\t3592\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "[\t3598\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "39(4\t3599\t39(4\tFalse\tFalse\tdd(d\tPROPN\tNNP\n",
      "-\t3603\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "165)/渭l],and\t3604\t165)/渭l],and\tFalse\tFalse\tddd)/xx],xxx\tNUM\tCD\n",
      "NK\t3617\tNK\tFalse\tFalse\tXX\tPROPN\tNNP\n",
      "cells\t3620\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "[\t3626\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "88(32\t3627\t88(32\tFalse\tFalse\tdd(dd\tNUM\tCD\n",
      "-\t3632\t-\tTrue\tFalse\t-\tSYM\tSYM\n",
      "279)/渭l\t3633\t279)/渭l\tFalse\tFalse\tddd)/xx\tNUM\tCD\n",
      "]\t3640\t]\tTrue\tFalse\t]\tPUNCT\t-RRB-\n",
      "and\t3642\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "elevation\t3646\televation\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t3656\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "human\t3659\thuman\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "leukocyte\t3665\tleukocyte\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "antigen\t3675\tantigen\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "-\t3682\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "D\t3683\td\tFalse\tFalse\tX\tNOUN\tNN\n",
      "related(HLA\t3685\trelated(hla\tFalse\tFalse\txxxx(XXX\tNOUN\tNN\n",
      "-\t3696\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "DR),and\t3697\tDR),and\tFalse\tFalse\tXX),xxx\tPROPN\tNNP\n",
      "CD38\t3705\tCD38\tFalse\tFalse\tXXdd\tPROPN\tNNP\n",
      "expression\t3710\texpression\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "in\t3721\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "CD8\t3724\tCD8\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t3728\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "T\t3730\tt\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cells\t3732\tcell\tFalse\tFalse\txxxx\tVERB\tVBZ\n",
      "[\t3738\t[\tTrue\tFalse\t[\tPUNCT\t-LRB-\n",
      "HLA\t3739\tHLA\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "-\t3742\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "DR\t3743\tDR\tFalse\tFalse\tXX\tPROPN\tNNP\n",
      "+\t3746\t+\tFalse\tFalse\t+\tSYM\tSYM\n",
      "CD8\t3747\tCD8\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t3751\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "/CD8\t3752\t/cd8\tFalse\tFalse\t/XXd\tX\tXX\n",
      "+\t3757\t+\tFalse\tFalse\t+\tINTJ\tUH\n",
      ",\t3758\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "60(40\t3759\t60(40\tFalse\tFalse\tdd(dd\tNUM\tCD\n",
      "-\t3764\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "68)%;CD38\t3765\t68)%;CD38\tFalse\tFalse\tdd)%;XXdd\tPROPN\tNNP\n",
      "+\t3775\t+\tFalse\tFalse\t+\tSYM\tSYM\n",
      "CD8\t3776\tCD8\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t3780\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "/CD8\t3781\t/cd8\tFalse\tFalse\t/XXd\tX\tXX\n",
      "+\t3786\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      ",\t3787\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "81(65\t3788\t81(65\tFalse\tFalse\tdd(dd\tNUM\tCD\n",
      "-\t3793\t-\tTrue\tFalse\t-\tPUNCT\t:\n",
      "90)%].The\t3794\t90)%].the\tFalse\tFalse\tdd)%].Xxx\tNUM\tCD\n",
      "most\t3804\tmost\tFalse\tFalse\txxxx\tADV\tRBS\n",
      "common\t3809\tcommon\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "species\t3816\tspecie\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t3824\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "NTM\t3827\tNTM\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "was\t3831\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "Mycobacterium\t3835\tMycobacterium\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "intracellular(n=6).Lymphocyte\t3849\tintracellular(n=6).Lymphocyte\tFalse\tFalse\txxxx(x=d).Xxxxx\tPROPN\tNNP\n",
      ",\t3878\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "CD8\t3879\tCD8\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t3883\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "T\t3885\tt\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cell\t3887\tcell\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t3891\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "B\t3893\tB\tFalse\tFalse\tX\tPROPN\tNNP\n",
      "cell\t3895\tcell\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t3899\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t3901\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "NK\t3905\tNK\tFalse\tFalse\tXX\tPROPN\tNNP\n",
      "cell\t3908\tcell\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "counts\t3913\tcount\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t3920\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "significantly\t3925\tsignificantly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "lower\t3939\tlow\tFalse\tFalse\txxxx\tADJ\tJJR\n",
      "in\t3945\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "dead\t3948\tdead\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "patients\t3953\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "than\t3962\tthan\tFalse\tFalse\txxxx\tADP\tIN\n",
      "surviving\t3967\tsurvive\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "patients(P\t3977\tpatients(P\tFalse\tFalse\txxxx(X\tPROPN\tNNP\n",
      "=\t3988\t=\tFalse\tFalse\t=\tPUNCT\tNFP\n",
      "0.045,P=0.045,P=0.032,and\t3989\t0.045,p=0.045,p=0.032,and\tFalse\tFalse\td.ddd,X=d.ddd,X=d.ddd,xxx\tNOUN\tNN\n",
      "P=0.010,respectively\t4015\tP=0.010,respectively\tFalse\tFalse\tX=d.ddd,xxxx\tPROPN\tNNP\n",
      ")\t4035\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ".\t4036\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "Conclusions\t4038\tconclusion\tFalse\tFalse\tXxxxx\tNOUN\tNNS\n",
      "Disseminated\t4050\tdisseminate\tFalse\tFalse\tXxxxx\tVERB\tVBD\n",
      "NTM\t4063\tNTM\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "disease\t4067\tdisease\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "in\t4075\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "HIV\t4078\tHIV\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "negative\t4082\tnegative\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "patients\t4091\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "is\t4100\tbe\tFalse\tFalse\txx\tVERB\tVBZ\n",
      "mainly\t4103\tmainly\tFalse\tFalse\txxxx\tADV\tRB\n",
      "manifested\t4110\tmanifest\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "as\t4121\tas\tFalse\tFalse\txx\tADP\tIN\n",
      "fever\t4124\tfever\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t4129\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "anemia\t4131\tanemia\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t4137\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "hypoalbuminemia\t4139\thypoalbuminemia\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t4154\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t4156\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "elevated\t4160\televate\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "inflammatory\t4169\tinflammatory\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "indicators\t4182\tindicator\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t4192\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "It\t4194\t-PRON-\tFalse\tFalse\tXx\tPRON\tPRP\n",
      "is\t4197\tbe\tFalse\tFalse\txx\tVERB\tVBZ\n",
      "more\t4200\tmore\tFalse\tFalse\txxxx\tADV\tRBR\n",
      "likely\t4205\tlikely\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "to\t4212\tto\tFalse\tFalse\txx\tPART\tTO\n",
      "occur\t4215\toccur\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "in\t4221\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "immunocompromised\t4224\timmunocompromise\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "patients\t4242\tpatient\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t4250\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "Patients\t4252\tpatient\tFalse\tFalse\tXxxxx\tNOUN\tNNS\n",
      "with\t4261\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "decreased\t4266\tdecrease\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "lymphocytes\t4276\tlymphocyte\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t4287\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "CD8\t4288\tCD8\tFalse\tFalse\tXXd\tPROPN\tNNP\n",
      "+\t4292\t+\tFalse\tFalse\t+\tCCONJ\tCC\n",
      "T\t4294\tt\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cells\t4296\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t4301\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "B\t4303\tb\tFalse\tFalse\tX\tNOUN\tNN\n",
      "cells\t4305\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "and\t4311\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "NK\t4315\tNK\tFalse\tFalse\tXX\tPROPN\tNNP\n",
      "cells\t4318\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "tend\t4324\ttend\tFalse\tFalse\txxxx\tVERB\tVBP\n",
      "to\t4329\tto\tFalse\tFalse\txx\tPART\tTO\n",
      "have\t4332\thave\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "a\t4337\ta\tFalse\tFalse\tx\tDET\tDT\n",
      "poor\t4339\tpoor\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "prognosis\t4344\tprognosis\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ".\t4353\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "\n",
      "\n",
      "\t4354\t\n",
      "\n",
      "\tFalse\tTrue\t\n",
      "\n",
      "\tSPACE\t_SP\n",
      "in\t4356\tin\tFalse\tFalse\txx\tADP\tIN\n",
      "\n",
      "\t\t\t\t\t4358\t\n",
      "\t\t\t\t\tFalse\tTrue\t\n",
      "\t\t\t\t\tSPACE\t_SP\n",
      "English\t4363\tEnglish\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      ",\t4370\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "Chinese鐩鐨\t4372\tChinese鐩鐨\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉\t4382\t閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔tert锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑htert鐗欏懆鑶滅粏鑳炵郴銆傛柟娉\tFalse\tFalse\txxxxXXXXxxxxXXXXxxxx\tNUM\tCD\n",
      "鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵\t4480\t鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵\tFalse\tFalse\txxxxXXxxxx\tPROPN\tNNP\n",
      "╁\t4497\t╁\tFalse\tFalse\t╁\tNOUN\tNN\n",
      "瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd\t4498\t瀐tert鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pad\tFalse\tFalse\txXXXXxxxxXx\tNUM\tCD\n",
      "-\t4533\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "pshuttle\t4534\tpshuttle\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "-\t4542\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "cmv\t4543\tcmv\tFalse\tFalse\txxx\tNOUN\tNN\n",
      "-\t4546\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋\t4547\thtert锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺pcr妫娴媓tert鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤rna鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝cck-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋\tFalse\tFalse\tLONG\tNUM\tCD\n",
      "鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁\t4708\t鎴愬姛鏋勫缓浜嗗惈htert鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺pcr缁撴灉鏄剧ずhtert鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣ck-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁\tFalse\tFalse\tLONG\tNUM\tCD\n",
      "閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂\t4879\t閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂\tFalse\tFalse\txxxxXXXXxxxx\tPROPN\tNNP\n",
      "┒\t4943\t┒\tFalse\tFalse\t┒\tNOUN\tNN\n",
      "鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE\t4944\t鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE\tFalse\tFalse\txxxx.XXXX\tPUNCT\t.\n",
      ":\t4981\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "This\t4983\tthis\tFalse\tFalse\tXxxx\tDET\tDT\n",
      "study\t4988\tstudy\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "aims\t4994\taim\tFalse\tFalse\txxxx\tVERB\tVBZ\n",
      "to\t4999\tto\tFalse\tFalse\txx\tPART\tTO\n",
      "establish\t5002\testablish\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "an\t5012\tan\tFalse\tFalse\txx\tDET\tDT\n",
      "effective\t5015\teffective\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "and\t5025\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "stable\t5029\tstable\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "periodontal\t5036\tperiodontal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ligament\t5048\tligament\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "cell\t5057\tcell\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "line\t5062\tline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "stably\t5067\tstably\tFalse\tFalse\txxxx\tADV\tRB\n",
      "expressing\t5074\texpress\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "human\t5085\thuman\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "telomerase\t5091\ttelomerase\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "reverse\t5102\treverse\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "transcriptase\t5110\ttranscriptase\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t5124\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "hTERT\t5125\thTERT\tFalse\tFalse\txXXXX\tPROPN\tNNP\n",
      ")\t5130\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "gene\t5132\tgene\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "by\t5137\tby\tFalse\tFalse\txx\tADP\tIN\n",
      "using\t5140\tuse\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "the\t5146\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "adenovirus\t5150\tadenovirus\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "method\t5161\tmethod\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ".\t5167\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "METHODS\t5168\tmethod\tFalse\tFalse\tXXXX\tNOUN\tNNS\n",
      ":\t5175\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "Polymerase\t5177\tpolymerase\tFalse\tFalse\tXxxxx\tVERB\tVB\n",
      "chain\t5188\tchain\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "reaction\t5194\treaction\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "(\t5203\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "PCR\t5204\tPCR\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t5207\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      "was\t5209\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "used\t5213\tuse\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "to\t5218\tto\tFalse\tFalse\txx\tPART\tTO\n",
      "amplify\t5221\tamplify\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "the\t5229\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "full\t5233\tfull\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "length\t5238\tlength\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t5245\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "hTERT\t5248\thtert\tFalse\tFalse\txXXXX\tNUM\tCD\n",
      "gene\t5254\tgene\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "to\t5259\tto\tFalse\tFalse\txx\tPART\tTO\n",
      "construct\t5262\tconstruct\tFalse\tFalse\txxxx\tVERB\tVB\n",
      "recombinant\t5272\trecombinant\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "adenovirus\t5284\tadenovirus\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "plasmid\t5295\tplasmid\tFalse\tFalse\txxxx\tX\tFW\n",
      "pAd\t5303\tpad\tFalse\tFalse\txXx\tX\tFW\n",
      "-\t5306\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "pshuttle\t5307\tpshuttle\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "-\t5315\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "cmv\t5316\tcmv\tFalse\tFalse\txxx\tNOUN\tNN\n",
      "-\t5319\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "hTERT\t5320\thTERT\tFalse\tFalse\txXXXX\tPROPN\tNNP\n",
      ".\t5325\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "Packaged\t5327\tpackage\tFalse\tFalse\tXxxxx\tVERB\tVBN\n",
      "adenovirus\t5336\tadenovirus\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "particles\t5347\tparticle\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t5357\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "used\t5362\tuse\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "for\t5367\tfor\tFalse\tFalse\txxx\tADP\tIN\n",
      "infection\t5371\tinfection\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t5381\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "human\t5384\thuman\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "periodontal\t5390\tperiodontal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ligament\t5402\tligament\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "cells\t5411\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t5416\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t5418\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "expression\t5422\texpression\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "levels\t5433\tlevel\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "of\t5440\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "hTERT\t5443\thtert\tFalse\tFalse\txXXXX\tNUM\tCD\n",
      "and\t5449\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "osteogenic\t5453\tosteogenic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "genes\t5464\tgene\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ",\t5469\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "such\t5471\tsuch\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "as\t5476\tas\tFalse\tFalse\txx\tADP\tIN\n",
      "alkaline\t5479\talkaline\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "phosphatase\t5488\tphosphatase\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t5499\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "Runt\t5501\tRunt\tFalse\tFalse\tXxxx\tPROPN\tNNP\n",
      "-\t5505\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "related\t5506\trelate\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "transcription\t5514\ttranscription\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "factor\t5528\tfactor\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "2\t5535\t2\tFalse\tFalse\td\tNUM\tCD\n",
      ",\t5536\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "bone\t5538\tbone\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "sialoprotein\t5543\tsialoprotein\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t5555\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "osteocalcin\t5557\tosteocalcin\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t5568\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "osteopontin\t5570\tosteopontin\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      ",\t5581\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t5583\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "collagen\t5587\tcollagen\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "鈪\t5596\t鈪\tFalse\tFalse\tx\tX\tXX\n",
      "mRNA\t5598\tmRNA\tFalse\tFalse\txXXX\tPROPN\tNNP\n",
      ",\t5602\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "were\t5604\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "detected\t5609\tdetect\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "by\t5618\tby\tFalse\tFalse\txx\tADP\tIN\n",
      "quantitative\t5621\tquantitative\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "real\t5634\treal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "-\t5638\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "time\t5639\ttime\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "PCR\t5644\tPCR\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "(\t5648\t(\tTrue\tFalse\t(\tPUNCT\t-LRB-\n",
      "qRT\t5649\tqRT\tFalse\tFalse\txXX\tPROPN\tNNP\n",
      "-\t5652\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "PCR\t5653\tPCR\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      ")\t5656\t)\tTrue\tFalse\t)\tPUNCT\t-RRB-\n",
      ".\t5657\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t5659\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "ability\t5663\tability\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "of\t5671\tof\tFalse\tFalse\txx\tADP\tIN\n",
      "osteogenic\t5674\tosteogenic\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "differentiation\t5685\tdifferentiation\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "was\t5701\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "observed\t5705\tobserve\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "by\t5714\tby\tFalse\tFalse\txx\tADP\tIN\n",
      "alizarin\t5717\talizarin\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "red\t5726\tred\tFalse\tFalse\txxx\tADJ\tJJ\n",
      "staining\t5730\tstaining\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      ",\t5738\t,\tTrue\tFalse\t,\tPUNCT\t,\n",
      "and\t5740\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "the\t5744\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "cell\t5748\tcell\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "proliferation\t5753\tproliferation\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "was\t5767\tbe\tFalse\tFalse\txxx\tVERB\tVBD\n",
      "determined\t5771\tdetermine\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "by\t5782\tby\tFalse\tFalse\txx\tADP\tIN\n",
      "CCK-8.RESULTS\t5785\tcck-8.results\tFalse\tFalse\tXXX-d.XXXX\tNOUN\tNN\n",
      ":\t5798\t:\tTrue\tFalse\t:\tPUNCT\t:\n",
      "Adenovirus\t5800\tAdenovirus\tFalse\tFalse\tXxxxx\tPROPN\tNNP\n",
      "particles\t5811\tparticle\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "containing\t5821\tcontain\tFalse\tFalse\txxxx\tVERB\tVBG\n",
      "the\t5832\tthe\tFalse\tFalse\txxx\tDET\tDT\n",
      "hTERT\t5836\thTERT\tFalse\tFalse\txXXXX\tPROPN\tNNP\n",
      "gene\t5842\tgene\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "were\t5847\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "successfully\t5852\tsuccessfully\tFalse\tFalse\txxxx\tADV\tRB\n",
      "constructed\t5865\tconstruct\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "and\t5877\tand\tFalse\tFalse\txxx\tCCONJ\tCC\n",
      "infected\t5881\tinfect\tFalse\tFalse\txxxx\tVERB\tVBN\n",
      "with\t5890\twith\tFalse\tFalse\txxxx\tADP\tIN\n",
      "periodontal\t5895\tperiodontal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ligament\t5907\tligament\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "cells\t5916\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t5921\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t5923\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "infected\t5927\tinfected\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "cells\t5936\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "were\t5942\tbe\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "similar\t5947\tsimilar\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "to\t5955\tto\tFalse\tFalse\txx\tADP\tIN\n",
      "normal\t5958\tnormal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "periodontal\t5965\tperiodontal\tFalse\tFalse\txxxx\tADJ\tJJ\n",
      "ligament\t5977\tligament\tFalse\tFalse\txxxx\tNOUN\tNN\n",
      "cells\t5986\tcell\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      ".\t5991\t.\tTrue\tFalse\t.\tPUNCT\t.\n",
      "The\t5993\tthe\tFalse\tFalse\tXxx\tDET\tDT\n",
      "qRT\t5997\tqrt\tFalse\tFalse\txXX\tNUM\tCD\n",
      "-\t6000\t-\tTrue\tFalse\t-\tPUNCT\tHYPH\n",
      "PCR\t6001\tPCR\tFalse\tFalse\tXXX\tPROPN\tNNP\n",
      "results\t6005\tresult\tFalse\tFalse\txxxx\tNOUN\tNNS\n",
      "showed\t6013\tshow\tFalse\tFalse\txxxx\tVERB\tVBD\n",
      "that\t6020\tthat\tFalse\tFalse\txxxx\tADP\tIN\n",
      "hTERT\t6025\thtert\tFalse\tFalse\txXXXX\tNUM\tCD\n"
     ]
    }
   ],
   "source": [
    "for token in doc[:1000]:\n",
    "    print(\"{0}\\t{1}\\t{2}\\t{3}\\t{4}\\t{5}\\t{6}\\t{7}\".format(\n",
    "        token.text,\n",
    "        token.idx,\n",
    "        token.lemma_,\n",
    "        token.is_punct,\n",
    "        token.is_space,\n",
    "        token.shape_,\n",
    "        token.pos_,\n",
    "        token.tag_\n",
    "    ))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "embedding = np.array([])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "word_list = []\n",
    "aa = []"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "for token in doc:\n",
    "    if not(token.is_punct) and not(token.text in word_list):\n",
    "        word_list.append(token.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['OBJECTIVE',\n",
       " 'To',\n",
       " 'evaluate',\n",
       " 'the',\n",
       " 'therapeutic',\n",
       " 'effects',\n",
       " 'of',\n",
       " 'entecavir',\n",
       " 'ETV',\n",
       " 'and',\n",
       " 'interferon-伪',\n",
       " 'IFN-伪',\n",
       " 'treatments',\n",
       " 'for',\n",
       " '48',\n",
       " 'weeks',\n",
       " 'chronic',\n",
       " 'hepatitis',\n",
       " 'B',\n",
       " 'CHB',\n",
       " 'in',\n",
       " 'patients',\n",
       " 'with',\n",
       " 'different',\n",
       " 'baseline',\n",
       " 'alanine',\n",
       " 'aminotransferase',\n",
       " 'ALT',\n",
       " 'levels',\n",
       " 'METHODS',\n",
       " 'We',\n",
       " 'retrospectively',\n",
       " 'analyzed',\n",
       " 'data',\n",
       " '369',\n",
       " 'receiving',\n",
       " 'compared',\n",
       " 'virological',\n",
       " 'response',\n",
       " 'rates',\n",
       " 'HBsAg',\n",
       " 'clearance',\n",
       " 'reduction',\n",
       " 'between',\n",
       " 'levels[鈮',\n",
       " '5脳upper',\n",
       " 'limits',\n",
       " 'normal',\n",
       " 'ULN',\n",
       " 'level',\n",
       " 'subgroup',\n",
       " '1',\n",
       " '5',\n",
       " '10脳ULN',\n",
       " '2',\n",
       " 'gt',\n",
       " '10脳',\n",
       " '3)].RESULTS',\n",
       " 'In',\n",
       " 'treatment',\n",
       " 'rate',\n",
       " 'was',\n",
       " '83.3',\n",
       " '91.4',\n",
       " '95.5',\n",
       " '3',\n",
       " 'as',\n",
       " '19.7',\n",
       " '40',\n",
       " '42.9',\n",
       " 'subgroups',\n",
       " 'respectively',\n",
       " 'showing',\n",
       " 'significantly',\n",
       " 'differences',\n",
       " 'both',\n",
       " 'among',\n",
       " 'same',\n",
       " 'P',\n",
       " 'lt',\n",
       " '0.05',\n",
       " 'HBeAg',\n",
       " 'were',\n",
       " '8.3',\n",
       " '16.7',\n",
       " '35.5',\n",
       " '1.8',\n",
       " '41.9',\n",
       " '38.1',\n",
       " 'significant',\n",
       " 'differed',\n",
       " 'only',\n",
       " 'group',\n",
       " 'to',\n",
       " 'below',\n",
       " '200',\n",
       " 'IU',\n",
       " 'ml',\n",
       " '2.5',\n",
       " '13.8',\n",
       " 'no',\n",
       " 'difference',\n",
       " 'two',\n",
       " 'also',\n",
       " 'similar',\n",
       " '30.6',\n",
       " 'vs',\n",
       " '33.3',\n",
       " 'but',\n",
       " '0.05).CONCLUSIONS',\n",
       " 'all',\n",
       " 'results',\n",
       " 'higher',\n",
       " 'than',\n",
       " 'a',\n",
       " '10',\n",
       " '脳ULN',\n",
       " 'can',\n",
       " 'result',\n",
       " 'comparable',\n",
       " 'more',\n",
       " 'effectively',\n",
       " 'reduces',\n",
       " 'The',\n",
       " 'relatively',\n",
       " 'high',\n",
       " '脳',\n",
       " 'show',\n",
       " 'better',\n",
       " 'responses',\n",
       " 'those',\n",
       " '5脳ULN',\n",
       " 'thus',\n",
       " 'recommend',\n",
       " 'either',\n",
       " 'or',\n",
       " 'beyond',\n",
       " '\\n\\n',\n",
       " '锘縊bjective',\n",
       " 'explore',\n",
       " 'clinical',\n",
       " 'laboratory',\n",
       " 'characteristics',\n",
       " 'prognosis',\n",
       " 'disseminated',\n",
       " 'non',\n",
       " 'tuberculous',\n",
       " 'mycobacteria(NTM)diseases',\n",
       " 'human',\n",
       " 'immunodeficiency',\n",
       " 'virus(HIV)negative',\n",
       " 'Methods',\n",
       " 'Cases',\n",
       " 'NTM',\n",
       " 'disease',\n",
       " 'collected',\n",
       " 'Peking',\n",
       " 'Union',\n",
       " 'Medical',\n",
       " 'College',\n",
       " 'Hospital',\n",
       " 'from',\n",
       " 'January',\n",
       " '2012',\n",
       " 'October',\n",
       " '2018.Clinical',\n",
       " 'manifestations',\n",
       " 'findings',\n",
       " 'these',\n",
       " 'cases',\n",
       " 'retrieved',\n",
       " 'electronic',\n",
       " 'medical',\n",
       " 'record',\n",
       " 'system',\n",
       " 'Results',\n",
       " 'Among',\n",
       " '23',\n",
       " 'HIV',\n",
       " 'negative',\n",
       " 'disease,21',\n",
       " 'had',\n",
       " 'underlying',\n",
       " 'diseases',\n",
       " 'rheumatoid',\n",
       " 'immune',\n",
       " 'disease(n=7)as',\n",
       " 'most',\n",
       " 'common',\n",
       " 'one',\n",
       " 'main',\n",
       " 'manifestation',\n",
       " 'fever(n=23).Laboratory',\n",
       " 'tests',\n",
       " 'showed',\n",
       " 'anemia',\n",
       " 'hemoglobin(85.78卤25.47)g',\n",
       " 'L],hypoalbuminemia',\n",
       " 'albumin',\n",
       " '29(27',\n",
       " '32)g',\n",
       " 'L],elevated',\n",
       " 'erythrocyte',\n",
       " 'sedimentation',\n",
       " '85.73卤43.78)mm',\n",
       " 'h',\n",
       " 'hypersensitive',\n",
       " 'C',\n",
       " 'reactive',\n",
       " 'protein',\n",
       " '112.00卤70.90)mg',\n",
       " 'L',\n",
       " 'lymphocyte',\n",
       " 'count',\n",
       " '0.69(0.29',\n",
       " '2.10)脳10',\n",
       " '9/L].Lymphocyte',\n",
       " 'subset',\n",
       " 'analysis',\n",
       " 'indicated',\n",
       " 'CD4',\n",
       " '+',\n",
       " 'T',\n",
       " 'cells',\n",
       " '213(113',\n",
       " '775)/渭l],CD8',\n",
       " '267(99',\n",
       " '457)/渭l],B',\n",
       " '39(4',\n",
       " '165)/渭l],and',\n",
       " 'NK',\n",
       " '88(32',\n",
       " '279)/渭l',\n",
       " 'elevation',\n",
       " 'leukocyte',\n",
       " 'antigen',\n",
       " 'D',\n",
       " 'related(HLA',\n",
       " 'DR),and',\n",
       " 'CD38',\n",
       " 'expression',\n",
       " 'CD8',\n",
       " 'HLA',\n",
       " 'DR',\n",
       " '/CD8',\n",
       " '60(40',\n",
       " '68)%;CD38',\n",
       " '81(65',\n",
       " '90)%].The',\n",
       " 'species',\n",
       " 'Mycobacterium',\n",
       " 'intracellular(n=6).Lymphocyte',\n",
       " 'cell',\n",
       " 'counts',\n",
       " 'lower',\n",
       " 'dead',\n",
       " 'surviving',\n",
       " 'patients(P',\n",
       " '=',\n",
       " '0.045,P=0.045,P=0.032,and',\n",
       " 'P=0.010,respectively',\n",
       " 'Conclusions',\n",
       " 'Disseminated',\n",
       " 'is',\n",
       " 'mainly',\n",
       " 'manifested',\n",
       " 'fever',\n",
       " 'hypoalbuminemia',\n",
       " 'elevated',\n",
       " 'inflammatory',\n",
       " 'indicators',\n",
       " 'It',\n",
       " 'likely',\n",
       " 'occur',\n",
       " 'immunocompromised',\n",
       " 'Patients',\n",
       " 'decreased',\n",
       " 'lymphocytes',\n",
       " 'tend',\n",
       " 'have',\n",
       " 'poor',\n",
       " '\\n\\t\\t\\t\\t',\n",
       " 'English',\n",
       " 'Chinese鐩鐨',\n",
       " '閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉',\n",
       " '鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵',\n",
       " '╁',\n",
       " '瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd',\n",
       " 'pshuttle',\n",
       " 'cmv',\n",
       " 'hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋',\n",
       " '鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁',\n",
       " '閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂',\n",
       " '┒',\n",
       " '鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE',\n",
       " 'This',\n",
       " 'study',\n",
       " 'aims',\n",
       " 'establish',\n",
       " 'an',\n",
       " 'effective',\n",
       " 'stable',\n",
       " 'periodontal',\n",
       " 'ligament',\n",
       " 'line',\n",
       " 'stably',\n",
       " 'expressing',\n",
       " 'telomerase',\n",
       " 'reverse',\n",
       " 'transcriptase',\n",
       " 'hTERT',\n",
       " 'gene',\n",
       " 'by',\n",
       " 'using',\n",
       " 'adenovirus',\n",
       " 'method',\n",
       " 'Polymerase',\n",
       " 'chain',\n",
       " 'reaction',\n",
       " 'PCR',\n",
       " 'used',\n",
       " 'amplify',\n",
       " 'full',\n",
       " 'length',\n",
       " 'construct',\n",
       " 'recombinant',\n",
       " 'plasmid',\n",
       " 'pAd',\n",
       " 'Packaged',\n",
       " 'particles',\n",
       " 'infection',\n",
       " 'osteogenic',\n",
       " 'genes',\n",
       " 'such',\n",
       " 'alkaline',\n",
       " 'phosphatase',\n",
       " 'Runt',\n",
       " 'related',\n",
       " 'transcription',\n",
       " 'factor',\n",
       " 'bone',\n",
       " 'sialoprotein',\n",
       " 'osteocalcin',\n",
       " 'osteopontin',\n",
       " 'collagen',\n",
       " '鈪',\n",
       " 'mRNA',\n",
       " 'detected',\n",
       " 'quantitative',\n",
       " 'real',\n",
       " 'time',\n",
       " 'qRT',\n",
       " 'ability',\n",
       " 'differentiation',\n",
       " 'observed',\n",
       " 'alizarin',\n",
       " 'red',\n",
       " 'staining',\n",
       " 'proliferation',\n",
       " 'determined',\n",
       " 'CCK-8.RESULTS',\n",
       " 'Adenovirus',\n",
       " 'containing',\n",
       " 'successfully',\n",
       " 'constructed',\n",
       " 'infected',\n",
       " 'that',\n",
       " 'osteogenesis',\n",
       " 'associated',\n",
       " 'highly',\n",
       " 'expressed',\n",
       " 'lines',\n",
       " 'adenoviruses',\n",
       " 'Alizarin',\n",
       " 'strong',\n",
       " 'capability',\n",
       " 'CCK-8',\n",
       " 'CONCLUSIONS',\n",
       " 'efficiency',\n",
       " 'established',\n",
       " 'thereby',\n",
       " 'providing',\n",
       " 'ideal',\n",
       " 'studying',\n",
       " 'mechanism',\n",
       " 'regeneration',\n",
       " 'FrenchCryoglobulin茅mies',\n",
       " 'La',\n",
       " 'cryoglobulin茅mie',\n",
       " 'est',\n",
       " 'd茅finie',\n",
       " 'par',\n",
       " 'la',\n",
       " 'pr茅sence',\n",
       " 'd鈥檜ne',\n",
       " 'cryoglobuline',\n",
       " 'circulante',\n",
       " 'immunoglobuline',\n",
       " 'pr茅cipitant',\n",
       " 'au',\n",
       " 'froid',\n",
       " 'Le',\n",
       " 'typage',\n",
       " 'de',\n",
       " 'cette',\n",
       " 'fondamental',\n",
       " 'En',\n",
       " 'effet',\n",
       " 'on',\n",
       " 'distingue',\n",
       " 'deux',\n",
       " 'sous',\n",
       " 'groupes',\n",
       " 'les',\n",
       " 'cryoglobulines',\n",
       " 'type',\n",
       " 'I',\n",
       " 'et',\n",
       " 'mixtes',\n",
       " 'physiopathologie',\n",
       " 'traitements',\n",
       " 'sont',\n",
       " 'diff茅rents',\n",
       " 'dans',\n",
       " 'ces',\n",
       " 'entit茅s',\n",
       " 'Les',\n",
       " 'cryoglobulin茅mies',\n",
       " 'li茅es',\n",
       " '脿',\n",
       " 'une',\n",
       " 'h茅mopathie',\n",
       " 'lympho茂de',\n",
       " 'monoclonale',\n",
       " 'jacente',\n",
       " 'alors',\n",
       " 'que',\n",
       " 'types',\n",
       " 'II',\n",
       " 'III',\n",
       " '茅mergent',\n",
       " 'des',\n",
       " 'situations',\n",
       " 'stimulation',\n",
       " 'antig茅nique',\n",
       " 'assez',\n",
       " 'vari茅es',\n",
       " 'plus',\n",
       " 'fr茅quente',\n",
       " '茅tant',\n",
       " 'le',\n",
       " 'virus',\n",
       " 'l鈥檋茅patite',\n",
       " 'C.',\n",
       " 'L鈥檌ntensit茅',\n",
       " 'sympt么mes',\n",
       " 'tr猫s',\n",
       " 'variable',\n",
       " 'beaucoup',\n",
       " 'asymptomatiques',\n",
       " 'Chez',\n",
       " 'symptomatiques',\n",
       " 'organes',\n",
       " 'fr茅quemment',\n",
       " 'touch茅s',\n",
       " 'peau',\n",
       " 'syst猫me',\n",
       " 'nerveux',\n",
       " 'p茅riph茅rique',\n",
       " 'glom茅rule',\n",
       " 'r茅nal',\n",
       " 'Quelques',\n",
       " 'rares',\n",
       " 'ont',\n",
       " 'atteintes',\n",
       " 'visc茅rales',\n",
       " 'mettant',\n",
       " 'en',\n",
       " 'jeu',\n",
       " 'pronostic',\n",
       " 'vital',\n",
       " 'traitement',\n",
       " 'prend',\n",
       " 'toujours',\n",
       " 'compte',\n",
       " 'l鈥檌ntensit茅',\n",
       " 'pathologie',\n",
       " 'Dans',\n",
       " 'du',\n",
       " 'clone',\n",
       " 'jacent',\n",
       " 'primordial',\n",
       " 'celles',\n",
       " 'associe',\n",
       " 'souvent',\n",
       " 'un',\n",
       " 'immunosuppresseur',\n",
       " 'cause',\n",
       " 'si',\n",
       " 'elle',\n",
       " 'identifi茅e',\n",
       " 'Cryoglobulinemia',\n",
       " 'defined',\n",
       " 'presence',\n",
       " 'circulating',\n",
       " 'cryoglobulin',\n",
       " 'cold',\n",
       " 'precipitating',\n",
       " 'immunoglobulin',\n",
       " 'typing',\n",
       " 'this',\n",
       " 'fundamental',\n",
       " 'Indeed',\n",
       " 'there',\n",
       " 'are',\n",
       " 'mixed',\n",
       " 'cryoglobulins',\n",
       " 'physiopathology',\n",
       " 'entities',\n",
       " 'monoclonal',\n",
       " 'lymphoid',\n",
       " 'hemopathy',\n",
       " 'while',\n",
       " 'cryoglobulinemia',\n",
       " 'emerge',\n",
       " 'quite',\n",
       " 'varied',\n",
       " 'antigenic',\n",
       " 'being',\n",
       " 'intensity',\n",
       " 'symptoms',\n",
       " 'very',\n",
       " 'many',\n",
       " 'asymptomatic',\n",
       " 'symptomatic',\n",
       " 'frequently',\n",
       " 'affected',\n",
       " 'organs',\n",
       " 'skin',\n",
       " 'peripheral',\n",
       " 'nervous',\n",
       " 'renal',\n",
       " 'glomerulus',\n",
       " 'Few',\n",
       " 'visceral',\n",
       " 'involvement',\n",
       " 'life',\n",
       " 'threatening',\n",
       " 'always',\n",
       " 'takes',\n",
       " 'into',\n",
       " 'account',\n",
       " 'pathology',\n",
       " 'essential',\n",
       " 'immunosuppressive',\n",
       " 'therapy',\n",
       " 'often',\n",
       " 'if',\n",
       " 'identified',\n",
       " 'Objective',\n",
       " 'measure',\n",
       " 'effect',\n",
       " 'duck',\n",
       " 'viperin',\n",
       " 'Tembusu',\n",
       " 'DTMUV',\n",
       " 'bioinformatics',\n",
       " 'Plasmids',\n",
       " 'pGEX-6P',\n",
       " 'pEGFP',\n",
       " 'N1-viperin',\n",
       " 'transformed',\n",
       " 'Rosseta',\n",
       " 'transfected',\n",
       " 'BHK-21',\n",
       " 'empty',\n",
       " 'vector',\n",
       " 'content',\n",
       " 'precipitation',\n",
       " 'supernatant',\n",
       " 'fluorescent',\n",
       " 'Finally',\n",
       " 'binding',\n",
       " 'proteins',\n",
       " 'captured',\n",
       " 'EGFP',\n",
       " 'antibody',\n",
       " 'evaluated',\n",
       " 'mass',\n",
       " 'spectrometry',\n",
       " 'Significant',\n",
       " 'other',\n",
       " 'Duck',\n",
       " 'found',\n",
       " 'inhibit',\n",
       " 'budding',\n",
       " 'Further',\n",
       " 'we',\n",
       " 'six',\n",
       " 'might',\n",
       " 'be',\n",
       " 'involved',\n",
       " 'inhibition',\n",
       " 'possibly',\n",
       " 'indicative',\n",
       " 'anti',\n",
       " 'pathway',\n",
       " 'ducks',\n",
       " 'Conclusion',\n",
       " 'Expression',\n",
       " 'patterns',\n",
       " 'reveal',\n",
       " 'how',\n",
       " 'inhibited',\n",
       " 'Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem',\n",
       " 'leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial',\n",
       " 'Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c',\n",
       " 'kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24',\n",
       " 'h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5',\n",
       " 'mmol',\n",
       " 'L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20',\n",
       " 'L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48',\n",
       " 'h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮',\n",
       " '┖',\n",
       " '鐧界粍銆佺',\n",
       " '鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺',\n",
       " '鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5',\n",
       " 'L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48',\n",
       " 'h锛岄噰鐢',\n",
       " '╓',\n",
       " 'estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit',\n",
       " '铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48',\n",
       " 'h鍚庯紝绌虹櫧缁勩佺',\n",
       " '鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To',\n",
       " 'determine',\n",
       " 'lentivirus',\n",
       " 'stem',\n",
       " 'leukemia',\n",
       " 'SCL',\n",
       " 'c',\n",
       " 'kit',\n",
       " 'damaged',\n",
       " 'interstitial',\n",
       " 'Cajal',\n",
       " 'ICC',\n",
       " 'under',\n",
       " 'glucose',\n",
       " 'condition.鈥',\n",
       " 'After',\n",
       " 'isolation',\n",
       " 'cultured',\n",
       " '24',\n",
       " 'hours',\n",
       " 'until',\n",
       " 'adherent',\n",
       " 'identification',\n",
       " 'inverted',\n",
       " 'microscope',\n",
       " 'immunofluorescence',\n",
       " 'divided',\n",
       " 'groups',\n",
       " 'A',\n",
       " 'control',\n",
       " 'added',\n",
       " 'medium',\n",
       " '20',\n",
       " 'continuous',\n",
       " 'cultivation',\n",
       " 'blank',\n",
       " 'experimental',\n",
       " 'PBS',\n",
       " 'solution',\n",
       " 'concentration',\n",
       " 'cultures',\n",
       " 'incubated',\n",
       " 'h.',\n",
       " 'each',\n",
       " 'Western',\n",
       " 'blot.鈥',\n",
       " 'it',\n",
       " 'still',\n",
       " 'P<0.05).鈥',\n",
       " 'up',\n",
       " 'regulate',\n",
       " 'functionally',\n",
       " 'impaired',\n",
       " 'condition',\n",
       " 'respiratory',\n",
       " 'syncytial',\n",
       " 'RSV',\n",
       " 'epidermal',\n",
       " 'growth',\n",
       " 'receptor',\n",
       " 'EGFR',\n",
       " 'tight',\n",
       " 'junction',\n",
       " 'association',\n",
       " 'mucin',\n",
       " 'airway',\n",
       " 'epithelial',\n",
       " 'Human',\n",
       " 'NCI',\n",
       " 'H292',\n",
       " 'randomly',\n",
       " 'treated',\n",
       " 'ultraviolet',\n",
       " 'light',\n",
       " 'inactivated',\n",
       " 'thawed',\n",
       " 'occludin',\n",
       " 'E',\n",
       " 'cadherin',\n",
       " 'phosphorylated',\n",
       " 'measured',\n",
       " 'blot',\n",
       " 'distribution',\n",
       " 'examined',\n",
       " 'technique',\n",
       " 'MUC5AC',\n",
       " 'assessed',\n",
       " 'RT',\n",
       " 'PCR.RESULTS',\n",
       " 'reduced',\n",
       " 'P<0.05',\n",
       " 'increased',\n",
       " 'P<0.05).CONCLUSIONS',\n",
       " 'may',\n",
       " 'down',\n",
       " 'which',\n",
       " 'contributes',\n",
       " 'barrier',\n",
       " 'dysfunction',\n",
       " 'phosphorylation',\n",
       " 'play',\n",
       " 'important',\n",
       " 'role',\n",
       " 'regulation',\n",
       " 'lymphoma',\n",
       " 'express',\n",
       " 'Epstein',\n",
       " 'Barr',\n",
       " 'latent',\n",
       " 'membrane',\n",
       " 'LMP1',\n",
       " 'coding',\n",
       " 'EcoRI',\n",
       " 'BamHI',\n",
       " 'restriction',\n",
       " 'sites',\n",
       " 'amplified',\n",
       " 'cloned',\n",
       " 'pcDNA3.1-EF1a',\n",
       " 'mcs-3FLAG',\n",
       " 'CMV',\n",
       " 'positive',\n",
       " 'competent',\n",
       " 'picked',\n",
       " 'sequencing',\n",
       " 'Ramos',\n",
       " 'electroporation',\n",
       " 'G418',\n",
       " 'green',\n",
       " 'Tag',\n",
       " 'confirmed',\n",
       " 'been',\n",
       " 'HungarianAbsztrakt',\n",
       " 'v铆rus',\n",
       " 'HCV',\n",
       " 'megk枚zel铆t艖leg',\n",
       " '4',\n",
       " 'milli贸',\n",
       " '煤j',\n",
       " 'fert艖z茅st',\n",
       " 'okoz',\n",
       " '茅vente',\n",
       " '茅s',\n",
       " '399聽000',\n",
       " 'beteg',\n",
       " 'hal',\n",
       " 'meg',\n",
       " 'fert艖z茅s',\n",
       " 'k枚vetkezt茅ben',\n",
       " 'kialakul贸',\n",
       " 'sz枚v艖dm茅nyek',\n",
       " 'cirrhosis',\n",
       " 'hepatocellularis',\n",
       " 'carcinoma',\n",
       " 'HCC',\n",
       " 'miatt',\n",
       " 'Id眉lt',\n",
       " 'fert艖z茅sben',\n",
       " 'mikrok枚rnyezeti',\n",
       " 'v谩ltoz谩sok',\n",
       " 'kiv谩ltotta',\n",
       " 'id眉lt',\n",
       " 'gyullad谩s',\n",
       " 'az',\n",
       " 'oxidat铆v',\n",
       " 'stressz',\n",
       " 'endoplazm谩s',\n",
       " 'reticulum',\n",
       " 'genetikai',\n",
       " 'epigenetikai',\n",
       " 'v谩ltoz谩sokon',\n",
       " 'kereszt眉l',\n",
       " '茅vtizedek',\n",
       " 'alatt',\n",
       " 'vezethetnek',\n",
       " 'primer',\n",
       " 'm谩jr谩k',\n",
       " 'kialakul谩s谩hoz',\n",
       " 'direkt',\n",
       " 'hepatocarcinogen',\n",
       " 'tulajdons谩ga',\n",
       " 'ismert',\n",
       " 'N茅gy',\n",
       " 'feh茅rje',\n",
       " 'core',\n",
       " 'NS3',\n",
       " 'NS4B',\n",
       " 'NS5A',\n",
       " 'transzform谩ci贸s',\n",
       " 'bizony铆tott',\n",
       " 'hat茅kony',\n",
       " 'antivir谩lis',\n",
       " 'kezel茅s',\n",
       " 'tart贸s',\n",
       " 'v铆rusv谩lasz',\n",
       " 'el茅r茅se',\n",
       " 'okozta',\n",
       " 'm谩j-',\n",
       " 'valamint',\n",
       " 'nem',\n",
       " 'm谩jeredet疟',\n",
       " 'hal谩loz谩st',\n",
       " 'cs枚kkenti',\n",
       " 'Az',\n",
       " 'interferonalap煤',\n",
       " 'el艖fordul谩s谩t',\n",
       " 'hat贸',\n",
       " 'szerek',\n",
       " 'DAA',\n",
       " 'el艖nye',\n",
       " 'nagyobb',\n",
       " 'ar谩ny煤',\n",
       " 'kevesebb',\n",
       " 'mell茅khat谩s',\n",
       " 'r枚videbb',\n",
       " 'ter谩pi谩s',\n",
       " 'id艖tartam',\n",
       " 'elm煤lt',\n",
       " 'n茅h谩ny',\n",
       " '茅vben',\n",
       " 'k枚zlem茅nyek',\n",
       " 'jelentek',\n",
       " 'amelyek',\n",
       " 'kezel茅sek',\n",
       " 'v谩rt',\n",
       " 'hat谩sair贸l',\n",
       " 'sz谩moltak',\n",
       " 'szerz艖k',\n",
       " 'ismertetik',\n",
       " 'kezel茅sekben',\n",
       " 'vizsg谩l贸',\n",
       " 'tanulm谩nyok',\n",
       " 'eredm茅nyeit',\n",
       " 'k茅rd茅s',\n",
       " 'pontos',\n",
       " 'eld枚nt茅s茅re',\n",
       " 'tov谩bbi',\n",
       " 'prospekt铆v',\n",
       " 'multicentrikus',\n",
       " 'vizsg谩latok',\n",
       " 'hosszabb',\n",
       " 'k枚vet茅si',\n",
       " 'id艖szakok',\n",
       " 'kontrollcsoportok',\n",
       " 'kiv谩laszt谩sa',\n",
       " 'sz眉ks茅ges',\n",
       " 'v铆rusellenes',\n",
       " 'befejez茅se',\n",
       " 'ut谩n',\n",
       " 'kiemelked艖',\n",
       " 'jelent艖s茅g疟',\n",
       " 'surveillance',\n",
       " 'amelyet',\n",
       " 'rendszeres',\n",
       " '3鈥6鈥12',\n",
       " 'havonta',\n",
       " 'v茅gzett',\n",
       " 'hasi',\n",
       " 'UH',\n",
       " 'vizsg谩lat',\n",
       " 'jelent',\n",
       " 'm茅g',\n",
       " 'sikeresen',\n",
       " 'kezelt',\n",
       " 'betegekn茅l',\n",
       " 'Orv',\n",
       " 'Hetil',\n",
       " '2019',\n",
       " '160(22',\n",
       " '846鈥853.Hepatitis',\n",
       " 'causes',\n",
       " 'approximately',\n",
       " 'million',\n",
       " 'new',\n",
       " 'infections',\n",
       " 'worldwide',\n",
       " 'deaths',\n",
       " 'due',\n",
       " 'its',\n",
       " 'complications',\n",
       " 'hepatocellular',\n",
       " 'Microenvironmental',\n",
       " 'changes',\n",
       " 'inflammation',\n",
       " 'oxidative',\n",
       " 'stress',\n",
       " 'endoplasmic',\n",
       " 'caused',\n",
       " 'via',\n",
       " 'genetic',\n",
       " 'epigenetic',\n",
       " 'primary',\n",
       " 'liver',\n",
       " 'cancer',\n",
       " 'during',\n",
       " 'decades',\n",
       " 'direct',\n",
       " 'oncogenic',\n",
       " 'property',\n",
       " 'wellknown',\n",
       " 'transforming',\n",
       " 'four',\n",
       " 'has',\n",
       " 'proven',\n",
       " 'Effective',\n",
       " 'antiviral',\n",
       " 'sustained',\n",
       " 'viral',\n",
       " 'decreases',\n",
       " 'general',\n",
       " 'mortality',\n",
       " 'Interferon',\n",
       " 'based',\n",
       " 'risk',\n",
       " 'development',\n",
       " 'Shorter',\n",
       " 'acting',\n",
       " 'agents',\n",
       " 'efficacy',\n",
       " 'fewer',\n",
       " 'side',\n",
       " 'Publications',\n",
       " 'reported',\n",
       " 'unexpected',\n",
       " 'authors',\n",
       " 'review',\n",
       " 'articles',\n",
       " 'focusing',\n",
       " 'occurrence',\n",
       " 'connection',\n",
       " 'therapies',\n",
       " 'There',\n",
       " 'need',\n",
       " 'prospective',\n",
       " 'multicentric',\n",
       " 'studies',\n",
       " 'longer',\n",
       " 'follow',\n",
       " 'examine',\n",
       " 'formation',\n",
       " 'importance',\n",
       " 'means',\n",
       " 'abdominal',\n",
       " 'ultrasound',\n",
       " 'every',\n",
       " '6',\n",
       " '12',\n",
       " 'months',\n",
       " 'well',\n",
       " '846',\n",
       " '853',\n",
       " 'Although',\n",
       " 'influenza',\n",
       " 'drug',\n",
       " 'oseltamivir',\n",
       " 'ameliorates',\n",
       " 'adverse',\n",
       " 'events',\n",
       " 'hypothermic',\n",
       " 'dose',\n",
       " 'dependent',\n",
       " 'hypothermia',\n",
       " 'mice',\n",
       " 'pharmacological',\n",
       " 'mechanisms',\n",
       " 'responsible',\n",
       " 'years',\n",
       " ...]"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word_list"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OBJECTIVE\n",
      ":O\n",
      "To\n",
      "evaluate\n",
      "the\n",
      "therapeutic\n",
      "effects\n",
      "of\n",
      "entecavir\n",
      "(O\n",
      "ETV\n",
      ")O\n",
      "and\n",
      "interferon-伪\n",
      "(O\n",
      "IFN-伪\n",
      ")O\n",
      "treatments\n",
      "for\n",
      "48\n",
      "weeks\n",
      "for\n",
      "chronic\n",
      "hepatitis\n",
      "B\n",
      "(O\n",
      "CHB\n",
      ")O\n",
      "in\n",
      "patients\n",
      "with\n",
      "different\n",
      "baseline\n",
      "alanine\n",
      "aminotransferase\n",
      "(O\n",
      "ALT\n",
      ")O\n",
      "levels\n",
      ".O\n",
      "METHODS\n",
      ":O\n",
      "We\n",
      "retrospectively\n",
      "analyzed\n",
      "the\n",
      "data\n",
      "of\n",
      "369\n",
      "CHB\n",
      "patients\n",
      "receiving\n",
      "ETV\n",
      "and\n",
      "IFN-伪\n",
      "treatments\n",
      "for\n",
      "48\n",
      "weeks\n",
      ".O\n",
      "We\n",
      "compared\n",
      "the\n",
      "virological\n",
      "response\n",
      "rates\n",
      ",O\n",
      "HBsAg\n",
      "clearance\n",
      ",O\n",
      "and\n",
      "HBsAg\n",
      "reduction\n",
      "between\n",
      "the\n",
      "patients\n",
      "receiving\n",
      "ETV\n",
      "and\n",
      "IFN-伪\n",
      "treatments\n",
      "with\n",
      "different\n",
      "baseline\n",
      "ALT\n",
      "levels[鈮\n",
      "5脳upper\n",
      "limits\n",
      "of\n",
      "normal\n",
      "(O\n",
      "ULN\n",
      ")O\n",
      "level\n",
      "(O\n",
      "subgroup\n",
      "1\n",
      ")O\n",
      ",O\n",
      "5\n",
      "-O\n",
      "10脳ULN\n",
      "(O\n",
      "subgroup\n",
      "2\n",
      ")O\n",
      ",O\n",
      "and\n",
      "&O\n",
      "gt\n",
      ";O\n",
      "10脳\n",
      "ULN\n",
      "(O\n",
      "subgroup\n",
      "3)].RESULTS\n",
      ":O\n",
      "In\n",
      "patients\n",
      "receiving\n",
      "ETV\n",
      "treatment\n",
      ",O\n",
      "the\n",
      "virological\n",
      "response\n",
      "rate\n",
      "was\n",
      "83.3\n",
      "%O\n",
      "in\n",
      "subgroup\n",
      "1\n",
      ",O\n",
      "91.4\n",
      "%O\n",
      "in\n",
      "subgroup\n",
      "2\n",
      ",O\n",
      "and\n",
      "95.5\n",
      "%O\n",
      "in\n",
      "subgroup\n",
      "3\n",
      ",O\n",
      "as\n",
      "compared\n",
      "with\n",
      "19.7\n",
      "%O\n",
      ",O\n",
      "40\n",
      "%O\n",
      ",O\n",
      "and\n",
      "42.9\n",
      "%O\n",
      "in\n",
      "the\n",
      "3\n",
      "subgroups\n",
      "with\n",
      "IFN-伪\n",
      "treatment\n",
      ",O\n",
      "respectively\n",
      ",O\n",
      "showing\n",
      "significantly\n",
      "differences\n",
      "both\n",
      "among\n",
      "different\n",
      "subgroups\n",
      "with\n",
      "the\n",
      "same\n",
      "treatment\n",
      "and\n",
      "between\n",
      "the\n",
      "same\n",
      "subgroup\n",
      "with\n",
      "different\n",
      "treatments\n",
      "(O\n",
      "P\n",
      "&O\n",
      "lt\n",
      ";O\n",
      "0.05\n",
      ")O\n",
      ".O\n",
      "HBeAg\n",
      "clearance\n",
      "rates\n",
      "in\n",
      "the\n",
      "3\n",
      "subgroups\n",
      "were\n",
      "8.3\n",
      "%O\n",
      ",O\n",
      "16.7\n",
      "%O\n",
      "and\n",
      "35.5\n",
      "%O\n",
      "in\n",
      "patients\n",
      "with\n",
      "ETV\n",
      "treatment\n",
      "and\n",
      "were\n",
      "1.8\n",
      "%O\n",
      ",O\n",
      "41.9\n",
      "%O\n",
      ",O\n",
      "and\n",
      "38.1\n",
      "%O\n",
      "in\n",
      "patients\n",
      "with\n",
      "IFN-伪\n",
      "treatment\n",
      ",O\n",
      "respectively\n",
      ",O\n",
      "showing\n",
      "significant\n",
      "differences\n",
      "among\n",
      "the\n",
      "3\n",
      "subgroups\n",
      "with\n",
      "the\n",
      "same\n",
      "treatment\n",
      "(O\n",
      "P\n",
      "&O\n",
      "lt\n",
      ";O\n",
      "0.05\n",
      ")O\n",
      ";O\n",
      "in\n",
      "the\n",
      "same\n",
      "subgroups\n",
      "with\n",
      "different\n",
      "treatments\n",
      ",O\n",
      "the\n",
      "rates\n",
      "differed\n",
      "significantly\n",
      "only\n",
      "between\n",
      "subgroups\n",
      "2\n",
      "(O\n",
      "P\n",
      "&O\n",
      "lt\n",
      ";O\n",
      "0.05\n",
      ")O\n",
      ".O\n",
      "In\n",
      "ETV\n",
      "group\n",
      ",O\n",
      "the\n",
      "rate\n",
      "of\n",
      "HBsAg\n",
      "reduction\n",
      "to\n",
      "below\n",
      "200\n",
      "IU\n",
      "/O\n",
      "ml\n",
      "was\n",
      "2.5\n",
      "%O\n",
      "in\n",
      "subgroup\n",
      "1\n",
      "and\n",
      "13.8\n",
      "%O\n",
      "in\n",
      "subgroup\n",
      "2\n",
      ",O\n",
      "showing\n",
      "no\n",
      "significant\n",
      "difference\n",
      "between\n",
      "the\n",
      "two\n",
      "subgroups\n",
      ";O\n",
      "in\n",
      "IFN-伪\n",
      "group\n",
      ",O\n",
      "the\n",
      "rates\n",
      "were\n",
      "also\n",
      "similar\n",
      "between\n",
      "subgroups\n",
      "1\n",
      "and\n",
      "2\n",
      "(O\n",
      "30.6\n",
      "%O\n",
      "vs\n",
      "33.3\n",
      "%O\n",
      ",O\n",
      "P\n",
      "&O\n",
      "gt\n",
      ";O\n",
      "0.05\n",
      ")O\n",
      ";O\n",
      "but\n",
      "the\n",
      "rates\n",
      "differed\n",
      "significantly\n",
      "between\n",
      "the\n",
      "same\n",
      "subgroups\n",
      "with\n",
      "different\n",
      "treatments\n",
      "(O\n",
      "P\n",
      "&O\n",
      "lt\n",
      ";O\n",
      "0.05).CONCLUSIONS\n",
      ":O\n",
      "In\n",
      "all\n",
      "the\n",
      "subgroups\n",
      "with\n",
      "different\n",
      "baseline\n",
      "ALT\n",
      "levels\n",
      ",O\n",
      "ETV\n",
      "treatment\n",
      "for\n",
      "48\n",
      "weeks\n",
      "results\n",
      "in\n",
      "significantly\n",
      "higher\n",
      "virological\n",
      "response\n",
      "rates\n",
      "than\n",
      "IFN-伪\n",
      "treatment\n",
      "in\n",
      "patients\n",
      "with\n",
      "CHB\n",
      ".O\n",
      "In\n",
      "patients\n",
      "with\n",
      "a\n",
      "baseline\n",
      "ALT\n",
      "of\n",
      "5\n",
      "-O\n",
      "10\n",
      "脳ULN\n",
      ",O\n",
      "IFN-伪\n",
      "can\n",
      "result\n",
      "in\n",
      "a\n",
      "higher\n",
      "HBeAg\n",
      "clearance\n",
      "rate\n",
      "than\n",
      "ETV\n",
      ".O\n",
      "In\n",
      "patients\n",
      "with\n",
      "comparable\n",
      "baseline\n",
      "ALT\n",
      "level\n",
      ",O\n",
      "IFN-伪\n",
      "more\n",
      "effectively\n",
      "reduces\n",
      "HBsAg\n",
      "level\n",
      "than\n",
      "ETV\n",
      ".O\n",
      "The\n",
      "patients\n",
      "with\n",
      "a\n",
      "relatively\n",
      "high\n",
      "baseline\n",
      "ALT\n",
      "level\n",
      "(O\n",
      "&O\n",
      "gt\n",
      ";O\n",
      "5\n",
      "脳\n",
      "ULN\n",
      ")O\n",
      "show\n",
      "better\n",
      "responses\n",
      "to\n",
      "both\n",
      "ETV\n",
      "and\n",
      "IFN-伪\n",
      "treatment\n",
      "than\n",
      "those\n",
      "with\n",
      "ALT\n",
      "level\n",
      "below\n",
      "5脳ULN\n",
      ".O\n",
      "We\n",
      "thus\n",
      "recommend\n",
      "IFN-伪\n",
      "for\n",
      "patients\n",
      "with\n",
      "a\n",
      "baseline\n",
      "ALT\n",
      "of\n",
      "5\n",
      "-O\n",
      "10脳ULN\n",
      "and\n",
      "ETV\n",
      "for\n",
      "patients\n",
      "with\n",
      "a\n",
      "baseline\n",
      "ALT\n",
      "either\n",
      "below\n",
      "5\n",
      "脳\n",
      "ULN\n",
      "or\n",
      "beyond\n",
      "10脳ULN\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "锘縊bjective\n",
      "To\n",
      "explore\n",
      "the\n",
      "clinical\n",
      "and\n",
      "laboratory\n",
      "characteristics\n",
      "and\n",
      "the\n",
      "prognosis\n",
      "of\n",
      "disseminated\n",
      "non\n",
      "-O\n",
      "tuberculous\n",
      "mycobacteria(NTM)diseases\n",
      "in\n",
      "human\n",
      "immunodeficiency\n",
      "virus(HIV)negative\n",
      "patients\n",
      ".O\n",
      "Methods\n",
      "Cases\n",
      "of\n",
      "disseminated\n",
      "NTM\n",
      "disease\n",
      "were\n",
      "retrospectively\n",
      "collected\n",
      "in\n",
      "Peking\n",
      "Union\n",
      "Medical\n",
      "College\n",
      "Hospital\n",
      "from\n",
      "January\n",
      "2012\n",
      "to\n",
      "October\n",
      "2018.Clinical\n",
      "manifestations\n",
      ",O\n",
      "laboratory\n",
      "findings\n",
      ",O\n",
      "treatment\n",
      ",O\n",
      "and\n",
      "prognosis\n",
      "of\n",
      "these\n",
      "cases\n",
      "were\n",
      "retrieved\n",
      "from\n",
      "the\n",
      "electronic\n",
      "medical\n",
      "record\n",
      "system\n",
      ".O\n",
      "Results\n",
      "Among\n",
      "the\n",
      "23\n",
      "HIV\n",
      "negative\n",
      "patients\n",
      "with\n",
      "disseminated\n",
      "NTM\n",
      "disease,21\n",
      "had\n",
      "underlying\n",
      "diseases\n",
      ",O\n",
      "with\n",
      "rheumatoid\n",
      "immune\n",
      "disease(n=7)as\n",
      "the\n",
      "most\n",
      "common\n",
      "one\n",
      ".O\n",
      "The\n",
      "main\n",
      "clinical\n",
      "manifestation\n",
      "was\n",
      "fever(n=23).Laboratory\n",
      "tests\n",
      "showed\n",
      "anemia\n",
      "[O\n",
      "hemoglobin(85.78卤25.47)g\n",
      "/O\n",
      "L],hypoalbuminemia\n",
      "[O\n",
      "albumin\n",
      "29(27\n",
      "-O\n",
      "32)g\n",
      "/O\n",
      "L],elevated\n",
      "erythrocyte\n",
      "sedimentation\n",
      "rate\n",
      "[O\n",
      "(O\n",
      "85.73卤43.78)mm\n",
      "/O\n",
      "h\n",
      "]O\n",
      "and\n",
      "hypersensitive\n",
      "C\n",
      "-O\n",
      "reactive\n",
      "protein\n",
      "[O\n",
      "(O\n",
      "112.00卤70.90)mg\n",
      "/O\n",
      "L\n",
      "]O\n",
      ",O\n",
      "and\n",
      "reduction\n",
      "of\n",
      "lymphocyte\n",
      "count\n",
      "[O\n",
      "0.69(0.29\n",
      "-O\n",
      "2.10)脳10\n",
      "9/L].Lymphocyte\n",
      "subset\n",
      "analysis\n",
      "indicated\n",
      "reduction\n",
      "in\n",
      "CD4\n",
      "+\n",
      "T\n",
      "cells\n",
      "[O\n",
      "213(113\n",
      "-O\n",
      "775)/渭l],CD8\n",
      "+\n",
      "T\n",
      "cells\n",
      "[O\n",
      "267(99\n",
      "-O\n",
      "457)/渭l],B\n",
      "cells\n",
      "[O\n",
      "39(4\n",
      "-O\n",
      "165)/渭l],and\n",
      "NK\n",
      "cells\n",
      "[O\n",
      "88(32\n",
      "-O\n",
      "279)/渭l\n",
      "]O\n",
      "and\n",
      "elevation\n",
      "of\n",
      "human\n",
      "leukocyte\n",
      "antigen\n",
      "-O\n",
      "D\n",
      "related(HLA\n",
      "-O\n",
      "DR),and\n",
      "CD38\n",
      "expression\n",
      "in\n",
      "CD8\n",
      "+\n",
      "T\n",
      "cells\n",
      "[O\n",
      "HLA\n",
      "-O\n",
      "DR\n",
      "+\n",
      "CD8\n",
      "+\n",
      "/CD8\n",
      "+\n",
      ",O\n",
      "60(40\n",
      "-O\n",
      "68)%;CD38\n",
      "+\n",
      "CD8\n",
      "+\n",
      "/CD8\n",
      "+\n",
      ",O\n",
      "81(65\n",
      "-O\n",
      "90)%].The\n",
      "most\n",
      "common\n",
      "species\n",
      "of\n",
      "NTM\n",
      "was\n",
      "Mycobacterium\n",
      "intracellular(n=6).Lymphocyte\n",
      ",O\n",
      "CD8\n",
      "+\n",
      "T\n",
      "cell\n",
      ",O\n",
      "B\n",
      "cell\n",
      ",O\n",
      "and\n",
      "NK\n",
      "cell\n",
      "counts\n",
      "were\n",
      "significantly\n",
      "lower\n",
      "in\n",
      "dead\n",
      "patients\n",
      "than\n",
      "surviving\n",
      "patients(P\n",
      "=\n",
      "0.045,P=0.045,P=0.032,and\n",
      "P=0.010,respectively\n",
      ")O\n",
      ".O\n",
      "Conclusions\n",
      "Disseminated\n",
      "NTM\n",
      "disease\n",
      "in\n",
      "HIV\n",
      "negative\n",
      "patients\n",
      "is\n",
      "mainly\n",
      "manifested\n",
      "as\n",
      "fever\n",
      ",O\n",
      "anemia\n",
      ",O\n",
      "hypoalbuminemia\n",
      ",O\n",
      "and\n",
      "elevated\n",
      "inflammatory\n",
      "indicators\n",
      ".O\n",
      "It\n",
      "is\n",
      "more\n",
      "likely\n",
      "to\n",
      "occur\n",
      "in\n",
      "immunocompromised\n",
      "patients\n",
      ".O\n",
      "Patients\n",
      "with\n",
      "decreased\n",
      "lymphocytes\n",
      ",O\n",
      "CD8\n",
      "+\n",
      "T\n",
      "cells\n",
      ",O\n",
      "B\n",
      "cells\n",
      "and\n",
      "NK\n",
      "cells\n",
      "tend\n",
      "to\n",
      "have\n",
      "a\n",
      "poor\n",
      "prognosis\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "in\n",
      "\n",
      "\t\t\t\t\n",
      "English\n",
      ",O\n",
      "Chinese鐩鐨\n",
      "閫氳繃鑵虹梾姣掓硶寤虹珛绋冲畾琛ㄨ揪澶栨簮鎬т汉绔绮掗叾鍙嶈浆褰曢叾锛坔TERT锛夊熀鍥犵殑鐗欏懆鑶滅粏鑳炵郴锛屼互鏋勫缓鑵虹梾姣掍粙瀵肩殑楂樻晥銆佺ǔ瀹氱殑hTERT鐗欏懆鑶滅粏鑳炵郴銆傛柟娉\n",
      "鑱氬悎閰堕摼鍙嶅簲锛圥CR锛夋硶鎵\n",
      "╁\n",
      "瀐TERT鍩哄洜缂栫爜搴忓垪锛屾瀯寤哄悓婧愰噸缁勮吅鐥呮瘨璐ㄧ矑pAd\n",
      "-O\n",
      "pshuttle\n",
      "-O\n",
      "cmv\n",
      "-O\n",
      "hTERT锛屾敹闆嗚吅鐥呮瘨棰楃矑鍚庢劅鏌撲汉鐗欏懆鑶滅粏鑳烇紝瀹炴椂鑽у厜瀹氶噺PCR妫娴媓TERT鍙婃垚楠ㄧ浉鍏冲熀鍥犵⒈鎬х７閰搁叾銆佹牳蹇冪粨鍚堝洜瀛2銆侀ㄦ稁铔嬬櫧銆侀ㄩ挋绱犮侀ㄦˉ绱犮佲厾鍨嬭兌鍘熻泲鐧絤RNA鐨勮〃杈炬按骞筹紝鑼滅礌绾㈡煋鑹茶傚療鎴愰ㄥ垎鍖栬兘鍔涳紝CCK-8妫娴嬬粏鑳炲炴畺鑳藉姏銆傜粨鏋\n",
      "鎴愬姛鏋勫缓浜嗗惈hTERT鍩哄洜鐨勮吅鐥呮瘨棰楃矑骞舵劅鏌撶墮鍛ㄨ啘缁嗚優锛屾劅鏌撶粏鑳炰笌姝ｅ父鐗欏懆鑶滅粏鑳炲舰鎬佺浉浼硷紱瀹炴椂鑽у厜瀹氶噺PCR缁撴灉鏄剧ずhTERT鍙婃垚楠ㄧ浉鍏冲熀鍥犲湪鎰熸煋缁嗚優涓楂樿〃杈撅紱鑼滅礌绾㈡煋鑹叉樉绀虹墮鍛ㄨ啘缁嗚優绯绘垚楠ㄨ兘鍔涘己锛汣CK-8缁撴灉绀虹墮鍛ㄨ啘缁嗚優绯诲炴畺鑳藉姏寮恒傜粨璁\n",
      "閫氳繃鑵虹梾姣掓硶鎴愬姛寤虹珛浜嗚繃琛ㄨ揪hTERT鐨勪汉鐗欏懆鑶滅粏鑳炵郴锛屽叾鍏锋湁杈冨己鐨勬垚楠ㄥ垎鍖栬兘鍔涳紝杩欎负鐮旂\n",
      "┒\n",
      "鐗欏懆鑶滃啀鐢熸満鍒舵彁渚涗簡涓涓鐞嗘兂鐨勭粏鑳炵郴銆.OBJECTIVE\n",
      ":O\n",
      "This\n",
      "study\n",
      "aims\n",
      "to\n",
      "establish\n",
      "an\n",
      "effective\n",
      "and\n",
      "stable\n",
      "periodontal\n",
      "ligament\n",
      "cell\n",
      "line\n",
      "stably\n",
      "expressing\n",
      "human\n",
      "telomerase\n",
      "reverse\n",
      "transcriptase\n",
      "(O\n",
      "hTERT\n",
      ")O\n",
      "gene\n",
      "by\n",
      "using\n",
      "the\n",
      "adenovirus\n",
      "method\n",
      ".O\n",
      "METHODS\n",
      ":O\n",
      "Polymerase\n",
      "chain\n",
      "reaction\n",
      "(O\n",
      "PCR\n",
      ")O\n",
      "was\n",
      "used\n",
      "to\n",
      "amplify\n",
      "the\n",
      "full\n",
      "length\n",
      "of\n",
      "hTERT\n",
      "gene\n",
      "to\n",
      "construct\n",
      "recombinant\n",
      "adenovirus\n",
      "plasmid\n",
      "pAd\n",
      "-O\n",
      "pshuttle\n",
      "-O\n",
      "cmv\n",
      "-O\n",
      "hTERT\n",
      ".O\n",
      "Packaged\n",
      "adenovirus\n",
      "particles\n",
      "were\n",
      "used\n",
      "for\n",
      "infection\n",
      "of\n",
      "human\n",
      "periodontal\n",
      "ligament\n",
      "cells\n",
      ".O\n",
      "The\n",
      "expression\n",
      "levels\n",
      "of\n",
      "hTERT\n",
      "and\n",
      "osteogenic\n",
      "genes\n",
      ",O\n",
      "such\n",
      "as\n",
      "alkaline\n",
      "phosphatase\n",
      ",O\n",
      "Runt\n",
      "-O\n",
      "related\n",
      "transcription\n",
      "factor\n",
      "2\n",
      ",O\n",
      "bone\n",
      "sialoprotein\n",
      ",O\n",
      "osteocalcin\n",
      ",O\n",
      "osteopontin\n",
      ",O\n",
      "and\n",
      "collagen\n",
      "鈪\n",
      "mRNA\n",
      ",O\n",
      "were\n",
      "detected\n",
      "by\n",
      "quantitative\n",
      "real\n",
      "-O\n",
      "time\n",
      "PCR\n",
      "(O\n",
      "qRT\n",
      "-O\n",
      "PCR\n",
      ")O\n",
      ".O\n",
      "The\n",
      "ability\n",
      "of\n",
      "osteogenic\n",
      "differentiation\n",
      "was\n",
      "observed\n",
      "by\n",
      "alizarin\n",
      "red\n",
      "staining\n",
      ",O\n",
      "and\n",
      "the\n",
      "cell\n",
      "proliferation\n",
      "was\n",
      "determined\n",
      "by\n",
      "CCK-8.RESULTS\n",
      ":O\n",
      "Adenovirus\n",
      "particles\n",
      "containing\n",
      "the\n",
      "hTERT\n",
      "gene\n",
      "were\n",
      "successfully\n",
      "constructed\n",
      "and\n",
      "infected\n",
      "with\n",
      "periodontal\n",
      "ligament\n",
      "cells\n",
      ".O\n",
      "The\n",
      "infected\n",
      "cells\n",
      "were\n",
      "similar\n",
      "to\n",
      "normal\n",
      "periodontal\n",
      "ligament\n",
      "cells\n",
      ".O\n",
      "The\n",
      "qRT\n",
      "-O\n",
      "PCR\n",
      "results\n",
      "showed\n",
      "that\n",
      "hTERT\n",
      "and\n",
      "osteogenesis\n",
      "-O\n",
      "associated\n",
      "genes\n",
      "were\n",
      "highly\n",
      "expressed\n",
      "in\n",
      "the\n",
      "periodontal\n",
      "ligament\n",
      "cell\n",
      "lines\n",
      "constructed\n",
      "by\n",
      "adenoviruses\n",
      ".O\n",
      "Alizarin\n",
      "red\n",
      "staining\n",
      "showed\n",
      "that\n",
      "the\n",
      "periodontal\n",
      "ligament\n",
      "cell\n",
      "line\n",
      "had\n",
      "strong\n",
      "osteogenic\n",
      "differentiation\n",
      "capability\n",
      ".O\n",
      "CCK-8\n",
      "showed\n",
      "that\n",
      "the\n",
      "periodontal\n",
      "ligament\n",
      "cell\n",
      "line\n",
      "had\n",
      "strong\n",
      "proliferation\n",
      "capability\n",
      ".O\n",
      "CONCLUSIONS\n",
      ":O\n",
      "The\n",
      "human\n",
      "periodontal\n",
      "ligament\n",
      "cell\n",
      "line\n",
      "with\n",
      "high\n",
      "efficiency\n",
      "and\n",
      "stable\n",
      "expression\n",
      "of\n",
      "hTERT\n",
      "was\n",
      "established\n",
      "by\n",
      "the\n",
      "adenovirus\n",
      "method\n",
      ",O\n",
      "thereby\n",
      "providing\n",
      "an\n",
      "ideal\n",
      "cell\n",
      "line\n",
      "for\n",
      "studying\n",
      "the\n",
      "mechanism\n",
      "of\n",
      "periodontal\n",
      "regeneration\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "in\n",
      "\n",
      "\t\t\t\t\n",
      "English\n",
      ",O\n",
      "FrenchCryoglobulin茅mies\n",
      ".O\n",
      "La\n",
      "cryoglobulin茅mie\n",
      "est\n",
      "d茅finie\n",
      "par\n",
      "la\n",
      "pr茅sence\n",
      "d鈥檜ne\n",
      "cryoglobuline\n",
      "circulante\n",
      ",O\n",
      "immunoglobuline\n",
      "pr茅cipitant\n",
      "au\n",
      "froid\n",
      ".O\n",
      "Le\n",
      "typage\n",
      "de\n",
      "cette\n",
      "cryoglobuline\n",
      "est\n",
      "fondamental\n",
      ".O\n",
      "En\n",
      "effet\n",
      ",O\n",
      "on\n",
      "distingue\n",
      "deux\n",
      "sous\n",
      "-O\n",
      "groupes\n",
      ":O\n",
      "les\n",
      "cryoglobulines\n",
      "de\n",
      "type\n",
      "I\n",
      "et\n",
      "les\n",
      "cryoglobulines\n",
      "mixtes\n",
      ".O\n",
      "La\n",
      "physiopathologie\n",
      "et\n",
      "les\n",
      "traitements\n",
      "sont\n",
      "diff茅rents\n",
      "dans\n",
      "ces\n",
      "deux\n",
      "entit茅s\n",
      ".O\n",
      "Les\n",
      "cryoglobulin茅mies\n",
      "de\n",
      "type\n",
      "I\n",
      "sont\n",
      "li茅es\n",
      "脿\n",
      "une\n",
      "h茅mopathie\n",
      "lympho茂de\n",
      "B\n",
      "monoclonale\n",
      "sous\n",
      "-O\n",
      "jacente\n",
      ",O\n",
      "alors\n",
      "que\n",
      "les\n",
      "cryoglobulin茅mies\n",
      "mixtes\n",
      "(O\n",
      "types\n",
      "II\n",
      "et\n",
      "III\n",
      ")O\n",
      "茅mergent\n",
      "dans\n",
      "des\n",
      "situations\n",
      "de\n",
      "stimulation\n",
      "antig茅nique\n",
      "assez\n",
      "vari茅es\n",
      ",O\n",
      "la\n",
      "plus\n",
      "fr茅quente\n",
      "茅tant\n",
      "le\n",
      "virus\n",
      "de\n",
      "l鈥檋茅patite\n",
      "C.\n",
      "L鈥檌ntensit茅\n",
      "des\n",
      "sympt么mes\n",
      "est\n",
      "tr猫s\n",
      "variable\n",
      ",O\n",
      "beaucoup\n",
      "de\n",
      "patients\n",
      "sont\n",
      "asymptomatiques\n",
      ".O\n",
      "Chez\n",
      "les\n",
      "patients\n",
      "symptomatiques\n",
      ",O\n",
      "les\n",
      "organes\n",
      "les\n",
      "plus\n",
      "fr茅quemment\n",
      "touch茅s\n",
      "sont\n",
      "la\n",
      "peau\n",
      ",O\n",
      "le\n",
      "syst猫me\n",
      "nerveux\n",
      "p茅riph茅rique\n",
      "et\n",
      "le\n",
      "glom茅rule\n",
      "r茅nal\n",
      ".O\n",
      "Quelques\n",
      "rares\n",
      "patients\n",
      "ont\n",
      "des\n",
      "atteintes\n",
      "visc茅rales\n",
      "mettant\n",
      "en\n",
      "jeu\n",
      "le\n",
      "pronostic\n",
      "vital\n",
      ".O\n",
      "Le\n",
      "traitement\n",
      "prend\n",
      "toujours\n",
      "en\n",
      "compte\n",
      "l鈥檌ntensit茅\n",
      "des\n",
      "sympt么mes\n",
      "et\n",
      "la\n",
      "pathologie\n",
      "sous\n",
      "-O\n",
      "jacente\n",
      ".O\n",
      "Dans\n",
      "les\n",
      "cryoglobulin茅mies\n",
      "de\n",
      "type\n",
      "I\n",
      ",O\n",
      "le\n",
      "traitement\n",
      "du\n",
      "clone\n",
      "sous\n",
      "-O\n",
      "jacent\n",
      "est\n",
      "primordial\n",
      ".O\n",
      "Dans\n",
      "celles\n",
      "de\n",
      "type\n",
      "II\n",
      ",O\n",
      "on\n",
      "associe\n",
      "le\n",
      "plus\n",
      "souvent\n",
      "un\n",
      "traitement\n",
      "immunosuppresseur\n",
      "au\n",
      "traitement\n",
      "de\n",
      "la\n",
      "cause\n",
      ",O\n",
      "si\n",
      "elle\n",
      "est\n",
      "identifi茅e\n",
      ".O\n",
      "Cryoglobulinemia\n",
      ".O\n",
      "Cryoglobulinemia\n",
      "is\n",
      "defined\n",
      "by\n",
      "the\n",
      "presence\n",
      "of\n",
      "a\n",
      "circulating\n",
      "cryoglobulin\n",
      ",O\n",
      "a\n",
      "cold\n",
      "-O\n",
      "precipitating\n",
      "immunoglobulin\n",
      ".O\n",
      "The\n",
      "typing\n",
      "of\n",
      "this\n",
      "cryoglobulin\n",
      "is\n",
      "fundamental\n",
      ".O\n",
      "Indeed\n",
      ",O\n",
      "there\n",
      "are\n",
      "two\n",
      "subgroups\n",
      ":O\n",
      "cryoglobulin\n",
      "type\n",
      "I\n",
      "and\n",
      "mixed\n",
      "cryoglobulins\n",
      ".O\n",
      "The\n",
      "physiopathology\n",
      "and\n",
      "treatments\n",
      "are\n",
      "different\n",
      "in\n",
      "these\n",
      "two\n",
      "entities\n",
      ".O\n",
      "Cryoglobulinemia\n",
      "type\n",
      "1\n",
      "is\n",
      "associated\n",
      "with\n",
      "an\n",
      "underlying\n",
      "monoclonal\n",
      "lymphoid\n",
      "B\n",
      "hemopathy\n",
      ",O\n",
      "while\n",
      "mixed\n",
      "cryoglobulinemia\n",
      "(O\n",
      "types\n",
      "II\n",
      "and\n",
      "III\n",
      ")O\n",
      "emerge\n",
      "in\n",
      "quite\n",
      "varied\n",
      "antigenic\n",
      "stimulation\n",
      "situations\n",
      ",O\n",
      "the\n",
      "most\n",
      "common\n",
      "being\n",
      "the\n",
      "hepatitis\n",
      "C\n",
      "virus\n",
      ".O\n",
      "The\n",
      "intensity\n",
      "of\n",
      "the\n",
      "symptoms\n",
      "is\n",
      "very\n",
      "variable\n",
      ",O\n",
      "many\n",
      "patients\n",
      "are\n",
      "asymptomatic\n",
      ".O\n",
      "In\n",
      "symptomatic\n",
      "patients\n",
      ",O\n",
      "the\n",
      "most\n",
      "frequently\n",
      "affected\n",
      "organs\n",
      "are\n",
      "the\n",
      "skin\n",
      ",O\n",
      "the\n",
      "peripheral\n",
      "nervous\n",
      "system\n",
      "and\n",
      "the\n",
      "renal\n",
      "glomerulus\n",
      ".O\n",
      "Few\n",
      "patients\n",
      "have\n",
      "visceral\n",
      "involvement\n",
      "that\n",
      "is\n",
      "life\n",
      "-O\n",
      "threatening\n",
      ".O\n",
      "The\n",
      "treatment\n",
      "always\n",
      "takes\n",
      "into\n",
      "account\n",
      "the\n",
      "intensity\n",
      "of\n",
      "the\n",
      "symptoms\n",
      "and\n",
      "the\n",
      "underlying\n",
      "pathology\n",
      ".O\n",
      "In\n",
      "cryoglobulinemia\n",
      "type\n",
      "I\n",
      ",O\n",
      "treatment\n",
      "of\n",
      "the\n",
      "underlying\n",
      "clone\n",
      "is\n",
      "essential\n",
      ".O\n",
      "In\n",
      "type\n",
      "II\n",
      ",O\n",
      "immunosuppressive\n",
      "therapy\n",
      "is\n",
      "most\n",
      "often\n",
      "associated\n",
      "with\n",
      "treatment\n",
      "of\n",
      "the\n",
      "cause\n",
      ",O\n",
      "if\n",
      "identified\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "Objective\n",
      "To\n",
      "measure\n",
      "the\n",
      "effect\n",
      "of\n",
      "duck\n",
      "viperin\n",
      "protein\n",
      "on\n",
      "the\n",
      "proliferation\n",
      "of\n",
      "duck\n",
      "Tembusu\n",
      "virus\n",
      "(O\n",
      "DTMUV\n",
      ")O\n",
      ".O\n",
      "Methods\n",
      "We\n",
      "analyzed\n",
      "the\n",
      "duck\n",
      "viperin\n",
      "gene\n",
      "using\n",
      "a\n",
      "bioinformatics\n",
      ".O\n",
      "Plasmids\n",
      "pGEX-6P\n",
      "-O\n",
      "viperin\n",
      "and\n",
      "pEGFP\n",
      "-O\n",
      "N1-viperin\n",
      "were\n",
      "constructed\n",
      "and\n",
      "transformed\n",
      "into\n",
      "Rosseta\n",
      "and\n",
      "transfected\n",
      "into\n",
      "BHK-21\n",
      "cells\n",
      ",O\n",
      "respectively\n",
      ".O\n",
      "BHK-21\n",
      "cells\n",
      "transfected\n",
      "with\n",
      "plasmid\n",
      "pEGFP\n",
      "-O\n",
      "N1-viperin\n",
      "and\n",
      "empty\n",
      "vector\n",
      "were\n",
      "infected\n",
      "with\n",
      "DTMUV\n",
      ".O\n",
      "The\n",
      "content\n",
      "of\n",
      "DTMUV\n",
      "in\n",
      "cell\n",
      "precipitation\n",
      "and\n",
      "supernatant\n",
      "was\n",
      "analyzed\n",
      "by\n",
      "real\n",
      "-O\n",
      "time\n",
      "fluorescent\n",
      "quantitative\n",
      "PCR\n",
      ".O\n",
      "Finally\n",
      ",O\n",
      "the\n",
      "effect\n",
      "of\n",
      "viperin\n",
      "on\n",
      "DTMUV\n",
      "proliferation\n",
      "and\n",
      "the\n",
      "binding\n",
      "proteins\n",
      "captured\n",
      "by\n",
      "EGFP\n",
      "monoclonal\n",
      "antibody\n",
      "were\n",
      "evaluated\n",
      "using\n",
      "mass\n",
      "spectrometry\n",
      ".O\n",
      "Results\n",
      "Significant\n",
      "differences\n",
      "were\n",
      "observed\n",
      "between\n",
      "the\n",
      "expression\n",
      "levels\n",
      "of\n",
      "viperin\n",
      "gene\n",
      "in\n",
      "duck\n",
      "compared\n",
      "to\n",
      "other\n",
      "species\n",
      ".O\n",
      "Duck\n",
      "viperin\n",
      "was\n",
      "found\n",
      "to\n",
      "inhibit\n",
      "the\n",
      "budding\n",
      "of\n",
      "DTMUV\n",
      "in\n",
      "BHK-21\n",
      "cells\n",
      ".O\n",
      "Further\n",
      ",O\n",
      "we\n",
      "identified\n",
      "six\n",
      "proteins\n",
      "that\n",
      "might\n",
      "be\n",
      "involved\n",
      "in\n",
      "the\n",
      "inhibition\n",
      "of\n",
      "the\n",
      "proliferation\n",
      "and\n",
      "budding\n",
      "of\n",
      "DTMUV\n",
      ",O\n",
      "possibly\n",
      "indicative\n",
      "of\n",
      "the\n",
      "viperin\n",
      "anti\n",
      "-O\n",
      "Tembusu\n",
      "virus\n",
      "pathway\n",
      "in\n",
      "ducks\n",
      ".O\n",
      "Conclusion\n",
      "Expression\n",
      "patterns\n",
      "of\n",
      "duck\n",
      "viperin\n",
      "reveal\n",
      "how\n",
      "the\n",
      "budding\n",
      "of\n",
      "duck\n",
      "Tembusu\n",
      "virus\n",
      "is\n",
      "inhibited\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "in\n",
      "\n",
      "\t\t\t\t\n",
      "English\n",
      ",O\n",
      "Chinese鐩鐨勶細鎺㈣ㄥ惈浜哄共缁嗚優鐧借鐥(stem\n",
      "cell\n",
      "leukemia锛孲CL)鍩哄洜閲嶇粍鎱㈢梾姣掑归珮绯栫幆澧冧笅鍙楁崯Cajal闂磋川缁嗚優(interstitial\n",
      "cells\n",
      "of\n",
      "Cajal锛孖CC)涓閰姘ㄩ吀婵閰跺彈浣(c\n",
      "-O\n",
      "kit)铔嬬櫧琛ㄨ揪鐨勫奖鍝嶃傛柟娉曪細鍒嗙籌CC锛屽煿鍏24\n",
      "h璐村侊紝缁忓掔疆鏄惧井闀溿佸厤鐤鑽у厜閴村畾鍚庯紝灏咺CC缁嗚優鍒嗕负瀵圭収缁勩侀珮绯栫粍锛屽圭収缁勫姞鍏ュ惈5\n",
      "mmol\n",
      "/O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝楂樼硸缁勫姞鍏ュ惈20\n",
      "mmol\n",
      "/O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝鍩瑰吇48\n",
      "h鍚庯紱瀵圭収缁勪笉鍙橈紝楂樼硸缁勫垎鎴愮\n",
      "┖\n",
      "鐧界粍銆佺\n",
      "┖\n",
      "鎱㈢梾姣掔粍鍜屽疄楠岀粍3涓浜氱粍锛3缁勫垎鍒鍔犲叆PBS銆佺\n",
      "┖\n",
      "鎱㈢梾姣掑拰鍚玈CL鍩哄洜閲嶇粍鎱㈢梾姣5\n",
      "mmol\n",
      "/O\n",
      "L钁¤悇绯栫殑鍩瑰吇鍩猴紝缁х画鍩瑰吇24鍜48\n",
      "h锛岄噰鐢\n",
      "╓\n",
      "estern鍗拌抗娉曟娴嬩袱涓鏃舵靛悇缁勪腑ICC涓璫-kit\n",
      "铔嬬櫧琛ㄨ揪鎯呭喌銆傜粨鏋滐細24鎴48\n",
      "h鍚庯紝绌虹櫧缁勩佺\n",
      "┖\n",
      "鎱㈢梾姣掔粍涓璉CC鐨刢-kit铔嬬櫧琛ㄨ揪姘村钩鍧囨槑鏄句綆浜庡圭収缁勶紝瀹為獙缁勪腑ICC涓璫-kit铔嬬櫧鐨勮〃杈炬按骞虫槑鏄惧潎楂樹簬绌虹櫧缁勫拰绌烘參鐥呮瘨缁勶紝浣嗘槸浠嶄綆浜庡圭収缁(鍧嘝<0.05)銆傜粨璁猴細SCL鍩哄洜閲嶇粍鎱㈢梾姣掑彲浠ヤ笂璋冮珮绯栫幆澧冧笅鍔熻兘鍙楁崯ICC涓璫-kit铔嬬櫧琛ㄨ揪閲忋.To\n",
      "determine\n",
      "the\n",
      "effect\n",
      "of\n",
      "a\n",
      "recombinant\n",
      "lentivirus\n",
      "containing\n",
      "human\n",
      "stem\n",
      "cell\n",
      "leukemia\n",
      "(O\n",
      "SCL\n",
      ")O\n",
      "gene\n",
      "on\n",
      "the\n",
      "expression\n",
      "of\n",
      "c\n",
      "-O\n",
      "kit\n",
      "protein\n",
      "in\n",
      "damaged\n",
      "interstitial\n",
      "cells\n",
      "of\n",
      "Cajal\n",
      "(O\n",
      "ICC\n",
      ")O\n",
      "under\n",
      "high\n",
      "glucose\n",
      "condition.鈥\n",
      "Methods\n",
      ":O\n",
      "After\n",
      "isolation\n",
      "of\n",
      "ICC\n",
      ",O\n",
      "the\n",
      "cells\n",
      "were\n",
      "cultured\n",
      "for\n",
      "24\n",
      "hours\n",
      "until\n",
      "the\n",
      "cells\n",
      "were\n",
      "adherent\n",
      ".O\n",
      "After\n",
      "identification\n",
      "by\n",
      "inverted\n",
      "microscope\n",
      "and\n",
      "immunofluorescence\n",
      ",O\n",
      "ICC\n",
      "cells\n",
      "were\n",
      "divided\n",
      "into\n",
      "two\n",
      "groups\n",
      ":O\n",
      "A\n",
      "control\n",
      "group\n",
      "and\n",
      "a\n",
      "high\n",
      "glucose\n",
      "group\n",
      ".O\n",
      "The\n",
      "control\n",
      "group\n",
      "was\n",
      "added\n",
      "with\n",
      "a\n",
      "medium\n",
      "containing\n",
      "5\n",
      "mmol\n",
      "/O\n",
      "L\n",
      "of\n",
      "glucose\n",
      ".O\n",
      "The\n",
      "high\n",
      "glucose\n",
      "group\n",
      "was\n",
      "added\n",
      "with\n",
      "a\n",
      "medium\n",
      "containing\n",
      "20\n",
      "mmol\n",
      "/O\n",
      "L\n",
      "of\n",
      "glucose\n",
      ".O\n",
      "After\n",
      "48\n",
      "h\n",
      "of\n",
      "continuous\n",
      "cultivation\n",
      ",O\n",
      "the\n",
      "high\n",
      "glucose\n",
      "group\n",
      "was\n",
      "divided\n",
      "into\n",
      "3\n",
      "subgroups\n",
      ":O\n",
      "A\n",
      "blank\n",
      "group\n",
      ",O\n",
      "an\n",
      "empty\n",
      "lentivirus\n",
      "group\n",
      ",O\n",
      "and\n",
      "an\n",
      "experimental\n",
      "group\n",
      ".O\n",
      "The\n",
      "blank\n",
      "group\n",
      ",O\n",
      "the\n",
      "empty\n",
      "lentivirus\n",
      "group\n",
      ",O\n",
      "and\n",
      "the\n",
      "experimental\n",
      "group\n",
      "were\n",
      "added\n",
      "a\n",
      "medium\n",
      "containing\n",
      "PBS\n",
      "solution\n",
      ",O\n",
      "empty\n",
      "lentivirus\n",
      ",O\n",
      "and\n",
      "a\n",
      "recombinant\n",
      "lentivirus\n",
      "containing\n",
      "the\n",
      "SCL\n",
      "gene\n",
      "with\n",
      "a\n",
      "glucose\n",
      "concentration\n",
      "of\n",
      "5\n",
      "mmol\n",
      "/O\n",
      "L\n",
      ",O\n",
      "respectively\n",
      ".O\n",
      "The\n",
      "cultures\n",
      "were\n",
      "incubated\n",
      "for\n",
      "24\n",
      "and\n",
      "48\n",
      "h.\n",
      "The\n",
      "expression\n",
      "of\n",
      "c\n",
      "-O\n",
      "kit\n",
      "protein\n",
      "in\n",
      "ICC\n",
      "in\n",
      "each\n",
      "group\n",
      "was\n",
      "detected\n",
      "by\n",
      "Western\n",
      "blot.鈥\n",
      "Results\n",
      ":O\n",
      "After\n",
      "24\n",
      "or\n",
      "48\n",
      "h\n",
      ",O\n",
      "the\n",
      "expression\n",
      "of\n",
      "c\n",
      "-O\n",
      "kit\n",
      "protein\n",
      "in\n",
      "ICC\n",
      "was\n",
      "significantly\n",
      "lower\n",
      "in\n",
      "the\n",
      "blank\n",
      "group\n",
      "and\n",
      "the\n",
      "lentivirus\n",
      "group\n",
      "than\n",
      "that\n",
      "in\n",
      "the\n",
      "control\n",
      "group\n",
      ",O\n",
      "and\n",
      "the\n",
      "expression\n",
      "of\n",
      "c\n",
      "-O\n",
      "kit\n",
      "protein\n",
      "in\n",
      "ICC\n",
      "was\n",
      "significantly\n",
      "higher\n",
      "in\n",
      "the\n",
      "experimental\n",
      "group\n",
      "than\n",
      "that\n",
      "in\n",
      "the\n",
      "blank\n",
      "group\n",
      "and\n",
      "the\n",
      "empty\n",
      "lentivirus\n",
      "group\n",
      ",O\n",
      "but\n",
      "it\n",
      "was\n",
      "still\n",
      "lower\n",
      "than\n",
      "that\n",
      "in\n",
      "the\n",
      "control\n",
      "group\n",
      "(O\n",
      "all\n",
      "P<0.05).鈥\n",
      "Conclusion\n",
      ":O\n",
      "The\n",
      "recombinant\n",
      "lentivirus\n",
      "of\n",
      "SCL\n",
      "gene\n",
      "can\n",
      "up\n",
      "-O\n",
      "regulate\n",
      "the\n",
      "expression\n",
      "of\n",
      "c\n",
      "-O\n",
      "kit\n",
      "protein\n",
      "in\n",
      "functionally\n",
      "impaired\n",
      "ICC\n",
      "under\n",
      "high\n",
      "glucose\n",
      "condition\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "OBJECTIVE\n",
      ":O\n",
      "To\n",
      "study\n",
      "the\n",
      "effects\n",
      "of\n",
      "respiratory\n",
      "syncytial\n",
      "virus\n",
      "(O\n",
      "RSV\n",
      ")O\n",
      "infection\n",
      "on\n",
      "epidermal\n",
      "growth\n",
      "factor\n",
      "receptor\n",
      "(O\n",
      "EGFR\n",
      ")O\n",
      ",O\n",
      "tight\n",
      "junction\n",
      "association\n",
      "proteins\n",
      "and\n",
      "mucin\n",
      "in\n",
      "the\n",
      "human\n",
      "airway\n",
      "epithelial\n",
      "cells\n",
      ".O\n",
      "METHODS\n",
      ":O\n",
      "Human\n",
      "airway\n",
      "epithelial\n",
      "cells\n",
      "NCI\n",
      "-O\n",
      "H292\n",
      "were\n",
      "randomly\n",
      "treated\n",
      "by\n",
      "ultraviolet\n",
      "light\n",
      "-O\n",
      "inactivated\n",
      "RSV\n",
      "(O\n",
      "control\n",
      "group\n",
      ")O\n",
      "or\n",
      "thawed\n",
      "RSV\n",
      "(O\n",
      "RSV\n",
      "infection\n",
      "group\n",
      ")O\n",
      ".O\n",
      "After\n",
      "48\n",
      "hours\n",
      "of\n",
      "treatment\n",
      ",O\n",
      "the\n",
      "protein\n",
      "levels\n",
      "of\n",
      "occludin\n",
      ",O\n",
      "E\n",
      "-O\n",
      "cadherin\n",
      ",O\n",
      "phosphorylated\n",
      "EGFR\n",
      "and\n",
      "EGFR\n",
      "in\n",
      "NCI\n",
      "-O\n",
      "H292\n",
      "cells\n",
      "were\n",
      "measured\n",
      "by\n",
      "Western\n",
      "blot\n",
      ".O\n",
      "The\n",
      "distribution\n",
      "and\n",
      "expression\n",
      "levels\n",
      "of\n",
      "occludin\n",
      "and\n",
      "E\n",
      "-O\n",
      "cadherin\n",
      "in\n",
      "NCI\n",
      "-O\n",
      "H292\n",
      "cells\n",
      "were\n",
      "examined\n",
      "by\n",
      "immunofluorescence\n",
      "technique\n",
      ".O\n",
      "The\n",
      "expression\n",
      "levels\n",
      "of\n",
      "MUC5AC\n",
      "mRNA\n",
      "in\n",
      "NCI\n",
      "-O\n",
      "H292\n",
      "cells\n",
      "were\n",
      "assessed\n",
      "by\n",
      "RT\n",
      "-O\n",
      "PCR.RESULTS\n",
      ":O\n",
      "The\n",
      "protein\n",
      "levels\n",
      "of\n",
      "occludin\n",
      "and\n",
      "E\n",
      "-O\n",
      "cadherin\n",
      "were\n",
      "significantly\n",
      "reduced\n",
      "in\n",
      "the\n",
      "RSV\n",
      "infection\n",
      "group\n",
      "compared\n",
      "with\n",
      "the\n",
      "control\n",
      "group\n",
      "(O\n",
      "P<0.05\n",
      ")O\n",
      ".O\n",
      "The\n",
      "protein\n",
      "levels\n",
      "of\n",
      "phosphorylated\n",
      "EGFR\n",
      "and\n",
      "EGFR\n",
      "increased\n",
      "significantly\n",
      "in\n",
      "the\n",
      "RSV\n",
      "infection\n",
      "group\n",
      "compared\n",
      "with\n",
      "the\n",
      "control\n",
      "group\n",
      "(O\n",
      "P<0.05\n",
      ")O\n",
      ".O\n",
      "The\n",
      "MUC5AC\n",
      "mRNA\n",
      "levels\n",
      "also\n",
      "increased\n",
      "significantly\n",
      "in\n",
      "the\n",
      "RSV\n",
      "infection\n",
      "group\n",
      "compared\n",
      "with\n",
      "the\n",
      "control\n",
      "group\n",
      "(O\n",
      "P<0.05).CONCLUSIONS\n",
      ":O\n",
      "RSV\n",
      "may\n",
      "down\n",
      "-O\n",
      "regulate\n",
      "the\n",
      "tight\n",
      "junction\n",
      "association\n",
      "proteins\n",
      "and\n",
      "up\n",
      "-O\n",
      "regulate\n",
      "the\n",
      "expression\n",
      "of\n",
      "MUC5AC\n",
      "in\n",
      "airway\n",
      "epithelial\n",
      "cells\n",
      ",O\n",
      "which\n",
      "contributes\n",
      "to\n",
      "epithelial\n",
      "barrier\n",
      "dysfunction\n",
      ".O\n",
      "EGFR\n",
      "phosphorylation\n",
      "may\n",
      "play\n",
      "an\n",
      "important\n",
      "role\n",
      "in\n",
      "regulation\n",
      "of\n",
      "airway\n",
      "barrier\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "Objective\n",
      "To\n",
      "establish\n",
      "a\n",
      "human\n",
      "B\n",
      "lymphoma\n",
      "cell\n",
      "line\n",
      "which\n",
      "can\n",
      "stably\n",
      "express\n",
      "Epstein\n",
      "-O\n",
      "Barr\n",
      "virus\n",
      "latent\n",
      "membrane\n",
      "protein\n",
      "1\n",
      "(O\n",
      "LMP1\n",
      ")O\n",
      ".O\n",
      "Methods\n",
      "The\n",
      "LMP1\n",
      "coding\n",
      "gene\n",
      "with\n",
      "EcoRI\n",
      "and\n",
      "BamHI\n",
      "restriction\n",
      "sites\n",
      "was\n",
      "amplified\n",
      ",O\n",
      "cloned\n",
      "into\n",
      "pcDNA3.1-EF1a\n",
      "-O\n",
      "mcs-3FLAG\n",
      "-O\n",
      "CMV\n",
      "-O\n",
      "EGFP\n",
      "plasmid\n",
      ",O\n",
      "and\n",
      "positive\n",
      "monoclonal\n",
      "competent\n",
      "cells\n",
      "were\n",
      "picked\n",
      "for\n",
      "PCR\n",
      "and\n",
      "sequencing\n",
      ".O\n",
      "The\n",
      "recombinant\n",
      "plasmid\n",
      "was\n",
      "transfected\n",
      "into\n",
      "Ramos\n",
      "cells\n",
      "by\n",
      "electroporation\n",
      ",O\n",
      "and\n",
      "the\n",
      "cell\n",
      "line\n",
      "stably\n",
      "expressing\n",
      "LMP1\n",
      "was\n",
      "picked\n",
      "by\n",
      "G418\n",
      ".O\n",
      "The\n",
      "expression\n",
      "of\n",
      "LMP1\n",
      "in\n",
      "Ramos\n",
      "cells\n",
      "was\n",
      "detected\n",
      "by\n",
      "PCR\n",
      ",O\n",
      "Western\n",
      "blot\n",
      "analysis\n",
      "and\n",
      "green\n",
      "fluorescent\n",
      "protein\n",
      "Tag\n",
      ".O\n",
      "Results\n",
      "PCR\n",
      "and\n",
      "sequencing\n",
      "confirmed\n",
      "that\n",
      "the\n",
      "LMP1\n",
      "recombinant\n",
      "plasmid\n",
      "was\n",
      "successfully\n",
      "constructed\n",
      "and\n",
      "a\n",
      "stably\n",
      "transfected\n",
      "Ramos\n",
      "cell\n",
      "line\n",
      "was\n",
      "established\n",
      ".O\n",
      "Western\n",
      "blot\n",
      "analysis\n",
      "confirmed\n",
      "that\n",
      "LMP1\n",
      "protein\n",
      "was\n",
      "successfully\n",
      "expressed\n",
      "in\n",
      "this\n",
      "cell\n",
      "line\n",
      ".O\n",
      "Conclusion\n",
      "The\n",
      "Ramos\n",
      "cells\n",
      "stably\n",
      "expressing\n",
      "LMP1\n",
      "have\n",
      "been\n",
      "successfully\n",
      "established\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "in\n",
      "\n",
      "\t\t\t\t\n",
      "English\n",
      ",O\n",
      "HungarianAbsztrakt\n",
      ":O\n",
      "A\n",
      "hepatitis\n",
      "C\n",
      "-O\n",
      "v铆rus\n",
      "(O\n",
      "HCV\n",
      ")O\n",
      "megk枚zel铆t艖leg\n",
      "4\n",
      "milli贸\n",
      "煤j\n",
      "fert艖z茅st\n",
      "okoz\n",
      "茅vente\n",
      ",O\n",
      "茅s\n",
      "399聽000\n",
      "beteg\n",
      "hal\n",
      "meg\n",
      "a\n",
      "fert艖z茅s\n",
      "k枚vetkezt茅ben\n",
      "kialakul贸\n",
      "sz枚v艖dm茅nyek\n",
      ",O\n",
      "cirrhosis\n",
      "茅s\n",
      "hepatocellularis\n",
      "carcinoma\n",
      "(O\n",
      "HCC\n",
      ")O\n",
      "miatt\n",
      ".O\n",
      "Id眉lt\n",
      "HCV\n",
      "-O\n",
      "fert艖z茅sben\n",
      "a\n",
      "mikrok枚rnyezeti\n",
      "v谩ltoz谩sok\n",
      ",O\n",
      "a\n",
      "fert艖z茅s\n",
      "kiv谩ltotta\n",
      "id眉lt\n",
      "gyullad谩s\n",
      ",O\n",
      "az\n",
      "oxidat铆v\n",
      "stressz\n",
      "茅s\n",
      "az\n",
      "endoplazm谩s\n",
      "reticulum\n",
      "stressz\n",
      "genetikai\n",
      ",O\n",
      "epigenetikai\n",
      "v谩ltoz谩sokon\n",
      "kereszt眉l\n",
      "茅vtizedek\n",
      "alatt\n",
      "vezethetnek\n",
      "primer\n",
      "m谩jr谩k\n",
      "kialakul谩s谩hoz\n",
      ".O\n",
      "A\n",
      "HCV\n",
      "direkt\n",
      "hepatocarcinogen\n",
      "tulajdons谩ga\n",
      "ismert\n",
      ".O\n",
      "N茅gy\n",
      "HCV\n",
      "-O\n",
      "feh茅rje\n",
      "(O\n",
      "core\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      ",O\n",
      "NS3\n",
      ",O\n",
      "NS4B\n",
      ",O\n",
      "NS5A\n",
      ")O\n",
      "transzform谩ci贸s\n",
      "tulajdons谩ga\n",
      "bizony铆tott\n",
      ".O\n",
      "A\n",
      "hat茅kony\n",
      "antivir谩lis\n",
      "kezel茅s\n",
      ",O\n",
      "a\n",
      "tart贸s\n",
      "v铆rusv谩lasz\n",
      "el茅r茅se\n",
      "a\n",
      "HCV\n",
      "okozta\n",
      "m谩j-\n",
      ",O\n",
      "valamint\n",
      "a\n",
      "nem\n",
      "m谩jeredet疟\n",
      "hal谩loz谩st\n",
      "cs枚kkenti\n",
      ".O\n",
      "Az\n",
      "interferonalap煤\n",
      "antivir谩lis\n",
      "kezel茅s\n",
      "a\n",
      "HCC\n",
      "el艖fordul谩s谩t\n",
      "cs枚kkenti\n",
      ".O\n",
      "A\n",
      "direkt\n",
      "hat贸\n",
      "antivir谩lis\n",
      "szerek\n",
      "(O\n",
      "DAA\n",
      ")O\n",
      "el艖nye\n",
      "a\n",
      "nagyobb\n",
      "ar谩ny煤\n",
      "tart贸s\n",
      "v铆rusv谩lasz\n",
      ",O\n",
      "a\n",
      "kevesebb\n",
      "mell茅khat谩s\n",
      ",O\n",
      "valamint\n",
      "a\n",
      "r枚videbb\n",
      "ter谩pi谩s\n",
      "id艖tartam\n",
      ".O\n",
      "Az\n",
      "elm煤lt\n",
      "n茅h谩ny\n",
      "茅vben\n",
      "k枚zlem茅nyek\n",
      "jelentek\n",
      "meg\n",
      ",O\n",
      "amelyek\n",
      "a\n",
      "DAA\n",
      "-O\n",
      "kezel茅sek\n",
      "nem\n",
      "v谩rt\n",
      "hat谩sair贸l\n",
      "sz谩moltak\n",
      "be\n",
      ".O\n",
      "A\n",
      "szerz艖k\n",
      "ismertetik\n",
      "a\n",
      "DAA\n",
      "-O\n",
      "kezel茅sekben\n",
      "a\n",
      "HCC\n",
      "el艖fordul谩s谩t\n",
      "vizsg谩l贸\n",
      "tanulm谩nyok\n",
      "eredm茅nyeit\n",
      ".O\n",
      "A\n",
      "k茅rd茅s\n",
      "pontos\n",
      "eld枚nt茅s茅re\n",
      "tov谩bbi\n",
      "prospekt铆v\n",
      ",O\n",
      "multicentrikus\n",
      "vizsg谩latok\n",
      ",O\n",
      "hosszabb\n",
      "k枚vet茅si\n",
      "id艖szakok\n",
      ",O\n",
      "a\n",
      "kontrollcsoportok\n",
      "pontos\n",
      "kiv谩laszt谩sa\n",
      "sz眉ks茅ges\n",
      ".O\n",
      "A\n",
      "v铆rusellenes\n",
      "kezel茅s\n",
      "befejez茅se\n",
      "ut谩n\n",
      "is\n",
      "kiemelked艖\n",
      "jelent艖s茅g疟\n",
      "a\n",
      "HCC\n",
      "-O\n",
      "surveillance\n",
      ",O\n",
      "amelyet\n",
      "a\n",
      "rendszeres\n",
      "(O\n",
      "3鈥6鈥12\n",
      "havonta\n",
      "v茅gzett\n",
      ")O\n",
      "hasi\n",
      "UH\n",
      "-O\n",
      "vizsg谩lat\n",
      "jelent\n",
      ",O\n",
      "m茅g\n",
      "a\n",
      "sikeresen\n",
      "kezelt\n",
      "betegekn茅l\n",
      "is\n",
      ".O\n",
      "Orv\n",
      "Hetil\n",
      ".O\n",
      "2019\n",
      ";O\n",
      "160(22\n",
      ")O\n",
      ":O\n",
      "846鈥853.Hepatitis\n",
      "C\n",
      "virus\n",
      "infection\n",
      "causes\n",
      "approximately\n",
      "4\n",
      "million\n",
      "new\n",
      "infections\n",
      "worldwide\n",
      ",O\n",
      "and\n",
      "399聽000\n",
      "deaths\n",
      "due\n",
      "to\n",
      "its\n",
      "complications\n",
      ",O\n",
      "cirrhosis\n",
      "and\n",
      "hepatocellular\n",
      "carcinoma\n",
      "(O\n",
      "HCC\n",
      ")O\n",
      ".O\n",
      "Microenvironmental\n",
      "changes\n",
      ",O\n",
      "chronic\n",
      "inflammation\n",
      ",O\n",
      "oxidative\n",
      "stress\n",
      ",O\n",
      "endoplasmic\n",
      "reticulum\n",
      "stress\n",
      "caused\n",
      "by\n",
      "HCV\n",
      "infection\n",
      ",O\n",
      "via\n",
      "genetic\n",
      "and\n",
      "epigenetic\n",
      "changes\n",
      "can\n",
      "result\n",
      "in\n",
      "primary\n",
      "liver\n",
      "cancer\n",
      "during\n",
      "decades\n",
      ".O\n",
      "The\n",
      "direct\n",
      "oncogenic\n",
      "property\n",
      "of\n",
      "HCV\n",
      "is\n",
      "wellknown\n",
      ".O\n",
      "The\n",
      "transforming\n",
      "effect\n",
      "of\n",
      "four\n",
      "HCV\n",
      "proteins\n",
      "(O\n",
      "core\n",
      ",O\n",
      "NS3\n",
      ",O\n",
      "NS4B\n",
      ",O\n",
      "NS5A\n",
      ")O\n",
      "has\n",
      "been\n",
      "proven\n",
      ".O\n",
      "Effective\n",
      "antiviral\n",
      "therapy\n",
      ",O\n",
      "sustained\n",
      "viral\n",
      "response\n",
      "decreases\n",
      "the\n",
      "HCV\n",
      "-O\n",
      "related\n",
      "general\n",
      "and\n",
      "liver\n",
      "-O\n",
      "related\n",
      "mortality\n",
      ".O\n",
      "Interferon\n",
      "-O\n",
      "based\n",
      "therapy\n",
      "reduces\n",
      "the\n",
      "risk\n",
      "of\n",
      "HCC\n",
      "development\n",
      ".O\n",
      "Shorter\n",
      "therapy\n",
      "with\n",
      "direct\n",
      "acting\n",
      "antiviral\n",
      "agents\n",
      "(O\n",
      "DAA\n",
      ")O\n",
      "has\n",
      "higher\n",
      "efficacy\n",
      ",O\n",
      "fewer\n",
      "side\n",
      "-O\n",
      "effects\n",
      ".O\n",
      "Publications\n",
      "have\n",
      "reported\n",
      "the\n",
      "unexpected\n",
      "effects\n",
      "of\n",
      "DAA\n",
      ".O\n",
      "The\n",
      "authors\n",
      "review\n",
      "the\n",
      "articles\n",
      "focusing\n",
      "on\n",
      "the\n",
      "occurrence\n",
      "of\n",
      "HCC\n",
      "in\n",
      "connection\n",
      "with\n",
      "DAA\n",
      "therapies\n",
      ".O\n",
      "There\n",
      "is\n",
      "a\n",
      "need\n",
      "for\n",
      "prospective\n",
      ",O\n",
      "multicentric\n",
      "studies\n",
      "with\n",
      "longer\n",
      "follow\n",
      "-O\n",
      "up\n",
      "to\n",
      "examine\n",
      "the\n",
      "risk\n",
      "of\n",
      "HCC\n",
      "formation\n",
      ".O\n",
      "After\n",
      "antiviral\n",
      "therapy\n",
      ",O\n",
      "HCC\n",
      "surveillance\n",
      "is\n",
      "of\n",
      "high\n",
      "importance\n",
      "which\n",
      "means\n",
      "abdominal\n",
      "ultrasound\n",
      "every\n",
      "3\n",
      "-O\n",
      "6\n",
      "-O\n",
      "12\n",
      "months\n",
      "in\n",
      "sustained\n",
      "viral\n",
      "response\n",
      "patients\n",
      "as\n",
      "well\n",
      ".O\n",
      "Orv\n",
      "Hetil\n",
      ".O\n",
      "2019\n",
      ";O\n",
      "160(22\n",
      ")O\n",
      ":O\n",
      "846\n",
      "-O\n",
      "853\n",
      ".O\n",
      "\n",
      "\n",
      "\n",
      "Although\n",
      "the\n",
      "anti\n",
      "-O\n",
      "influenza\n",
      "virus\n",
      "drug\n",
      "oseltamivir\n",
      "ameliorates\n",
      "the\n",
      "fever\n",
      "of\n",
      "influenza\n",
      ",O\n",
      "adverse\n",
      "events\n",
      "related\n",
      "to\n",
      "its\n",
      "hypothermic\n",
      "effect\n",
      "have\n",
      "been\n",
      "reported\n",
      ".O\n",
      "We\n",
      "found\n",
      "that\n",
      "oseltamivir\n",
      "causes\n",
      "dose\n",
      "-O\n",
      "dependent\n",
      "hypothermia\n",
      "in\n",
      "normal\n",
      "mice\n",
      ",O\n",
      "and\n",
      "have\n",
      "been\n",
      "studying\n",
      "the\n",
      "pharmacological\n",
      "mechanisms\n",
      "responsible\n",
      "for\n",
      "12\n",
      "years\n",
      ".O\n",
      "Oseltamivir\n",
      "blocks\n",
      "nicotinic\n",
      "cholinergic\n",
      "transmission\n",
      "at\n",
      "sympathetic\n",
      "ganglia\n",
      "and\n",
      "reduces\n",
      "sympathetic\n",
      "modulation\n",
      "of\n",
      "brown\n",
      "adipose\n",
      "tissue\n",
      "(O\n",
      "BAT\n",
      ")O\n",
      ",O\n",
      "a\n",
      "heat\n",
      "generator\n",
      ".O\n",
      "Oseltamivir\n",
      "was\n",
      "found\n",
      "to\n",
      "target\n",
      "the\n",
      "ion\n",
      "channels\n",
      "of\n",
      "nicotinic\n",
      "acetylcholine\n",
      "receptors\n",
      ",O\n",
      "as\n",
      "demonstrated\n",
      "by\n",
      "patch\n",
      "clamp\n",
      "experiments\n",
      "with\n",
      "cells\n",
      "expressing\n",
      "the\n",
      "human\n",
      "伪3尾4\n",
      "nicotinic\n",
      "receptor\n",
      ".O\n",
      "Metabolized\n",
      "oseltamivir\n",
      "carboxylate\n",
      ",O\n",
      "which\n",
      "inhibits\n",
      "the\n",
      "influenza\n",
      "virus\n",
      "neuraminidase\n",
      ",O\n",
      "did\n",
      "not\n",
      "elicit\n",
      "hypothermia\n",
      "and\n",
      "ion\n",
      "channel\n",
      "suppression\n",
      ".O\n",
      "Body\n",
      "temperature\n",
      "was\n",
      "decreased\n",
      "by\n",
      "intracerebroventricular\n",
      "administration\n",
      "of\n",
      "oseltamivir\n",
      ".O\n",
      "Because\n",
      "this\n",
      "hypothermic\n",
      "effect\n",
      "was\n",
      "inhibited\n",
      "by\n",
      "dopamine\n",
      "D2\n",
      "receptor\n",
      "blockade\n",
      ",O\n",
      "it\n",
      "was\n",
      "suggested\n",
      "that\n",
      "oseltamivir\n",
      "centrally\n",
      "stimulates\n",
      "the\n",
      "D2\n",
      "receptor\n",
      ".O\n",
      "In\n",
      "Japan\n",
      ",O\n",
      "the\n",
      "package\n",
      "inserts\n",
      "for\n",
      "oseltamivir\n",
      "and\n",
      "amantadine\n",
      "indicate\n",
      "very\n",
      "similar\n",
      "adverse\n",
      "neuropsychiatric\n",
      "reactions\n",
      "for\n",
      "the\n",
      "two\n",
      "drugs\n",
      "(O\n",
      "abnormal\n",
      "behavior\n",
      ",O\n",
      "consciousness\n",
      "disturbance\n",
      ",O\n",
      "convulsion\n",
      ",O\n",
      "delirium\n",
      ",O\n",
      "delusion\n",
      ",O\n",
      "hallucination\n",
      ")O\n",
      ".O\n",
      "A\n",
      "literature\n",
      "search\n",
      "revealed\n",
      "that\n",
      "in\n",
      "some\n",
      "previous\n",
      "studies\n",
      ",O\n",
      "oseltamivir\n",
      "and\n",
      "amantadine\n",
      "were\n",
      "shown\n",
      "to\n",
      "block\n",
      "the\n",
      "ion\n",
      "channel\n",
      "systems\n",
      "and\n",
      "activate\n",
      "the\n",
      "dopaminergic\n",
      "nervous\n",
      "system\n",
      "via\n",
      "several\n",
      "mechanisms\n",
      ".O\n",
      "Therefore\n",
      "the\n",
      "similarity\n",
      "of\n",
      "the\n",
      "adverse\n",
      "reactions\n",
      "elicited\n",
      "by\n",
      "oseltamivir\n",
      "and\n",
      "amantadine\n",
      "was\n",
      "considered\n",
      "attributable\n",
      "to\n",
      "their\n",
      "similar\n",
      "pharmacological\n",
      "effects\n",
      ".O\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for token in doc:\n",
    "    if(token.is_punct):\n",
    "        print(token.text+\"O\")\n",
    "    else:\n",
    "        print(token.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[':O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " ':O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '&O',\n",
       " ';O',\n",
       " '(O',\n",
       " ':O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " ',O',\n",
       " '(O',\n",
       " '&O',\n",
       " ';O',\n",
       " ')O',\n",
       " '.O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " '%O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " '%O',\n",
       " ',O',\n",
       " ',O',\n",
       " '(O',\n",
       " '&O',\n",
       " ';O',\n",
       " ')O',\n",
       " ';O',\n",
       " ',O',\n",
       " '(O',\n",
       " '&O',\n",
       " ';O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " '/O',\n",
       " '%O',\n",
       " '%O',\n",
       " ',O',\n",
       " ';O',\n",
       " ',O',\n",
       " '(O',\n",
       " '%O',\n",
       " '%O',\n",
       " ',O',\n",
       " '&O',\n",
       " ';O',\n",
       " ')O',\n",
       " ';O',\n",
       " '(O',\n",
       " '&O',\n",
       " ';O',\n",
       " ':O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '(O',\n",
       " '&O',\n",
       " ';O',\n",
       " ')O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '[O',\n",
       " '/O',\n",
       " '[O',\n",
       " '-O',\n",
       " '/O',\n",
       " '[O',\n",
       " '(O',\n",
       " '/O',\n",
       " ']O',\n",
       " '-O',\n",
       " '[O',\n",
       " '(O',\n",
       " '/O',\n",
       " ']O',\n",
       " ',O',\n",
       " '[O',\n",
       " '-O',\n",
       " '[O',\n",
       " '-O',\n",
       " '[O',\n",
       " '-O',\n",
       " '[O',\n",
       " '-O',\n",
       " '[O',\n",
       " '-O',\n",
       " ']O',\n",
       " '-O',\n",
       " '-O',\n",
       " '[O',\n",
       " '-O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '-O',\n",
       " '-O',\n",
       " ':O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " ':O',\n",
       " '(O',\n",
       " ')O',\n",
       " '-O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '-O',\n",
       " '(O',\n",
       " '-O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " ':O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " '.O',\n",
       " ':O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " ':O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " ':O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '/O',\n",
       " '/O',\n",
       " '/O',\n",
       " '(O',\n",
       " ')O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " ':O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ':O',\n",
       " '.O',\n",
       " '/O',\n",
       " '.O',\n",
       " '/O',\n",
       " '.O',\n",
       " ',O',\n",
       " ':O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '/O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " ':O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " '(O',\n",
       " ':O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " ':O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '.O',\n",
       " ':O',\n",
       " '-O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '-O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '-O',\n",
       " ':O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " '(O',\n",
       " ':O',\n",
       " '-O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '-O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " ':O',\n",
       " '-O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '-O',\n",
       " '(O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " ';O',\n",
       " ')O',\n",
       " ':O',\n",
       " ',O',\n",
       " ',O',\n",
       " '(O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " '(O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " '.O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '.O',\n",
       " ',O',\n",
       " '-O',\n",
       " '-O',\n",
       " '.O',\n",
       " '.O',\n",
       " ';O',\n",
       " ')O',\n",
       " ':O',\n",
       " '-O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " '-O',\n",
       " ',O',\n",
       " '.O',\n",
       " '(O',\n",
       " ')O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " ',O',\n",
       " '(O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ',O',\n",
       " ')O',\n",
       " '.O',\n",
       " ',O',\n",
       " '.O',\n",
       " '.O']"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:deeplearning1]",
   "language": "python",
   "name": "conda-env-deeplearning1-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
